University of Mississippi

eGrove
Electronic Theses and Dissertations

Graduate School

1-1-2011

Design and Synthesis of Novel Agrofungicides Based on Naturally
Occurring PBDEs
Robert Alexander Smith
University of Mississippi

Follow this and additional works at: https://egrove.olemiss.edu/etd
Part of the Organic Chemistry Commons

Recommended Citation
Smith, Robert Alexander, "Design and Synthesis of Novel Agrofungicides Based on Naturally Occurring
PBDEs" (2011). Electronic Theses and Dissertations. 1445.
https://egrove.olemiss.edu/etd/1445

This Dissertation is brought to you for free and open access by the Graduate School at eGrove. It has been
accepted for inclusion in Electronic Theses and Dissertations by an authorized administrator of eGrove. For more
information, please contact egrove@olemiss.edu.

DESIGN AND SYNTHESIS OF NOVEL
AGROFUNGICIDES BASED ON NATURALLY OCCURRING PBDEs

A Dissertation
Presented for the
Doctor of Philosophy Degree
The University of Mississippi

Robert Alexander Smith
August 2011

Copyright © 2011 by Robert Alexander Smith
All rights reserved

ABSTRACT

Cyanobacterial symbionts of Indo-Pacific marine sponges, e.g. Dysidea sp., produce
hydroxylated (OH-) polybrominated diphenyl ethers (PDBEs) which likely function as chemical
deterrents owing to their antifungal and antibacterial properties. Limiting the therapeutic
potential and agricultural use of these antimicrobial natural products are the negative
connotations associated with non-hydroxylated anthropogenic PBDEs. Anthropogenic PBDEs
are pervasive global pollutants used as flame retardant additives in many household goods, e.g.
furniture, textiles, and electronics. These molecules have a propensity to bioaccumulate in living
organisms, they easily traverse the trophic food-chains, they are readily passed from mother to
offspring, and many of these compounds are known endocrine disruptors. Bioisosteric
replacements within the OH-PBDE chemical structure represent an attractive synthetic chemistry
approach towards developing novel agrochemicals and potential therapeutics. The objective of
this dissertation was to design, synthesize, and evaluate bioisosteric mimics of the OH-PBDEs in
an attempt to exploit the antimicrobial benefits of the OH-PBDEs while moving away from their
related toxicities and concerns. Several novel classes of compounds were successfully designed
and synthesized, and many of these synthetic analogs proved equipotent to the OH-PBDEs when
screened for inhibitory activity against various fungi and bacteria. The synthetic analogs
described herein additionally elicit alluring insecticidal activities and serve as lead molecules for
future optimizations.

ii

DEDICATION

This work is dedicated to my family,
who has provided me with undying love and support.

iii

LIST OF ABBREVIATIONS AND SYMBOLS

13

Carbon Nuclear Magnetic Resonance

1

Hydrogen Nuclear Magnetic Resonance

C NMR

H NMR

6-OH-BDE-47

6-Hydroxy-2,2',4,4'-tetrabromodiphenyl ether

Ac

Acetyl

ACN

Acetonitrile

AcOH

Acetic acid

ATP

Adenosine triphosphate

BDE

Brominated diphenyl ether

BDE-47

2,2',4,4'-Tetrabromodiphenyl ether

BmT

Bipolaris maydis race T toxin

BOC

t-Butoxycarbonyl

BuLi

Butyllithium

CAA

Carboxylic acid amides

CFU

Colony forming units

cms-T

Texas cytoplasmic male sterility

DDQ

2,3-Dichloro-5,6-dicyano-1,4-benzoquinone

DMAP

N,N-4-Dimethyaminopyridine

DMF

N,N-Dimethylformamide

DMF-DMA

N,N‑Dimethylformamide dimethyl acetal
iv

DMI

Sterol demethylation inhibitor

DMSO

Dimethylsulfoxide

EDG

Electron-donating group

EWG

Electron-withdrawing group

FDA

Food and Drug Administration

FRAC

Fungicide Reistance Action Committee

HPLC

High pressure liquid chromatography

IC50

The concentration that affords 50% inhibition of growth

LRMS

Low resolution mass spectrometry

M&S

Murashige and Skoog basal salt mixture

MBC

Minimum bactericidal concentration

MES

2-N-morpholino ethanesulfonic acid

MFC

Minimum fungicidal concentration

MIC

Minimum inhibitory concentration

Ms

Mesyl

NAFTA

North American Free Trade Agreement

NBS

N-Bromosuccinimde

NT

Not tested

OH-PBDE

Hydroxylated polybrominated diphenyl ether

PBDE

Polybrominated diphenyl ether

PDA

Potato dextrose agar

Ph

Phenyl

PO

Potato dextrose & oatmeal agar

v

PPA

Polyphosphoric acid

ppm

Parts per million

pTSA

para-Tolylsulfonic acid

Py

Pyridine

QoI

Quinone outside inhibitor

RT

Room temperature

SAR

Structure-activity relationship

T3

Triiodothyronine

T4

Thyroxine

TBAF

Tetra-N-butylammonium fluoride

TBS

tert-Butyldimethylsilyl

TFA

Trifluoroacetic acid

THF

Tetrahydrofuran

TLC

Thin layer chromatography

USDA

United States Department of Agriculture

vi

ACKNOWLEDGMENTS

I thank Dr. John M. Rimoldi from the bottom of my heart for his keen guidance, constant
support, and encouragement throughout my graduate studies. His appreciation of students is
worn proudly on his sleeve and showcased daily by the animated enthusiasm of his lectures and
teaching style. I thank Dr. Rimoldi also for expressing quite regularly that we, as his students and
postdocs, work with him and not for him, for this viewpoint forever changed my approach to
research and catalyzed my motivation to provide my highest standard of work.
I thank Dr. Rama Sarma Gadepalli for his superlative mentorship over the years and for
his self-sacrificing time spent helping me to polish my research techniques and skills. He is a
wealth of knowledge and I am extremely thankful to him for sharing his insights with me. For all
the Rimoldi lab mates who I have had the pleasure to work with over the years, words will never
express the thanks I feel for providing me the best graduate school experience in the world. To
Dr. Sarma, Dr. Kirkland, Dr. Anand, Dr. Kim, Dr. Slauson, Dr. Braga, Sarah, Brian, Kimberly,
and Zarana—thank you guys so much!
A huge thank you goes out to my committee members, Dr. Marc Slattery, Dr. John
Williamson, and Dr. Stephen Cutler, for all their input and guidance. Dr. Williamson and Dr.
Cutler had a considerable influence towards my education outside of their committee roles as
they both served as faculty members and educators in the Department of Medicinal Chemistry,
alongside Dr. Mitchell Avery, Dr. Robert Doerksen, Dr. Christopher McCurdy, and Dr. Ronald
Borne—thank you, to all the MedChem Faculty!
vii

A special thanks also to Dr. Slattery for his

years of financial support towards this research project. This dissertation certainly would not
have been possible without Dr. Slattery‘s extraordinary commitment to research.
With regard to the training I received in the USDA‘s plant pathology labs and the early
biological screenings, I thank Dr. David Wedge, Linda Robertson, Ramona Pace, and Xiaoning
Wang. Thank you also to the many people at Syngenta, like Rogerio Duarte, Eileen Watson,
Naomi Pain, Allison Tally, Josie Hugie, Marilia Vecchia, and the many others who have helped
me establish new collaborative ties between Syngenta and The University of Mississippi. This
collaboration played a critical role in progress of this dissertation. And special thanks to the
individuals in the University‘s Division of Technology Management, like Dr. Walt Chambliss,
Dr. Allyson Best, and Dr. Jessica Adkins, for also helping to establish indispensable agreements
with Syngenta. An especially important thank you goes to my very own mother-in-law and
fellow scientist, Celina Ferraz do Valle, for it was she who played the most vital role in
establishing the collaborations with Syngenta.
And where would I be without the support of my beautiful loving wife, Ana? She has
been close by my side through all the ups and downs of learning to become a young researcher
and for that I will never be able to say thank you enough. And to my parents, family, and friends
I owe tremendous thanks to all of them for providing an outstanding support network and
impeccable source of motivation.
Lastly, I owe a deep graditude for the financial support provided by the National Science
Foundation‘s IGERT program and the Ocean Biotechnology Center & Repository program at
NOAA‘s National Institute for Undersea Science and Technology (NIUST).

viii

PREFACE

With support from the National Institute of Undersea Science and Technology (NIUST),
this dissertation was built around their aim to help bring to market new products derived from
marine ecosystems. Specifically, we sought to design and develop novel agrochemicals, inspired
by marine natural products, to help protect food crops and allow farmers to continue gaining
optimal food production from existing farmland. The marine natural product of our interest is a
potent antimicrobial agent but has many negative connotations associated with its chemical
structure.
It may be important to note at this time that the terms ―fungicide‖ and ―fungicidal‖ have
been used throughout this manuscript, for conciseness, to refer to any agent or chemical that kills
fungi, or slows its growth and reproduction. In this context, the terms are meant to include
fungistats (agents that inhibit the growth of fungi) and fungicides (agents that kill fungi). While it
is important to note the distinctions between fungicide and fungistat, the compounds described
herein have yet to be designated as true fungicides or fungistats and have therefore been
described broadly herein as fungicides.
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I. INTRODUCTION

Within the modern era of agriculture, agriculturalists stand atop many centuries worth of
innovative ideas that have helped shaped the way crops are cultivated. From the gargantuan
aqueducts, to the most miniscule of molecules used as pesticides, farmers call upon a wide array
of tools to help protect the crops which they cultivate. Billions upon billions of dollars have been
invested to protect crops so that agriculturalists can continue to supply the more than 6 billion
people in the world with food, clothing, and other unimaginable ‗naturally based‘ products.
Unfortunately, with today‘s conveniences, many people in industrialized societies have become
blasé to the ever present threat of crop disease epidemics, such as the late blight scourge that
caused the 1845 European potato famine,1 the black stem rust epidemic of 1935 that killed more
than 50% of the wheat crop in Minnesota and the Dakotas,2 and more recently the southern corn
leaf blight epidemic of 1970 that destroyed 15% of the U.S. corn crop worth US$1 billion.3
Consider the fact that people don‘t just consume crops for food and nutrition. Soybeans,
for instance, are used in the manufacture of worldwide plastics and linoleums. Cotton is used for
clothing and commercial cooking oils. Turf grasses supply ground cover for sporting arenas and
golf courses. As well, livestock also depend on reproducible yields of nutritional crops.
Fungicides help to protect all of these resources.
Agriculturally, most major societies are at the forefront of innovation. Farmers utilize
massive spray-booms capable of covering more acreage than ever thought possible. They use
aerial techniques and equipment to make spray applications faster and more efficient. As well,
1

farmers exploit mammoth irrigation systems to protect their crops from drought. But why, if at
the top of innovative ideas, do farmers still witness strawberries that rot on the vine mid-season?
Why do harvested fruits still rot upon storage? Why are vast quantities of fruits, vegetables, and
other crops, still being decimated by microscopic organisms? Crop disease epidemics, like those
of recent past, continue to be genuine threats that must actively be guarded against.
Because of recent globalization, scourges in particular parts of the world no longer affect
just one region. Walk into nearly any major U.S. grocery store and there, one will likely find
watermelons and cantaloupes from Guatemala, plums and peaches from Chile, papayas from
Belize, coconuts from the Dominican Republic, tomatoes and bell peppers from Canada, limes
and pecans from Mexico, pineapples and mangos from as far away as Thailand, along with
beans, onions, apples, lettuces, potatoes, and corn grown right here in the U.S. Without chemical
fungicides, global farmers would fail to provide enough food and resources for everyone. It is
sometimes easy to forget that adequate nutrition and clean water are often more essential to
human health than developing groundbreaking pharmaceuticals. Human diseases, such as
diabetes and coronary disease, would be a thing of the past should the world succumb to famine
first.
There are an estimated 20,000 fungal phytopathogens in the world3 and only about 150
marketable fungicides used to control all of them. As regulations change, so do the available
fungicides. Organomercurials, for example, were introduced onto the market around the 1920s;
but after more knowledge was gathered about the toxicity of mercury these compounds were
later phased out of use. Triphenyltins, first introduced around the 1960s, also suffered a similar
fate. On the other hand, fungal pathogens have their own defenses against chemical fungicides,
often developing the ability to survive exposure to many fungicides. Benzimidazoles, 2-amino-
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pyrimidines, phenylamides, quinone outside inhibitors, and melanin biosynthesis inhibitors have
all grappled with such resistance problems. As societies endure a relentless vulnerability to
losing their agricultural fungicides, there exists an ever present necessity to continuously develop
more. This research is meant to explore novel fungicides through the use of synthetic chemistry.

1.1. BACKGROUND TO PURSUEING
6-OH-BDE-47 AS A NOVEL FUNGICIDE
6-OH-BDE-47 is a marine natural product originally identified in the early 1980s4,

5

(Figure 1) from the marine sponge Dysidea herbacea and later determined to be a secondary
metabolite biosynthesized by the cyanobacterial symbiont of the sponge.6 Similar hydroxylated
(OH-) polybrominated diphenyl ethers (PBDEs) were soon isolated from other marine species7
and placed under scrutiny as to what role they played in biological systems. Presently, the
molecules are known to inhibit several species of fungi, bacteria, and some cancer cell lines,8, 9
though their exact role in biological systems is still not well understood.
Sharing a striking chemical resemblance to 6-OH-BDE-47, is a pervasive global pollutant
denoted BDE-47 (Figure 1). Because 6-OH-BDE-47 possesses potent antifungal activity
amongst a variety of phytopathogenic fungi, but negative associations with BDE-47, it was
hypothesized that bioisosteric replacements within the molecule
could potentially provide a more environmentally friendly fungicide.
Without chemical alteration, the opportunity to exploit the benefits
of 6-OH-BDE-47 would be hopeless.
Before starting the

synthesis

of any 6-OH-BDE-47

bioisosteres, it was highly noted that anthropogenic PBDEs, e.g.
BDE-47, are considered hazardous molecules because of their

3

Figure 1.

widespread use and their unknown toxicological impact on the environment. Several studies
have recently publicized that PBDEs may have toxicological effects on many mammalian
systems, predominately as endocrine disruptors that can perturb early neurodevelopment.10-13
These studies were primarily initiated because of the structural similarities known to exist
between PBDEs and endogenous thyroid hormones, e.g. triiodothyronine (T3) and thyroxine
(T4; Figure 2).

Figure 2. Side-by-side structural comparison of mammalian
hormones, T3 and T4, and anthropogenic pollutant, BDE-47.

Though hazardous, PBDEs have long been known for their flame retardant capabilities14,
15

and have been used since the 1970s as additives to many polymer containing products, e.g.

plastics, textiles, and electronics. No longer just associated with industrial scale activities,
PBDEs are now present in most home and office furnishings. These molecules have a propensity
to bioaccumulate in living organisms and can even be passed from mother to offspring through
breast milk,16, 17 as well as possibly getting passed through the placenta during intrauterine life.
PBDE pollutants are so prevalent that they have been detected in appreciable amounts within
both the Arctic and Antarctic,14, 18-21 and as close to home as to be present in common indoor
dust.22, 23 In fact, humans in many industrialized nations have alarming amounts of quantifiable
PBDEs within their tissues.24-26

4

Aside from the humanitarian reasons to provide agriculturalists with effective,
environmentally friendly fungicides, there is also a substantial financial benefit to help motivate
the development of such agricultural tools. DuPont for example, revenued more than US$580
million in 2009 from the sale of its agrofungicides alone. Figure 3 compares the annual net
fungicide sales of a few of the industry leaders. And to better illustrate the potential for profit,
consider that if a fungicide resulting from this research were able to capture only 5% of DuPont‘s
fungicide market the resulting revenue would be on the order of US$29 million—a substantial
amount for any fledgling startup company or university. Of course, DuPont represents only one
company within the market, implying that there is a much larger margin of revenue to be gained.
Compare DuPont to other fungicide producers, as illustrated in Figure 3, and see that DuPont‘s
share of the market is only a diminutive percentage of the whole market. In point of fact,
DuPont‘s agricultural sector only boasts about 5% of the global fungicide market.

Figure 3. Annual net fungicide sales of leading chemical companiess.

5

The total global market value for conventional agrofungicides is currently around US$10
billion per year,27, 28 with most fungicide sales occurring in Europe (Figure 4, p. 7). Considering
the more country-specific markets, Brazil is the single largest agrofungicide consumer in the
world (Figure 5, p. 7),28 with a growing market valued at US$1.46 billion. France, Japan, the
U.S., and Germany follow Brazil as major agrofungicide consumers. The global agrofungicide
market is huge, and with the correct compound in hand, entry barriers into the market could be
more easily overcome than if the compound of interest were going onto the human drug market.
Atop the opportunity to bring novel fungicides to the agricultural markets, there also
exists significant potential to create compounds that could traverse into the pharmaceutical
markets or, at least, stand as exceptional leads for drug development.29 Aside from the obvious
links between treating crop fungal diseases and human fungal diseases, it should be noted that
because many fungicides target microtubule formation or kinase activity, it is reasonable to
consider that some examples may well prove valuable for such things as anticancer drugs. In
fact, epothilones,30 triazolopyrimidines,31 fluconazole,32 and fenpropidine33 originated as
agrofungicides and subsequently found pharmaceutical applications, namely as anticancer and
antimycotic agents. With regard back to 6-OH-BDE-47, it and several other OH-PBDEs have
also already shown promising anticancer8, 34 and antibacterial9 activities. The significance of this
innately alludes to the possibilty that antifungal mimics of 6-OH-BDE-47 may also possess
anticancer or antibacterial activity. Without further assertion, 6-OH-BDE-47 is an exceptional
choice to be used as a lead molecule in the design of novel fungicides.

6

Figure 4. Regional fungicide markets with respective market values . aTotal market value in
2009 was US$9,726 million. bNorth American Free Trade Agreement (NAFTA)—includes
United States, Canada, & Mexico. Source: Phillips McDougall AgriService.

Figure 5. Top 10 fungicide markets in 2009 with respective values. Total world market in 2009
was valued at US$9,726 million. Source: Phillips McDougall AgriService.
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1.2. THE IDEAS BEHIND MAKING
6-OH-BDE-47 MIMICS A REALITY
Bioisosteric replacement is an improvement tactic that the pharmaceutical industry has
embraced for years and, now, with merging chemistries being the largest commonality, the
agrochemical industry has come to embrace the same tactics when trying to optimize their
chemical pesticides. Essentially, the concept of bioisosteric replacement involves replacing
chemical functional groups with equivalent groups of atoms in hopes of mimicking the original
physicochemical properties of the parent molecule while improving ‗drugability‘. Perhaps the
best example of classical bioisosteric replacement is the substitution of an –H atom for an –F
atom, as Zhang et al.35 have elegantly showcased in their pursuit of better benzodiazepine
receptor ligands (Table 1). Following this same line of thinking, industry has unintentionally
provided a classical bioisostere of 6-OH-BDE-47 commercially known as triclosan (Figure 6).

Table 1.35 In vitro IC50 values of new ligands at the benzodiazepine
receptor

compound
1a
1b
2a
2b

X
H
F
H
F

IC50 (nM)
1000
260
1000
55

Figure 6. Structural comparison of 6-OH-BDE-47 and
its synthetic bioisostere, triclosan.
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Triclosan is a relatively small molecule that was introduced 40 years ago and is currently
used as a safe antibacterial in many worldwide soaps, deodorants, shampoos, and toothpastes.36
Antibacterial cleaning items on the market today typically contain concentrations of triclosan
ranging from 0.1 to 1%. In addition to cleaning products, triclosan is also infused into many toys,
kitchen utensils, athletic clothing, furniture, etc. The U.S. Food and Drug Administration (FDA)
continues to stand behind the assertions that triclosan is not known to be hazardous to humans,
though because of recent animal studies37-44 triclosan is currently under closer review by the
FDA. Their findings won‘t be released to the public until winter 2012.45
Particularly fascinating to this research, triclosan is also antifungal, though anecdotal
evidence shows that triclosan is not nearly as potent a fungicide as 6-OH-BDE-47. Because of
this suppressed activity, along with the controversial use of triclosan and the flame retardant
PBDEs, bioisosteric replacements within 6-OH-BDE-47 were predominately focused around its
phenolic and ethereal moieties in order to completely alter the skeletal characteristics of the
molecules. Considering the phenol isosteric options, the monovalent amino-hydroxy interchange
has often successfully been employed (as in Table 2),46 as both of these two functionalities can
typically act as hydrogen bond donors or acceptors. Alternatively, Figure 7 lists a variety of
nonclassical phenolic bioisosteres that occur in the literature47-52 and which were also considered

Table 2.46 Benzodiazepine Receptor Binding Activity
of Substituted 6-(Dimethylamino)-9-benzyl-9H-purines

compound
3a
3b

R
NH2
OH
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IC50 (µM)
0.9
1.2

for the replacement. Monovalent isosteres involving fluoro-, chloro-, bromo-, and
trifluoromethyl-interchanges at the –OH position were grossly ignored in this study since
unpublished evidence produced within this lab suggested that the donatable –H atom within the
molecule was absolutely necessary for biological activity. This conclusion was drawn by making
synthetic alkylations and acylations at the phenolic –OH position of 6-OH-BDE-47 then
subsequently testing for biological activity.

Figure 7. Examples of phenol bioisosteres.

Ultimately, indole was chosen as the ideal bioisostere to initially substitute the phenolic
moiety of 6-OH-BDE-47 because it allowed intriguing questions to be answered about rigidity,
acidity, hydrogen bond donation/acceptation, lipophilicity, and spatial constraints while at the
same time allowing the ether moiety to be replaced with a more stable carbon linker. Indoles are
also readily available through facile synthesis.
The overall intention was to synthesize small libraries of compounds with seemingly
small changes to various functional groups so that a complete understanding of the molecular
structure-activity relationship (SAR) could be concluded—that is, this research was anticipated
to reveal more than just SAR data regarding the phenolic and ethereal moieties. To concentrate
and build upon success, a deliberate effort was made to submit small batches of compounds to

10

the biological assay, as this strategy allowed subsequent batches of compounds to be built around
the quintessential components that gave biological activity to previous compounds. Thus, the
assay was used to drive the decision making process of subsequent syntheses. This approach
proved flexibly important since it meant not having to adhere strictly to indole-phenol
interchanges. In fact, indazoles, 2-carboxyindoles, and oxindoles were later chosen to help probe
deeper questions, like the importance of pKa values.

1.3. SPECIAL CONSIDERATIONS
Personal communications with other scientists studying OH-PBDEs suggested that their
fungicidal activity was almost certainly due the acidic nature of the phenol (Dale Nagle, personal
communication, fall 2008). Further hypotheses ensued that OH-PBDEs likely elicited their
activity by either inhibiting succinate dehydrogenase of the mitochondrial electron transport
chain or by uncoupling oxidative phosphorylation, thus shutting down adenosine triphosphate
(ATP) production and halting cellular respiration. As of the writing of this dissertation, only a
modest amount of experimental data supporting these claims has been published.53 Regardless,
when designing experiments for this research, special merit was given to the legitimacy that
OH-PBDEs could possibly target these aspects of cellular respiration and that their lowered pKas
could be vital to their fungicidal activity.
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Figure 8. Equilibriums observed at physiological pHs. Indole exists
predominately in the non-ionized form at these pHs.

Figure 9. pKa lowering effects of EWGs on phenol.

Phenol and indole are inherently different when considering their respective acidities.
Phenol, for example, is a rather weak acid which can moderately ionize into its enolate form at
physiological pHs. Indole, on the other hand, is quite neutral, existing predominately in the nonionized form at physiological pHs (Figure 8). However, electron-withdrawing groups (EWGs)
considerably stabilize the conjugate bases and thus increase the strength of each acid. This has a
significant effect as Figure 9 clearly illustrates with picric acid and similar phenol derivatives.
Because of the four bromine atoms on 6-OH-BDE-47, its pKa is more than three log units
lower than that of phenol, making its acidic characteristics closer to that of carboxylic acids than
of phenols. In pursuing indole-phenol interchanges while attempting to match the exact bromo
substitution pattern of 6-OH-BDE-47, the lowest pKa expected of the indole moiety would be ca.
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12, based on in silico predictions (Figure 10). This is inevitably due to the electrostatic
differences between nitrogen and oxygen—oxygen being far more capable of holding the
negative charge. In addition, the peculiarities of how each ring system delocalizes and, thus,
stabilizes the negative charge of the conjugate base is also of importance to predicting pKas,
though perhaps to a lesser degree than the obvious electrostatic differences in this case. These
disparities culminate in a limited pKa range achievable by the indole-phenol interchange and,
consequently, drove the decision to also incorporate other phenolic bioisosteres into this study.
Again, in trying to maintain the assertion that questions should be answered about rigidity and
ether replacement, the original indole proposal was amended to incorporate additional electronwithdrawing elements into analogous structures, as exemplified in Figure 10.

Figure 10. pKa limitations of various indole derivatives become apparent
when trying to match exactly the bromo substitution pattern on 6-OH-BDE47.

Noting that the newly proposed indole derivatives, like those in Figure 10, were lower
than the desired pKa range, further concerns were largely disregarded at this point because of the
recollection that the chemical structure of triclosan only partially complements the substitution
pattern of 6-OH-BDE-47, nor does it contain bromine, yet it retains antifungal activity. Also
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influencing this disregard was the predication that if dealing with an inhibitor of succinate
dehydrogenase or an uncoupler of oxidative phosphorylation, approaches could be taken to
incorporate similar functionalities as those that exist in currently used fungicides which inhibit
these targets. Figure 11 illustrates a number commercially important agrofungicides that fall into
these pharmacological classes.

Figure 11. A selection of modern, commercially important agrofungicides. Inhibitors of
succinate dehydrogenase are colored blue, uncouplers of oxidative phosphorylation are
red.

In the extreme case that all four bromine atoms within indole 4 were replaced with the
tenaciously electron-withdrawing nitro group, the pKa of the resulting indole would actually be
lower than that of 6-OH-BDE-47. Other proposed indole derivatives would in fact be even more
acidic, as pointed out in Figure 12. In the case of a compound like oxindole 11, notable attention
must be paid to the detail that this is an amide and will thus behave differently than the indoles.
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In addition, compound 11 also lacks the additional aromaticity needed for the most distant
EWGs to ‗reach‘ the nitrogen, hence its relatively higher pKa of 8.9. Though extreme, this simple
exercise yields ample evidence that indole-phenol interchanges can be employed with strategic
placement of suitable EWGs to effectively control pKas.

Figure 12. Nitro groups are used here to demonstrate that functionalities
which are more electron-withdrawing than bromine can be used to further
lower pKas.

In addition to the preparations mentioned thus far, care also had to be taken to ensure that
this research was not inadvertently going to repeat something that had already been done, thus
reinventing the wheel, so to speak. Consequently, Chapter 2 is meant as a means of addressing
this care by providing a brief history and literature review of agrochemical fungicides. Now,
having gathered an introductory understanding of the planning process that stood behind this
research, along with an appreciation of the goals it sought to achieve, note that further discussion
detailing precisely how the milestones and objectives of this project were to be met will be
postponed until later chapters.
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II. A HISTORY OF
AGRICULTURAL FUNGICIDES

It is reasonable to assume that people have been struggling with fungal plant pathogens
since humans first began cultivating crops in the Neolithic Era. And though it wasn‘t until about
the most recent 200 years that fungicide development began growing into a science, humans
have been trying in vain to resolve crop losses for thousands of years. Initially, people once
thought that fungal crop diseases were the result of poor growing conditions and not a causative
feature. For this reason, remedies over the ages have ranged from ritualistic prayers and
sacraments to treating plants with ashes of cow dung and nurturing with milk and honey.54 The
idea of using inorganic sulfur as an antifungal to treat crop diseases didn‘t come about until the
Late Bronze Age, as evidenced by the ancient Greek poet, Homer, having made reference to
using ‗pest-averting sulfur‘ in the 8th century B.C.3, 55 Over a slow progression of time, people
eventually began to realize that fungi were causing their crop losses, rather than simply being the
effect of inadequate conditions. With this apparentness followed a demand to collect and classify
the culpable organisms in a meticulous scientific manner. And from this organized effort grew a
healthier understanding of plant disease epidemiology.
By about the mid-18th century people were observing that copper sulfate could control
bunt on wheat (Tilletia caries),56 though their explanations were mostly speculative. In addition,
others, like Mathieu Tillet (1755), had begun to show that chemicals such as saltpeter, lime, and
brine solutions could partially prevent plant disease. In 1807, after observing that seed wheat
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steeped in verdigris copper vessels produced bunt-free fields, Bénédict Prévost, through further
experimentation, published the first scientific evidence that copper sulfate was indeed
antifungal.57 His research, in effect, also conclusively proved that bunt disease on wheat was
caused by a fungus and, thus, helped to pioneer germ theory. Controversial at the time, many
people rejected Prévost‘s research and held firm to their beliefs in ‗spontaneous generation‘, the
theory that regarded fungi as symptomatic aspects of disease. In agreement with Prévost‘s
observations, John Robertson (1824) accurately interpreted the causative role of fungi and
successfully demonstrated, by scientific method, that sulfur was able to remedy powdery mildew
on peaches.58 Unfortunately, the work by both scientists went unrecognized and in 1845 potato
late blight disease descended upon Ireland. Caused by Phytophthora infestans, several successive
epidemics of the late blight went uncontrolled and caused Ireland to lose more than 20% of its
population: one million to starvation and another 1.5 million emigrated out of the country.3
In the years following the Irish potato famine, scientific research began to hit its stride.
Improved microscopes were beginning to help unearth the mysterious nature of living cells,
Charles Darwin was preparing to release his breakthrough manuscript on the origin of species,
and individuals, like Anton de Bary and Louis Pasteur, were closely studying microbial life
cycles while taking careful notes of their cellular peculiarities. And so it wasn‘t until the latter
half of the 19th century that contemporary thinking began to adapt and the concepts of
spontaneous generation were slowly abandoned. By the 1860s, it was becoming a generally
accepted recommendation to use copper sulfate or sulfur to protect crops, though with some
consequence of phytotoxicity to the plant. As a result, people were adding lime to curb the
problem. While in the Bordeaux region of France, Pierre Millardet (1882) noticed that farmers
had been treating their roadside vineyards with solutions of copper sulfate and lime, not to ward
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off disease but rather to discourage would-be thieves from stealing the grapes. He also noted that
the vines closest to the roadways showed no signs of downy mildew (Plasmopara viticola), a
disease which was poorly managed by the lime sulfur mixtures of the day. Although not the first
to recommend lime and copper sulfate, it was Millardet who best perfected the mixture and
brought about what is now known as Bordeaux mixture (1885), the world‘s first commercial
fungicide and still popular today.59, 60 Though effective, it would be several more decades before
organic chemists involved themselves with fungicides.

2.1. EARLY 20TH CENTURY: A TIME OF
SUCCESS WITH UNFORTUNATE CONSEQUENCES
Fungicide development at the turn of the 20th century was marked by a gross neglect for
safety concerns—both for the environment and for the operators involved with applying the
chemical treatments. The inorganic compounds of the time were proving sporadically ineffective
and sometimes phytotoxic. In addition, the inorganics had to be applied frequently and in
enormous quantities. Within only a few years of Millardet‘s Bordeaux mixture, other more novel
fungicides began emerging. Unfortunately, most were quite toxic.
In 1912, German chemists, having knowledge that mercuric chloride was proving itself
effective in other parts of the world, began dabbling in the research of organomercurials. 61
Finding them to be highly effective, 1912 proved to be too early for the organomercurials, as
most of the compounds were far too expensive for scale-up. However, after the initial discovery
of their potential value, these compounds were further developed and by the 1940s a number of
organomercurials were made cheaply available (Figure 13).
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Figure 13. Organomercurials used as fungicides during the early 20 th century.

Aside from the obvious concerns that people today would have with mercury compounds,
it‘s noteworthy to recognize that the provisions of pre-formulated, premixed ingredients were
virtually nonexistent at the time. During the early 20th century, only a very miniscule amount of
fungicides were being sold as ‗ready mix‘ formulations (Bordeaux mixture was one of the few).
As a direct consequence, much of the hired labor used to chemically treat seed stocks and crops
fell sick. Often, symptoms of the afflicted ranged from headaches and fatigue to spastic muscle
movements and deteriorated mental capacity, and as well, death also frequently occurred.
Additionally, impoverished farming families would sometimes consume bread made from
mercury-treated wheat seed intended for planting,62,

63

and poisonings were also noted from

having eaten grain-fed livestock raised on mercury-treated seed.64 Regrettably, stricter
regulations didn‘t arise until much later and many countries allowed the use of organomercurials
well into the 1970s.

2.2. THE MID-20TH CENTURY:
THE RISE OF ORGANIC FUNGICIDES
At long last, the 1930s and 1940s saw the first true success stories begin to emerge.
Nonconformists, like James Horsfall, were advocating that Bordeaux mixture, because it was
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deleterious on tomatoes and potatoes, was like a dead horse that just hadn‘t fallen over.65
Devotees of the inorganics were perturbed by assertions like this and lashed out by claiming that
farmers would never pay the higher prices for organic fungicides when they could buy Bordeaux
for 5-10% cost, what amounted to only a few cents per pound. Eager to prove the aficionados
wrong, supporters of the organic fungicide movement forged ahead. Basing assumptions off the
tenet that copper induced oxidative stress, Horsfall et al. established that the organic pro-oxidant,
tetrachloroquinone (chloranil), was similarly fungicidal, and by 1940, New York farmers were
ecstatic to pay $1.50 per pound.65, 66 Detrimental to the overall success of chloranil was the fact
that it suffered a facile hydrolysis in the sun and the dew. Soon thereafter, 2,3-dichloro-1,4naphthoquinone was introduced as the successor to chloranil. Dichlone, as it was later christened,
displayed resistance to decomposing on the leaf and was warranted commercial use as a foliar
spray, yet it was still not conducive to protecting all crops, particularly not potatoes.
In 1934, a few years prior to the introduction of chloranil and dichlone, Wendell Tisdale
and Ira Williams, both assignors to Du Pont, patented the first organosulfur compounds to be
used as fungicides,67 a class known as the dithiocarbamates. These compounds were originally
used by the rubber industry for their vulcanization processes, processes used for crosslinking the
rubber. As with nearly all fungicides produced up until this point, the dithiocarbamates elicited
fungicidal behavior via multi-site inhibition. Setting them apart was the unique difference that
they were not general biocides, for this meant they were more selective for fungi and less toxic to
the plants they were intended to protect. In turn, they were also safer for the operators applying
them. After their original patent date in 1934, the dithiocarbamate fungicides were slow to take
off and the premier compound from this class, thiram, wouldn‘t hit commercialization until
about seven years later, about the same time that the chloroquinones were beginning to take off.
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Like chloranil, thiram performed poorly in foliage applications and so was best used as a
seed treatment. Still agitated that conventional wisdom still felt Bordeaux mixture was best, and
driven to prove that superior fungicides for potato crops could exist, Horsfall, in collaboration
with Rohm and Haas Company, developed several dithiocarbamates from ethylenediamine, and
in 1943 disodium ethylenebisdithiocarbamate (nabam) was introduced.68 Within the same year as
the publication release of nabam, John Heuberger, then working with Horsfall, formulated
nabam into a zinc version of Bordeaux mixture (lime + zinc sulfate), which was meant to serve a
two-fold purpose: (1) to stabilize nabam from degradation and (2) to provide for a more adhesive
foliar spray.69 Later learned from these experiments was that once exposed to air the combination
of chemicals converted nabam into its zinc salt, zineb.70 As a result, the response was to directly
apply the zinc salt of the ethylenebisdithiocarbamate. By using zineb, farmers could now avoid
dwarfing crops like potatoes while getting exceptional pest protection on their fields. By the mid1940s, dithiocarbamates had effectively become the most important fungicides of the time and
Bordeaux mixture was finally retired. This occurred not because the new fungicides controlled
disease better, but because they harmed the crops less. Throughout the mid-20th century,
chemists continued to expand on the dithiocarbamates, experimenting often with other heavy
metal combinations (Figure 14). Most were highly successful and many are still used today.

Figure 14. Dithiocarbamates and related fungicides.
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With the emergence of the organic fungicide era, many companies began to take serious
interest in fungicide chemistry. A revolution of sorts was beginning to take shape. Prior to the
mid-20th century, there was virtually no chemical crop protection industry to speak of, but after
the induction of the dithiocarbamates competition had grown common. Having never been an
industry prior to this, most agrochemicals at this time were being developed by already
established chemical or oil companies, e.g., Du Pont, U.S. Rubber, Standard Oil, Merck and Co.,
etc. More than ever before, scientific efforts world-wide were being put into understanding
exactly how fungicides worked. Mechanistic studies were beginning to get underway and
considerable amounts of man-hours were being spent gathering knowledge of both plant and
fungal physiology. Insightful biological information was being amassed by both companies and
academics alike. On the heels of success following the dithiocarbamates, the phthalimides
equally impacted the market for the better. These classes of compounds, together, represented a
drastic improvement over the previously used inorganics and organomercurials. Not only were
these compounds popular and effective then, these classes have grown into some of the most
important fungicides in today‘s world.
Post-World War II conditions allowed for substantial growths to be made within the
industry. Environmental concerns were still largely nonexistent and ‗acquired‘ fungicidal
resistance was still unheard of, and so the repertoire of chemical fungicides grew unbounded
from restrictions. Table 3 bares a relatively small amount of the chemical diversity introduced
between 1940 and 1970.54
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Table 3.54 Key classes of fungicides introduced 1940-1970

Chemical Class
Dithiocarbamate

Fungicide and Year of Introduction
thiram (1942), zineb (1943), nabam
(1943), maneb (1955), mancozeb (1961),
propineb (1963)

Mechanism of Action
multi-site contact
activity

Aromatic Hydrocarbon biphenyl (1944), dicloran (1960)

lipid and membrane
synthesis

Phthalimide

captan (1952), folpet (1952), captafol
(1962)

multi-site contact
activity

Antibiotic

blasticidin S (1955), kasugamycin (1965),
polyoxins (1965)

protein synthesis;
glucan synthesis

Triazine

anilazine (1955)

multi-site contact
activity

Guanidine

dodine (1957), guazatine (1968)

unknown; multi-site
contact activity

Benzimidazole

thiabendazole (1964), benomyl (1968)

β-tubulin assembly

Sulfamide

dichlofluanid (1964), tolyfluanid (1967)

multi-site contact
activity

Phthalonitrile

chlorothalonil (1964)

multi-site contact
activity

Organophosphorous

pyrazophos (1965), ditalimfos (1965)

phospholipid
biosynthesis

Morpholine

dodemorph (1965), tridemorph (1969)

sterol biosynthesis

Carboxanilide

carboxin (1966), oxycarboxin (1966)

respiration

2-Aminopyrimidine

dimethirimol (1969), ethirimol (1969)

nucleic acid synthesis

Prior to the 1960s, relatively little was known about fungicidal resistance. Penicillin
resistance was known, as it had just begun to emerge ca. 1947, but similar problems had yet to
occur in the fields of farmers. Most of the previous agricultural fungicides were multi-site
inhibitors and, thus, resistance wasn‘t much of an issue. As plant and fungal physiology revealed
more secrets, the fungicides used to protect the crops became much more focused in what they
targeted. What followed was that fungi, being the exceptionally adaptable organisms that they
are, could then make facile mutations and survive prolonged exposure to the fungicide. Because
it was not well understood at the time, when resistance began to transpire in fungal pathogens the
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human response was usually to apply more fungicide or to make applications more frequently.
This significantly perpetuated the problem.
Natural fungicide resistance was fairly well documented so farmers knew that if a
particular fungicide didn‘t work initially, they could always apply a different fungicide and all
would be solved. This ‗pre-existing‘ resistance was, and continues to be, quite common
(sometimes called ‗inherent resistance‘). Often though, the reason for this type of resistance is
seldom investigated as the more trivial, cost-effective solution is simply to try something else
that might work. When a fungicide is able to kill a specific strain of fungi, that particular
organism is said to be ‗sensitive‘ to that fungicide. What was being witnessed in the 1950s and
60s was that numerous fungal strains were slowly losing their sensitivity to tried and true
fungicides. Sadly, the overuse and mismanagement of chemical applications often led to the
complete failure of disease control.
Also, new to the time period was the appearance of ‗cross-resistance‘. Once able to
aimlessly substitute one fungicide for another, farmers were now seeing entire classes of
fungicides lose their effectiveness. For example, if an individual accustomed to using imazalil
(an imidazole fungicide) to protect orchard crops started observing diminished efficacy, that
individual might‘ve changed to using prochloraz (also an imidazole fungicide) but to no avail
because both fungicides are in the imidazole class and, thus, are effected by the same resistance
mechanism. What‘s worse is that a farmer might‘ve tried changing from an imidazole fungicide
to a fungicide in the pyrimidine class, but also to no avail because both imidazoles and
pyrimidines are inhibitors of C14-demethylase in the sterol biosynthesis pathway. Crossresistance like this is generally found among any two or more compounds that elicit obvious
chemical similarities or identical modes of action. Therefore, when a dimethylation inhibitor
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(DMI) fungicide, like imazalil, surrendered to resistance from a fungal species, it was generally
clever to concede that that organism was now resistant to all DMIs. The same situation was
especially true for the benzimidazoles, dicarboximides, phenylamides, quinone outside inhibitors
(QoIs), and carboxylic acid amides (CAA).71
Acquired resistance was becoming a threatening matter by the close of the mid-20th
century. Several scourges had already decimated various regions and now it seemed like all the
progress made in recent decades was being erased by these epidemics.3 Successive generations
of chemists and plant pathologists would soon find themselves fighting a new battlefront.

2.3. THE CLOSE OF THE 20TH CENTURY:
PATHOGENS FIGHT BACK AND WAR IS DECLARED
The 1970s opened with the southern corn leaf blight epidemic emerging in the southeast
U.S. and quickly sweeping northward across the great American corn belt. Since the first half of
the 20th century, the field of genetics had been developing disruptive technologies that were fast
becoming competitive with the chemical pesticides of the day. Selective breeding programs
allowed seed companies to supply the world with ample access to a variety of hybrid seeds that
were capable of producing plants with greater crop yields, insect resistance, herbicide resistance,
etc. Unlike the Irish potato famine of the 1840s, the southern corn leaf blight epidemic was a
direct result of humans manipulating plant genetics without full knowledge of the potential
consequences.

2.3.1. The Fungicide Industry Becomes Permanent
In the late 19th and early 20th centuries, corn was being selectively bred by planting
alternating rows of two different corn varieties then manually removing the pollen-producing
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tassel of the female parent. This emasculation process (called detasseling) was done as a form of
pollination control to insure that the female parent didn‘t self-pollinate, thus, only allowing the
desired cross-breed to result. Expensive, manual detasseling was commonplace for seed
producers until the 1950s, when it was learned that backcrossing techniques allowed for stable
hybrids to be made which where inherently male-sterile. The cytoplasmic genetics that gave rise
to these male-sterile plants fostered faster and more profitable production of hybrid seeds for the
next 20 years, as manual labor and machines were no longer needed for detasseling. These
varieties of corn that harbored the genetics for male-sterility were designated Texas cytoplasmic
male sterility (T cytoplasm or cms-T) maize due to the discovery of the cytoplasmic genetics
having been made in Texas.
By 1970, it was estimated that 85% of all corn planted within the U.S. was of the cms-T
varieties.72 Bearing a catastrophic disadvantage, the cms-T lines carried an inextricable
susceptibility to Bipolaris maydis race T (formerly known as Helminthosporium maydis race
T),72, 73 which caused massive devastation to the U.S. corn crop. Within only a 4 month period in
1970, the pathogen had destroyed 15% of all U.S. corn, which amounted to 20 million metric
tons worth approximately $US 1 billion.3 The U.S. farmers took the most direct loss but
downstream from them were the investment bankers and businessmen who had loaned them the
money necessary to plant their fields. While the investors were worrying about repayment, the
U.S. government was agonizing about the loss of exportable grains. The southern corn leaf blight
epidemic of 1970 had a huge impact that rippled throughout the economy.
With the approach of the 1970 harvest, officials from the U.S. Department of Agriculture
(USDA) were beginning to acknowledge that U.S. farmers weren‘t going to have enough
disease-resistant seed to replant the following year. Seed companies were already hard at work
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trying to generate new seed stocks in Latin American countries, but by the spring of 1971 only
23% of corn seed going into the U.S. soil was blight-resistant.74 Fearing that southern corn leaf
blight would ravage the landscape again, most of the remaining cms-T varieties were planted in
the drier regions of the western corn belt so as to dampen the tenacity of the blight, while much
of the blight-resistant corn was planted in the southern states so as to buffer the northward spread
of a second epidemic. Several severe outbreaks of southern corn leaf blight were reported in
1971, but the devastation did not approach that of the previous year. By 1972, the U.S. farmers
had been supplied with enough blight-resistant seed that the crisis was finally considered to be
over.
Due to the difficulty of reacquiring blight-resistant varieties of corn, bushel prices
doubled during the early 1970s.74 And had it not been for the previous years‘ grain surplus and
having had the ability to substitute other grains into livestock feeds, then other commodities that
depend heavily on the corn production, e.g. beef, poultry, etc., most certainly would have seen
more drastic stock market changes. In the wake of the 1970 blight epidemic, optimists who once
thought that genetic alterations would replace the use of agrofungicides were now quickly
shedding their beliefs, for it was apparent to all that the need for chemical fungicides would
never be quenched.

2.3.2. The Industry Booms
From the 1970s onward, agrochemical technology advanced into an exponential growth
period as entirely new chemical classes were rapidly being introduced (Table 4).54 New
companies were materializing all over the globe to address the expanding market. Larger, more
established companies, like BASF and Bayer, were budding new divisions especially devoted to
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plant protection. As well, mergers were becoming commonplace events used to offset the
increased costs of business while allowing effective competition.75, 76
Because of the high cost of doing research, many companies strategized to focus
extensively on analog chemistry, the so-called ‗me-too‘ strategy. Once a new class of compound
was introduced, competitors would make facile adjustments to the preeminent compounds and
quickly gain new high ground by patenting their new chemical entities without the extensive
research costs. Table 4 exemplifies this me-too strategy with the MBCs, triazole DMIs,
phenylamides, and quinone outside inhibitors (QoIs). While at the same time new classes were
emerging, companies, academics, and governments were all investing extensive efforts to
elucidate the underlying modes of action. Conceptually, understanding exactly how a class of
compounds worked should‘ve provided a means to better understand fungal biology enough to
allow for the design of subsequent fungicides with unsurpassed disease control. However, fungi
once again proved far more unpredictable than anticipated. And though there was an obvious
necessity to transition science from the empirical discovery approaches of yesteryear to a more
intellectual knowledge-based approach, science, to this date, is still struggling to idealize this
approach.
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Table 4. 54 Key fungicide classes introduced 1970-present.

Chemical Class

Fungicide and Year of Introduction

Mechanism of Action

Methylbenzimidazole
carbamate (MBC)

thiophanate (1970), thiophanate-methyl
(1970), carbendazim (1976)

β-tubulin assembly

Phosphorothioate

iprobenfos (1970)

lipid and membrane
synthesis

Triazole DMIa

triadimefon (1973), bitertanol (1979),
diclobutrazol (1979), fultriafol (1983),
hexaconazole (1986), metconazole
(1992), prothioconazole (2002)

sterol biosynthesis in
membranes

Imidazole DMIa

imazalil (1973), prochloraz (1977),
triflumizole (1982)

sterol biosynthesis in
membranes

Pyrimidine DMIa

fenarimol (1975), nuarimol (1975)

sterol biosynthesis in
membranes

Pyridine DMIa

buthiobate (1975), pyrifenox (1986)

sterol biosynthesis in
membranes

Dicarboximide

iprodione (1974), vinclozolin (1975),
procymidone (1976)

signal transduction

Benzanilide

benodanil (1973)

respiration

Cyanoacetamide oxime

cymoxanil (1976)

unknown

Phenylamide

metalaxyl (1977), furalaxyl (1977),
benalaxyl (1981), oxadixyl (1983),
mefenoxam (1996)

nucleic acids
synthesis

Morpholine SBIb

fenpropimorph (1979), fenpropidin (1986)

sterol biosynthesis in
membranes

Cinnamic acid

dimethomorph (1988)

lipid and membrane
synthesis

Phenylpyrrole

fenpiclonil (1990), fludioxonil (1990)

signal transduction

Dinitroaniline

fluazinam (1992)

respiration

Quinone Outside
Inhibitor

azoxystrobin (1992), metaminostrobin
(1993), fenamidone (1998),
trifloxystrobin (1998), picoxystrobin
(2000), pyraclostrobin (2000)

respiration

Phenoxyquinoline

quinoxyfen (1997)

signal transduction

Hydroxyanilide

fenhexamid (1998)

sterol biosynthesis in
membranes

a

demethylation inhibitor; bsterol biosynthesis inhibitor
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As the market broadened and chemists continued striving to reach the apogee of potency
and efficiency, farmers slowly abandoned the older fungicides to concentrate on the higher return
on investment offered by the newer fungicides. Figure 15 very much epitomizes just how
efficient fungicides have become over the years, illustrating that usage needs in the U.S. have
gone from 300 million pounds per year in the 1940s to only 108 million pounds per year in
recent past, which amounts to only ~0.1 lb/acre versus 10-60 lb/acre.77 Unfortunately, what
wasn‘t appreciated until the late 1970s was the fact that most of the newer fungicides were
mono-site inhibitors and hence, were at higher risk to resistant populations. Though resistance
was seen in the 1960s, e.g. mercury seed treatments,78 it was perceived as a minor annoyance.
For the duration of the 1970s, farmers witnessed far more severe cases of resistance in which
major classes of fungicides were failing due to their overuse and mono-site inhibitory activity.
To thwart the problem, companies would either formulate their product mixtures to include at
least two different fungicides with separate modes of action or they would completely withdraw
a fungicide from a particular market region until resistant populations were believed to have
disappeared. This cunning strategy worked, but only to a relatively small degree because there

Figure 15.77 U.S. Crop Production Fungicide Use.
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was no crosstalk between other companies within the industry. In order to make a profound
difference, the industry had to work as a whole. Thus, in 1981 the Fungicide Resistance Action
Committee (FRAC) was formed to collate information on international fungicide resistance and
distribute that information to researchers, manufactures, farmers, and regulators. As well, FRAC
provided a multitude of guidelines and advice as to how resistance should be managed.
Throughout the past few decades, new fungicides have continued to enter the market.
Perhaps most successful of the new and expanding classes were the triazoles and strobilurins,
several of which are illustrated in Figure 16. Resistance problems have inevitably occurred
within both classes,79-81 but owing in large part to the FRAC guidelines these classes continue to

Figure 16. Examples from the triazole and strobilurin fungicides along with respective release dates.

31

be quite useful today. In addition, pathogens and fungicides—or particular combinations of the
two—each possess an inherent amount of risk to resistance (Figure 17).82 For example, it‘s well
known that benzimidazoles carry a high risk of susceptibility to resistance, regardless to which
crop disease they are being applied. And in perfect likeness, Botrytis is a pathogen at notoriously
high risk to resistance regardless of which fungicide is used to control it. As one should expect
from looking at Figure 17, using a benzimidazole fungicide to control Botrytis would be an utter
disaster. Most governments and regulation agencies appreciate these innate risks and now require
strict regulations and product labeling to insure that fungicides and pathogens are well paired to
minimize resistance risk. While the established countermeasures aren‘t perfect, a wide variety of
fungicides continue to be effective in many situations, seemingly protected from bereavement.

Figure 17..82 Combined resistance risk diagram based on inherent fungicide risk and inherent pathogen
risk. Red shading indicates higher risk.
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2.4. PRESENT AND FUTURE NEEDS
Throughout the past 200 years, each successive fungicide has offered some
unquestionable degree of variable advantage over precursory chemistries, whether it is potency,
mobility, spectrum, safety, etc. But to all appearances, the globally invoked resistance
management strategies, along with advances in formulations and delivery systems, are allowing
many of 20th century fungicides to remain highly effective. As most of the early fungicides are
now coming off patent, the crop protection industry is now confronted with a market inundated
with highly affordable fungicides that are still commercially attractive, e.g. mancozeb and many
of the early triazoles. But does this mean that the future of fungicide discovery and development
is fated? Perhaps not.
Though it does seem that fungicide discovery has slowed in recent years, it is paramount
to acknowledge that the world population is projected to grow from 6.1 billion in 2000 to 8.9
billion by 2050, increasing therefore by about 60 million per year.83 At this rate, the annual
demand for grain is expected to increase by about 26 million tons.75 Moreover, as standards of
living improve in developing nations and people become more opulent, it is expected that grain
demands will increase even more so because of the desire of many people to eat more meat and
animal products—since about 7 pounds of grain is required for each pound of beef produced.75
With the aggravated population strain and food demand, there is little doubt that future
farmers may be forced to over-rely on the use of fertilizers and hybrid cultivars to maximize
yields, which in turn could predispose crops to fungal attack, much in the same way that cms-T
genetics predisposed maize to the 1970 southern corn leaf blight.84 In addition, chemical
fungicides have recently begun to attract a heightened amount of economic and public concern as
global trends move towards providing a more ‗green‘ society—that is, a society which relies on
goods and services that inflict no harm to the environment. This unfortunately alludes to the
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possibilty that more stringent regulatory processes could someday end the use of such fungicides
as the multi-site inhibitors, given that such compounds are often considered general
toxophores.54 Thus, many of the older compounds heavily relied upon for effective resistance
management strategies, e.g. dithiocarbamates and phthalimides, could potentially be lost to
future regulatory battles. It is crucial then, that regulators carefully weigh the risks and benefits,
for cancelling the use of older fungicides will almost certainly result in more serious resistance
problems for other fungicides.
As resistance continues to erode the value of new fungicides and hybrid cultivars, the
crop protection industry will inevitably have to rely on more integrated strategies to support
future needs. Biotechnologies and genetics will undeniably be of great importance, but equally
important to sustainable disease control are chemical fungicides. Indeed, fungicides will continue
to be a critically important part of disease control as will be their continued discovery and
development.
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III. SYNTHETIC APPROACHES
TOWARDS 6-OH-BDE-47 BIOISOSTERES

For nearly 200 years people have been researching and utilizing chemical fungicides, yet
no one has explicitly recognized in the literature that indoles, similar to those generated from this
particular research, may possess antifungal properties. The initial idea for this research spurred
from the mental conception that when compared structurally, certain indolic compounds can
greatly approximate the skeletal framework of 6-OH-BDE-47. Figure 18 provides an excellent
visual comparison of this concept. And, of course, it was already known that 6-OH-BDE-47, and
other closely related OH-PBDEs, elicited potent
antifungal behavior against a number of pathogenic
fungi, especially those relating to agricultural
significance, e.g. Botrytis cinerea. Consequently, it
was hypothesized that if OH-PBDEs are antifungal
then structurally similar phenylindoles should also

Figure 18. 3-Dimentional overlay of 6-OHBDE-47 (magenta) and proposed bioisostere 4
(green).

be antifungal.
From the inception of this project, it was found that the scientific literature had never
made reference to polybrominated 3-phenylindoles, nor similar polyhalogenated phenylindoles.
This seemed bizarre at first that such a simple looking molecule had not been reported, but upon
further inspection of the synthesis one quickly realizes that getting the halogen-substitution
pattern exactly right is deceptively difficult. Thus, in order to test the hypothesis of antifungal
phenylindoles, a formidable synthesis might have to be applied to access these novel compounds.
And so, the retrosynthetic analysis of the polyhalogenated indoles began.
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Basing the retrosynthetic analysis on known, reliable reactions, the most obvious
disconnection that stood out was the C—C bond linking the indole ring system to the phenyl
group (Figure 19). Though a Suzuki coupling was the first reaction that came into mind, other
such C—C bond forming reactions, e.g. Negishi, Stille, Kumada, etc., were also considered for
this coupling step. After surveying the wide
commercial availability of aryl boronic
acids it quickly seemed that the Suzuki
coupling would provide the fastest route to

Figure 19. First retrosynthetic disconnection of the
ideal target molecule 4.

derivatizing similar compounds—that is, if
the 3-iodoindole could indeed be made.
As of the writing of this dissertation, 3-iodo-4,6-dibromoindole had never been reported
in the literature. However, decades of compiled knowledge surrounding indole chemistry
strongly advised that the C-3 position of indoles was the second most nucleophilic site on the
ring system, just after the N-1 position (recall indole numbering on p. 12). Hence, if both the C-2
and C-3 positions of indoles are unoccupied, in addition to any unoccupied positions on the fused
benzene ring, then electrophilic aromatic substitution occurs preferentially at the C-3 position.
Further inspection of the retrosynthetic analysis (Figure 20) implied that a synthetic route
towards 4,6-dibromoindole must now be achieved. Fortunately, 4,6-dibromindole is a known
compound,85, 86 just not as readily available as one would
desire. As a result, semi-novel methods had to be
developed to arrive at such a molecule in good,
Figure 20. Second retrosynthetic
disconnection of target molecule 4.

affordable yields.
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3.1. SYNTHESIS OF THE
POLYHALOGENATED INDOLE SCAFFOLD
In 1985, Higa et al. first isolated 4,6-dibromoindole from the marine acorn worm
Glossobalanus sp.87 The very closely related natural product 3,4,6-tribromoindole was also
isolated by the same group in 1980 from Balanoglossus carnosus,88 yet another species of acorn
worm. Because of the unusual halogen-substitution pattern of
both molecules, and their antibacterial properties,87 chemists in
the late 1980s became interested in synthesizing these bizarre

Figure 21.

molecules so that people could better study their properties.
By 1987, Pierre Martin, then working at Ciba-Geigy in Basel, Switzerland, became the
first chemist to report on the total synthesis of both 4,6-dibromoindole and 3,4,6tribromoindole.85,

86

Traditional synthetic avenues employed to access 2- and 3-unsubstituted

indoles, e.g. the Reissert,89 Fischer,90 and Rees-Moody91 routes, frequently prove problematic
due to the subsequent need to remove the ensuing 2-carboxyl function (Scheme 1).92 Often,
extremely harsh and prolonged thermolysis conditions are unavoidable to remove this function
and often these conditions will decompose the product of interest. Alternatively, it has become
conventional to instead use decarbonylative procedures to remove the 2-carboxyl function, but of
course, this inconveniences the reaction scheme with additional steps. Martin was able to avoid
both of these problems in his synthesis by exercising a previous method developed by his group
in 1984.93 This, then novel, method of indole synthesis employees as its quintessential step a
hetero-Cope-rearrangement of various intermediate N-phenyl-O-vinylhydroxylamine derivatives.
Martin‘s novel synthesis of 4,6-dibromoindole and 3,4,6-dibromoindole is outlined in Scheme 2.
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Scheme 1a

a

Typical Fischer Indole synthesis. Generally involves thermolysis or
decarbonylative conditions to remove the 2-carboxyl function.

Scheme 2a

a

Reaction conditions: (a) H2, Pt/C, THF, DMSO, NH3, H2O, 20 °C; (b) AcCl, Na2CO3, H2O,
Et2O, 0 °C, 76% (two steps); (c) vinylacetate, 2-mol% Li2PdCl4, 55 °C, 55%; (d) NaOH, MeOH,
room temp, 76%; (e) Br2, CH2Cl2, 0 °C, 95%. (f) NaOH, MeOH, room temp, 95%.

In addition to the synthesis offered by Pierre Martin, other indole syntheses were also
considered herein for the occasion that some of the desired compounds couldn‘t be effectively
accessed through Martin‘s synthesis. Figure 22 offers a cognizant overview of other various
routes that have been employed to construct the indole ring system, however, this depiction is
not all-inclusive and additional approaches abound in the literature. As will be discussed later,
other routes were in deed utilized later in this research project.
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Figure 22.

3.1.1. Cost Considerations
To follow exactly Martin‘s procedure outlined in Scheme 2 meant using
1,3-dibromo-5-nitrobenzene and immediately subjecting the material to platinum on carbon. In
addition to the high cost of platinum, 1,3-dibromo-5-nitrobenzene is also highly valued, often
retailed from U.S. chemical supply companies at greater than $60/g. In the interest of pursuing a
more affordable route to the N-phenylhydroxylamine intermediates, it was decided that a more
novel approach should be obeyed. In 2005, Ung et al. developed a highly effective method for
the controlled reduction of nitro compounds using zinc metal and ammonium chloride under
ultrasonic activation.94 By carefully governing the equivalents of zinc used in the reaction,
various N-phenylhydroxylamines could be afforded in substantial yields within less than
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10 minutes of reaction time. Best of all, this newer reduction method is extremely cost effective.
Proceeding via single electron transfer, the mechanism proposed by Ung‘s group is outlined in
Scheme 3.
Scheme 3

As for the expensive 1,3-dibromo-5-nitrobenzene, it was considered optimal to instead
rehearse a series of ‗mock‘ reactions in which a cheaper substrate was carried through the
reaction scheme. 1,3-dichloro-5-nitrobenzene proved ideal for this job since it was
physiochemically similar to the desired substrate, yet, the cost of the material was only $2/g.
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Once it was felt that the techniques and methods of the synthesis were streamlined using the
inexpensive materials, 1,3-dibromo-5-nitrobenzene would be subjected to the same conditions.

3.1.2. Synthetic Pursuits of Halogenated 3-Phenylindoles
Having purchased 1,3-dichloro-5-nitrobenzene 26, this inexpensive starting material was
sonicated in the presence of zinc dust and ammonium chloride to afford hydroxylamine 27 in
respectable yields (Scheme 4). The only other compound detected by TLC was the starting
material 26, which could of course be re-isolated quickly on a silica flash column. Purification of
27 was seldom done as the reaction often produced high enough purity product that it was
frequently directly engaged in the next step of the synthesis without further purification. A very
facile acetylation with acetyl chloride promptly gave way to N-phenylhydroxamic acid 28 in
great yield. Next came the palladium catalyzed formation of N-phenyl-O-vinylhydroxylamine
followed by the in situ hetero-Cope-rearrangement to provide N-acetylindole 29 in respectable
yields, however, the reaction took a disheartening 72 h to complete. When the reaction was
halted prior to this, the yield was significantly less, often giving only 15-20% of the desired
product 29. As will be addressed later in this manuscript, this particular indole-forming step was
later reevaluated and optimized to allow superior yields within a fraction of the time. Regardless
of the initial drawbacks, enough 29 was afforded at that point that subsequent chemistry could be
easily investigated.
Scheme 4a

a

Reagents and conditions: (a) zinc dust, sat. aq. NH4Cl, H2O, acetone, ))), room temp, 5
min.; (b) NaHCO3, AcCl, Et2O, 0 °C, 1 h, 79% (two steps); (c) Li2PdCl4•xH2O, vinyl
acetate, reflux, 72 h, 78%; (d) THF, NBS, -78 °C, 2 h, 56%.
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In the interest of pursuing Suzuki style couplings, a ‗handle‘ was added to the C-3
position in the form of a bromide substituent. Indole 30 was the resulting compound. Bromine
was originally chosen as the halogen handle because the necessary bromination conditions were
well described by Martin et al.86 Small gram quantities of indole 30 were prepared by the method
in Scheme 4 and, thus, adequate material was available to explore optimal coupling conditions.
X-Ray crystallography confirmed the absolute structure of 3-bromoindole 30.

Figure
23.
X-Ray
crystal
structure
of
N-acetyl-3-bromo-4,6-dichloro-1H-indole 30. Crystallized from hot
EtOAc.

Unfortunately, the N-acetyl functionality in 30 prohibited successful Suzuki couplings of
various phenylboronic acids (Scheme 5, Route A). If the desired 3-phenylindoles 31 and 32
were, in fact, formed by Route A, they were not of significant yields to produce detectable
amounts. A brief survey of the literature showed very few examples of N-acetylindoles involved
in coupling reactions; indoles possessing tert-butyldimethylsilyl (TBS), N-methyl, and
phenylsulfonyl protecting groups were far more common. Thinking that a different N-protecting
group would favor better coupling conditions N-acetylindole 29 was efficiently deprotected and
subsequently protected with TBS (Scheme 5, Route B). Though Route B was plagued by
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additional steps and a poor yielding coupling step (5% yield), 32 was successfully synthesized
for the first time, unequivocally demonstrating that 32 was synthetically obtainable and stable.
Scheme 5a

a

Reagents and conditions: (a) 4-chlorophenylboronic acid, PhH, MeOH, sat. aq. Na2CO3, Pd(PPh3)4, 110
°C, 8 h, 0 – 7%; (b) MeOH, NaOH, room temp, 1 h, quant.; (c) THF, -78 °C, n-BuLi, TBSCl, 2 h, 90%; (d)
THF, -78 °C, NBS, 2 h, 75%; (e) THF, TBAF, room temp, 1 h, 90%.

A devastating problem found within the Suzuki coupling of Route B was finding that 35
not only yielded 36, but also debrominated early in the reaction progress to afford a nearly
inseparable mixture of 34 and 36. Frustratingly, attempts to deprotect the N-1 position only
afforded inseparable mixtures of 33 and 32. When trying to purify either mixture using normal
phase silica columns the compounds repeatedly co-eluted. Crystallization was regrettably not an
option at this juncture as the mixtures presented as oils. Mercifully, a significantly taller column
separated only enough 33 and 32 to be well characterized by LR-MS and NMR, though the
majority of 33 and 32 had again co-eluted.
Endeavoring to divert the debromination problem, further experimentation revealed
N-protecting groups were not strictly necessary for successful bromination and coupling
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(Scheme 5, Route C), nonetheless, Suzuki couplings of 3-bromo-4,6-dichloroindole 37 continued
to result in entangled mixtures of 33 and 32. Opting to reverse the roles of the boronic acid and
halogen similarly resulted in co-eluting mixtures of product and debrominated side-product, as
illustrated by Scheme 6.
Scheme 6a

a

Reagents and conditions: (a) i. t-BuLi, THF, -78 °C,
15 min.; ii. B(OMe)3, H2O, -78 °C, 1 h; (b)
1-bromo-4-chlorobenzene, PhH, MeOH, sat. aq. Na2CO3,
Pd(PPh3)4, 110 °C, 8 h, < 5%.

Moreover, indole 35 was converted to the corresponding zinc chloride and Negishi
conditions were applied. Again, a mixture of 34 and 36 resulted. An extensive review of the
literature unearthed other chemists who articulated similar problems with Stille couplings, 95 thus
Stille conditions were disregarded.
Perhaps the most influential decision addressing the co-elution problem was to simply
subject the mixture to reverse-phase semi-preparative HPLC. Though the yields of these
particular Suzuki conditions were poor, the appropriate HPLC methods allowed enough of the
desired 3-phenylindole 32 to be collected for characterization and biological assay. With the help
of HPLC, the synthetic routes described in Schemes 4 and 5 were now fruitful, though
optimization was preferred to insure sufficient material could be prepared for the biological
assay.
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3.2. OPTIMIZING THE SYNTHETIC ROUTE
TOWARDS HALOGENTATED 3-PHENYLINDOLES
Miyaura and Suzuki provided an extensive review96 of their coupling reactions in which
they addressed the reactivity of numerous organoborons, halogens, and pseudohalogens. It is
clearly stated therein, ―The order of reactivity of halides and triflates for the cross-coupling
reaction of boron reagents is I > Br > OTf >> Cl.‖96 Understanding this, logic seemed to suggest
that an iodine handle would accelerate the cross-coupling reaction and provide less opportunity
for dehalogenation to occur at the C-3 position. With some experimentation, this rationale
proved accurate—the yields of the cross-coupling were increased from 5% to 10% in most cases.
Though only a 5% increase, this improvement rendered significant benefit to the milligram
reactions being performed. In contrast to the bromination, the iodination also generally occurred
quantitatively, thus providing higher yields to the overall synthesis.
Successful iodination of 4,6-dichloroindole 33 was achieved by following the
undemanding procedures of Tanoue et al.97 Therein is described a method for regioselectively
iodinating 1H-indoles at the C-3 position using sodium hydroxide, iodine, and aqueous
potassium iodide. Recalling the previous step, deacetylation, also required sodium hydroxide,
experiments were hastily conducted to telescope the reactions into a simple, one-pot reaction.
Success was swiftly attained and Scheme 7 illustrates the improved route. Note: 3-iodoindoles
are labile and must be immediately engaged in next step; decomposition was observed
within 24 h at < 0 °C. Unfortunately, dehalogenation still occurred during the Suzuki coupling,
though to a slightly lesser degree.
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Scheme 7a

a

Reagents and conditions: (a) i. EtOH, NaOH, room temp, 1 h; ii. KIaq,
I2, room temp, 1 h, 95% (2 steps); (b) 4-chlorophenylboronic acid, PhH,
MeOH, sat. aq. Na2CO3, Pd(PPh3)4, 110 °C, 8 h, 0 – 7%.

Going back one more step, to the hetero-Cope-rearrangement mentioned in Schemes 2
and 4 (p. 38 and 41, respectively), optimization was desired at this juncture due to the long,
sluggish reaction times required—often 72 h at reflux. Before the suggested mechanism for this
reaction was excavated from the literature, in-house chromatographic efforts afforded a major
side product which, when monitored by thin layer chromatography (TLC), slowly disappeared
from the reaction as time progressed. Intriguingly, the amount of desired product was inversely
proportional to the amount of side product witnessed on TLC. 1H- and

13

C-NMR revealed the

unknown compound to possess two saturated carbons, though X-ray crystallography was the key
analytical technique that brought to light the absolute structure of the compound. While
preparing another halogenated derivative of N-acetylindole 29, the corresponding side product
beautifully crystalized from ethyl acetate. Figure 24 provides the crystal structure of the
aggravating side product, which had been chromatographically purified from the crude reaction
mixture.
In his 1984 publication,93 Martin did not report the use of a protic acid and, likewise, he
reported significant amounts of isolable indolines within his 1988 publication.86 With a new
understanding of the reaction mechanism, it seemed a protic acid catalyst would speed the
time-consuming dehydration step. In-house experiments promptly began to disclose which
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Figure 24. X-Ray structure of 2-hydroxy- 4-bromo-N-acetylindolin.
Ellipsoid diagram is no longer available due to loss of .cif file and raw
acquisition data. Crystallized from EtOAc and hexanes.

particular acid would be best suitable for this reaction. Of the four acids attempted (HCl, NH4Cl,
pTSA, and formic acid), formic acid proved far superior, resulting in approximately 85% yields
within only 2 h of reflux—a significant improvement over the lower yielding 72 h reaction.
pTSA also catalyzed the dehydration, though the workup became painstakingly involved,
resulting in lower yields with more time-consumption. NH4Cl and HCl were of negligible help,
most likely due to their aqueous nature. AcOH was overlooked during these experiments, though
it should be predicted to work equally as well as formic acid.
To the best knowledge available, a precise mechanism for the palladium-mediated
catalytic cycle has not been explicitly reported for these indole forming reactions reported by
Pierre Martin. It would appear, and others agree, that palladium is used to coordinate the olefinic
functionality of vinyl acetate, thus, making it appropriately electrophilic enough for nucleophilic
attack to occur by hydroxamic acid. A consensus seems to exist that the vinylation of
hydroxamic acid is palladium-mediated but chemists are unsure if the subsequent
hetero-Cope-rearrangement is a purely spontaneous event or if palladium also mediates the
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rearrangement.93,

98

At least for the vinylation occurrence, Scheme 8 could represent a viable

mechanism for the catalytic cycle. Unfortunately, no statement can be made as to whether the
sigmatropic rearrangement is Pd-catalyzed or merely expires thermally.
Turning attention back to the coupling step, the low yield was still problematic.
Numerous solvents, boronic acids, boronic esters, bases, catalysts, and anhydrous conditions
were explored but to no avail. Dehalogenation continued to occur. Astonishingly, few reports
detail observations of dehalogenation products occurring in the Suzuki-coupling. Recently,
however, there have been a few notable reports of this defiant problem resulting in
dehalogenation as the major product.95, 99-101 Significant to this particular dissertation research,
one such report specifically states therein:
Interestingly, as we were pursuing these investigations, Dr. Cai of
Hoffmann-La Roche informed us of a similar [dehalogentation]
observation that they have made in the coupling of 3-bromoindoles
in which protection of the indole nitrogen is required to avoid
extensive dehalogenation.95
To thwart the dehalogenation problem during the Suzuki coupling of 4-bromopyrroles,
Handy et al.95 experimented with the influence of pyrrole protecting groups to control the degree
of dehalogenation. Their results concluded that the BOC protecting group on the nitrogen
prevented the dehalogenation and, thus, significantly improved yields. In addition, the BOC
protecting group is thermally cleaved at the high temperatures normally required for the Suzuki
coupling, therefore, there were no additional steps required to remove the BOC group.
This discovery marked a profound landmark within this dissertation project. Immediately,
a procedure102 was adapted to BOC protect the halogenated indoles at hand and methodology
experiments were promptly applied. In agreement with Handy et al.,95 the N-BOC group
provided higher yields of the polyhalogenated 3-phenylindoles. Though dehalogenation
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persisted, reaction yields were now topping 25% desired product, more than double and triple the
previous yields, depending on substrate.
Scheme 8a

a

Proposed mechanism for the palladium-mediated vinylation of hydroxamic acids. Subsequent
sigmatropic rearrangement and dehydration yields 2- and 3-unsubstituted indoles.

Silica TLC analysis was of significant value to monitoring the Suzuki coupling for the
reason that 2,3-diunsubstituted indoles habitually stained red upon p-anisaldehyde staining, while
3-phenylindoles consistently stained purple (Figure 25). To a short degree, TLC was used as a
crude estimate of the product yield prior to workup: the more intense the red spot the more
dehalogenated byproduct, while the more intense the purple spot the more 3-phenylindole
(Figure 25, Lane 1). Ideally, one would like to see TLC profiles, in these cases, with ONLY a

49

single purple spot—indicative of an effortlessly isolable product. Unfortunately, this was never
the circumstance.
Figure 25, Lane 1 represents a highly unique occurrence within this series of compounds,
i.e. the Rf values were distinctive enough to allow for facile separation. Having dealt with
numerous compounds within this series, the most pragmatic explanation for the separation
observed in Figure 25 was owed to the H-bonding nature of fluorine. Abidingly, when no
considerable H-bonding groups existed to differentiate the product, the two Rf values were
consistently inextricable on silica gel, irrespective of solvent choice.

Figure 25. TLC profile highlights the significance of the dehalogenation problem.
Lane 1 - crude reaction mixture; Lane 2 – boronic acid derivative; Lane 3 – dehalogenated
by-product; Lane 4 – desired product. The hydrogen-bonding nature of fluorine allowed for
moderate separation to occur in this particular example; without fluorine these spots would
share the same exact Rf value, thus overlapping. TLC was developed 1-dimentionally in 25%
EtOAc/Hexanes on SiO2 and subsequently stained with p-anisaldehyde. Each compound was
isolated and well identified with NMR spectroscopy and low resolution mass spectrometry.
Compounds of the 3-phenylindole series habitually flush purple upon p-anisaldehyde
staining while the less conjugated indoles often flush bright red. This is true of all
polyhalogenated 2-unsubstituted indoles studied within this research.
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Figure 26. TLC demonstrates the exceptional influence of the BOC
protecting group during the Suzuki coupling. TLC also demonstrates the
matching Rf values. Lane 1 – crude reaction mixture resulting from a
non-protected substrate; Lane 2 – crude reaction mixture resulting from a
BOC-protected substrate. Purple coloration is indicative of 3-phenylindoles,
while red is the dehalogenated byproduct. TLC suggests the
BOC-protecting group significantly suppressed dehalogenation. Recovery
of purified products confirmed BOC‘s influence (yield of desired product
was tripled). TLC was developed 1-dimentionally in 25% EtOAc/Hexanes
on SiO2 and subsequently stained with p-anisaldehyde. Each compound was
isolated and identified with NMR spectroscopy and low resolution mass
spectrometry.

Figure
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inseparable
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dehalogenated

example

of

counterpart,

4,6-dichloro-1H-indole 33. Having a BOC-protected substrate allowed for significantly more
product to be accessed via Suzuki coupling (Figure 26, Lane 2), yet 55 and 33 were still found
overlapping in both Lanes 1 & 2 (observed color difference was owed to relative concentrations
of 55 and 33). Preparative C18 reversed phase HPLC was unequivocally required the resolve 55
and 33. With the help of BOC protection and HPLC, 15 - 30 mg of each desired polyhalogenated
3-phenylindole could now be reasonably attained and subjected to various biological assays.
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Scheme 9 provides the complete, optimized synthetic route used to obtain meaningful amounts
of polyhalogenated 3-phenylindoles.
Scheme 9a

a

Reagents and conditions: (a) zinc dust, sat. aq. NH4Cl, H2O, acetone, ))), room
temp, 5 min.; (b) NaHCO3, AcCl, Et2O, 0 °C, 1 h, 79% (two steps); (c)
Li2PdCl4•xH2O, vinyl acetate, HCO2H, reflux, 2 h, 85%; (d) i. EtOH, NaOH, room
temp, 1 h; ii. KIaq, I2, room temp, 1 h, 95%; (e) CH2Cl2, Boc2O, Et3N, DMAP, room
temp, 1 h, 95%; (f) phenylboronic acid, PhH, MeOH, sat. aq. Na2CO3, Pd(PPh3)4,
110 °C, 8 h; (g) C18 reversed phase HPLC, 65% ACN/H 2O → 100% ACN, 10 - 35%
(two steps).

With the synthesis outlined in Scheme 9, numerous compounds could be effortlessly
derivatized from compounds 61, depending solely on the boronic acid introduced at that
particular juncture. Indeed, many compounds were made this way. If repeating this synthetic
route, recall 3-iodoindoles are unstable (p. 45) and CANNOT be stored! Consequently,
indoles 59 are the most stable intermediates to stockpile prior to derivatization. To exemplify
some of the diversity achieved by Scheme 9, Figure 27 illustrates some select compounds
synthesized herein by this method.
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Figure 27. Examples of 6-OH-BDE-47 mimics synthesized by the methods outlined in Scheme 9. As
will be discussed in the next chapter, all of these compounds successfully mimicked the biological
activity for which they were designed.

3.2.1. Leimgruber-Batcho Indole Synthesis
When affordable o-nitrotoluenes were readily available, the Leimgruber-Batcho indole
synthesis was applied to the construction of 6-OH-BDE-47 mimics. The Leimgruber-Batcho
synthesis is a brief series of reactions in which o-nitrotoluenes 75 are converted to enamines 76
using N,N-dimethylformamide dimethyl acetal (DMF-DMA) and pyrrolidine, then reductively
cyclized to afford 1H-indoles 62 (Scheme 10). This particular synthesis is highly efficient when
the correct starting materials are available. Most appealing, this reaction affords
2,3-diunsubstited indoles—a valuable feature to the project objectives.
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Scheme 10a

a

Reagents and conditions: (a) DMF, DMF-DMA,
pyrrolidine, 90 °C, 1.5 h; (b) NH 4OAc, DMF, H2O,
20% TiCl3 in 3% HCl, NaOH, 0 °C, 30 min., 90% (two
steps).

Pierre Martin‘s indole synthesis (p. 38) was capable of achieving the exact same
substitution pattern on indoles 62 as the Leimgruber-Batcho synthesis, but Martin‘s synthesis
afforded isomeric mixtures if the nitroarene starting materials 56 were not symmetrical. Using
Martin‘s approach, unsymmetrical polyhalogenated indoles were, in fact, successfully
synthesized herein (e.g. Figure 24 [p. 47] provides x-ray data of one such indoline intermediate
isolated using Martin‘s approach). However, because of the short length and ease of synthesis,
the Leimgruber-Batcho approach was used whenever possible. Generally though, halogenated
o-nitrotoluenes are difficult to come by commercially (Figure 28).

Figure 28. Commercially available halogenated o-nitrotoluenes.
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Of course, if indoles 62 can be synthesized by the Leimgruber-Batcho method then a
simple iodination of the C-3 position and subsequent BOC protection stages the derivatization
junction for which the Suzuki coupling can then be applied. Figure 29 exemplifies a few of the
indole scaffolds prepared by the Leimgruber-Batcho method during the course of this project.

Figure 29. Examples of indole scaffolds synthesized
herein by the Leimgruber-Batcho indole synthesis.

3.2.2. Synthesis of Polynitrated 3-Phenylindoles
6-OH-BDE-47 mimics resulting from this research were continually being subjected to
biological assays (discussed in next Chapter) and the activity results were periodically conveyed
back to the synthesis investigators. Results from those assays, and anecdotal evidence from
others, suggested that the pKa of the indole nitrogen might have influence over the observed
biological activities, as mentioned earlier (p. 11). What transpired was a move to synthesize
similar 3-phenylindoles with lowered pKas. In theory, it seemed that placing highly
electron-withdrawing groups (EWGs) ortho and para to the N-1 position would best pull
electron density away from the nitrogen, thus stabilizing the conjugate base of the mimics and
lowering their pKas. One of strongest EWGs known is the NO2 group, and installing this group
ortho and para to the indole nitrogen was not sincerely straightforward.
If one wanted to attempt electrophilic aromatic nitration on a naked indole ring it would
be earnestly impossible to accomplish nitration at the C-7 position (ortho position to the
nitrogen; recall indole numbering on p. 12). Likewise, Pierre Martin‘s synthesis (p. 38) and the
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Leimgruber-Batcho indole synthesis (p. 53) were unlikely routes to realize the preferred
5,7-dinitroindole scaffold. Traditional indole syntheses, e.g. the Fischer indole synthesis, were
also not contemplated for this investigation because of their antecedent problems (p. 37). As an
alternative, a new approach was developed herein for accessing the polynitrated 3-phenylindoles.
Scheme 11 illustrates this notable synthesis.
Scheme 11a

a

Reagents and conditions: (a) AcOH, AcCl, reflux, 5 h, quant.; (b) TFA, NaNO 3, room temp, 21 h,
58%; (c) MeOH, THF, sat. aq. K2CO3, room temp, 3 h, 95%; (d) 1,4-Dioxane, DDQ, HCO2H, reflux,
13 h, 98%; (e) EtOH, NaOH, KIaq, I2, room temp, 1 h, 95%; (f) CH2Cl2, Boc2O, Et3N, DMAP, room
temp, 1 h, 95%; (g) 3-nitrophenylboronic acid, PhH, MeOH, sat. aq. Na2CO3, Pd(PPh3)4, 110 °C, 8 h;
(h) C18 reversed phase HPLC, 65% ACN/H2O → 100% ACN, 20% (two steps).

Helgen et al.103 recently published a straightforward synthetic route towards indoline 83.
With facile access to 83, the next challenge became oxidizing the indoline to its respective indole
84. Initially, MnO2 was employed for this experiment as many similar indolines have been
oxidized in this way.104-106 The first oxidation attempt herein used MnO2 in CH2Cl2 at room
temperature—the reaction failed. Heating the CH2Cl2/MnO2 mixture to reflux was also
ineffective. Experimenting separately with refluxing benzene, toluene, and 1,4-dioxane
additionally proved fruitless. Adding protic organic acids to the reaction changed nothing.
Amusingly, the use of DDQ in refluxing 1,4-dioxane and formic acid promptly oxidized the
indoline to indole 84 in near quantitative yield. The DDQ reaction was immediately repeated and
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the results unmistakably confirmed reproducibility. 5,7-dinitroindole 84 was now readily
available for further chemistries.
Similarly as established earlier (p. 52), 84 was successfully iodinated at the C-3 position
and subsequently BOC protected (Scheme 11). Suzuki coupling and purification afforded the
astonishing trinitrated 3-phenylindole 87, a seemingly stable compound. The pKa of 87 was
estimated to be around pKa ~10. Though only weakly acidic, 87 was significantly more acidic
than the corresponding trichloro derivative 55 (p. 53), which had a calculated pKa ~14. Upon
triumphant synthesis, 87 was submitted to biological screening. Further derivatization of
iodoindole 86 was postponed to await the assay results.

3.3. EXPLORING ALTERNATIVE INDOLE-LIKE DERIVATIVES
Another way in which to lower pKa is to place EWGs in the C-2 position of the indole
scaffold. Adding additional heteroatoms to the ring, e.g. in the case of purines, also lowers pKa.
Initially, this tactic was avoided because it was felt that (1) by encumbering the C-2 position with
functionality the resulting indoles would not provide great overlay with PBDE1 (Figure 18,
p. 35) and (2) additional heteroatoms were expected to overcomplicate the initial hypothesis.
With biological proof in hand demonstrating the fungicidal activity of the 3-phenylindole
series, efforts were next geared towards understanding the constraints of the C-2 position and the
heteroatom allowances of the heterocyclic system. Figure 30 illustrates general structures of
desired compounds chosen for this task.
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Figure 30. General indole-like derivatives desired to explore the
extended constraints of the C-2 position and heterocyclic ring.

Carboxylates 88 were most intriguing from a design perspective because they could be
easily accessed using the Fischer indole synthesis. Additionally, the carboxylate functionality
seemed an exquisite attachment point to explore solid-phase chemistries. The idea behind this
spurred from the notion that the indole core could be bound to resins, Suzuki couplings could be
accomplished, byproducts and reagents washed away, and the product cleanly cleaved from the
resin to afford a pure product—no chromatography needed. Synthesis towards this goal began
shortly before the discovery of the dehalogenation problem that occurred during the Suzuki
coupling. Scheme 12 directs attention to this first synthetic approach towards carboxylates 88.
Scheme 12a

a

Reagents and conditions: (a) i. AcOH, conc. HCl, 0 °C; ii. NaNO2, H2O, 0 °C; iii. SnCl2, conc.
HCl, 0 °C, 21 h, 90% (b) abs. EtOH, conc. H2SO4, ethyl pyruvate, reflux, 17 h, 90%; (c) PPA, 70 °C,
20 min, 92%; (d) THF, LiOH, H2O, reflux, 4 h, 90%; (e) Cs2CO3, KI, Merrifield Resin, DMF, 90 °C;
(f) iodination or bromination; (g) DME, Pd(PPh3)4, phenylboronic acid, sat. aq. Na2CO3, reflux; (h)
THF, MeOH, NaOMe, reflux, 17 h.
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Technically speaking, the solid-phase route of Scheme 12 afforded carboxylate 88, but
regrettably this particular scheme was also plagued by the now notorious dehalogenation
problem. That is, the carboxylic acid 95 could easily be linked to Merrifield Resin using the
prescribed methods of Frenette et al.107 and subsequently halogenated with pyridinium
tribromide108 or similar method, however the ensuing Suzuki coupling108 gave resin bound
product 98 in addition to resin bound 99 (Scheme 13). Consequently, when cleaved from the
resin the resultant product still required HPLC purification. In light of this flaw, the solid-phase
approach was quickly abandoned for a more direct solution-phase approach.
The solution-phase route in Scheme 14 allowed the first synthetic access to carboxylate
88b in sufficient amounts to allow for biological testing. As before, BOC-protection also proved
fruitful and could easily be protected and deprotected as described before (p. 52). Interestingly,
compounds from this series elicited absolutely no fungicidal activity when assayed.

Scheme 13a

a

Reagents and conditions: (a) DME, Pd(PPh3)4, phenylboronic acid, sat. aq. Na2CO3, reflux; (b)
THF, MeOH, NaOMe, reflux, 17 h.
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Scheme 14a

a

Reagents and conditions: (a) i. AcOH, conc. HCl, 0 °C; ii. NaNO2, H2O, 0 °C; iii. SnCl2, conc. HCl,
0 °C, 21 h, 90% (b) abs. EtOH, conc. H2SO4, ethyl pyruvate, reflux, 17 h, 90%; (c) PPA, 70 °C, 20 min,
92%; (d) EtOH, NaOH, KIaq, I2, room temp, 1 h, 95%; (e) phenylboronic acid, PhH, MeOH, sat. aq.
Na2CO3, Pd(PPh3)4, 110 °C, 8 h; (f) C18 reversed phase HPLC, 65% ACN/H2O → 100% ACN, 10 - 35%
(two steps).

In addition to the carboxylates just described, a handful of halogenated indazoles were
also synthesized and tested for fungicidal behavior. Bewilderingly, they too witnessed a
significantly diminished activity compared to the 3-phenylindoles, though slightly more activity
than the carboxylates. Figure 31 illustrates three particular indazoles screened in this study. All
indazoles were synthesized as outlined in Scheme 15.

Figure 31. Select indazoles synthesized and screened for
fungicide activity.
Scheme 15a

a

Reagents and conditions: (a) MeOH, Py, H2NOH•HCl, reflux, 16 h, 89%; (b) CH2Cl2, Et3N, MsCl,
room temp, 16 h, 19%.
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The indazoles illustrated in Figure 31 were used to gather preliminary biological data
before attempting to synthesize the more involved polyhalogenated derivatives. Unfortunately,
oximes 106 were difficult to acquire in which halogen groups were present on either ring. Few
benzophenones 105 were commercially available, as only a select few could be synthesized by
the Friedel–Crafts acylation.109 In attempting to synthesize benzophenones yielding
polyhalogenated derivatives, difficulties persisted in the Friedel-Crafts acylation. Most likely,
this could be associated to the overt deactivating nature of the halogen groups. Alternatively,
indazole 104 was subjected to bromination conditions using Br2 in AcOH.110 Di- and
tri-brominated indazoles resulted though it never was ascertained which positions were
brominated. Regardless, both partially characterized compounds were subjected to biological
analysis and both possessed insignificant activities. Perhaps other synthetic routes could have
been explored to access additional halogenated indazoles, but considering the loss of activity
witnessed it seemed unwise to pursue indazoles.
Owing to the considerable loss of fungicidal activity observed in the carboxylate and
indazole series, further efforts to alter the C-2 position were abandoned and attention was again
turned to exploring more extensive derivatization of the 3-phenylindoles. Figure 32 demonstrates
some of the carboxylates, indazoles, and intermediate compounds which possessed little or no
activity in the fungicide screening.
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Figure 32. Carboxylates, indazoles, and intermediates possessing little or no fungicidal activity.

With the successful synthetic routes developed herein, screening assays promptly
commenced to test the biological activity of the various 6-OH-BDE-47 mimics. Chapter 4 offers
to discuss the significance of the biological assays and the associate data and methods.
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IV. BIOLOGICAL SCREENING OF
6-OH-BDE-47 AND ITS BIOISOSTERES

The initial appreciation for 6-OH-BDE-47‘s fungicidal activity came about when extracts
from the marine sponge Dysidea herbacea were first submitted to Mississippi‘s National Center
for Natural Products Research wherein the extracts were screened against a number of
microorganisms and relevant drug controls (Table 5). Once purified from the extracts, 6-OHBDE-47 exhibited inhibitory activities comparable to amphotericin B and ciprofloxacin.

Table 5. Initial microorganism screen.

0.18

MIC
(µg/ml)b
0.63

MFC/MBC
(µg/ml)c
0.63

Amphotericin B

0.23

1.25

1.25

Candida krusei

Amphotericin B

0.54

1.25

1.25

Aspergillus fumigatus

Amphotericin B

0.43

0.63

2.50

Cryptococcus neoformans

Amphotericin B

0.37

0.63

0.63

Staphylococcus aureus
Methicillin-resistant S.
aureus
Escherichia coli

Ciprofloxacin

0.10

0.25

0.50

Ciprofloxacin

0.13

0.25

0.50

Ciprofloxacin

0.007

0.031

0.13

Pseudomonas aeruginosa

Ciprofloxacin

0.089

1.000

NT

Mycobacterium
intracellulare

Ciprofloxacin

0.34

0.50

NT

Drug Control

IC50 (µg/ml)a

Candida albicans

Amphotericin B

Candida glabrata

Microorganism

a

The concentration that affords 50% inhibition of growth; bMIC (Minimum Inhibitory Concentration) is
the lowest test concentration that allows no detectable growth; cMFC/MBC (Minimum
Fungicidal/Bactericidal Concentration) is the lowest test concentration that kills the organism; NT = not
tested. Biological data reflects activity of the respective drug controls (not 6-OH-BDE-47).
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Though 6-OH-BDE-47 elicited both fungicidal and bactericidal activity, its fungicidal
activity was particularly interesting for the reason that triclosan (p. 8), with its astounding
structural similarities, could not mimic the fungicidal potency of 6-OH-BDE-47 (hence, triclosan
is only marketed as an antibacterial agent). With an activity profile established from the
preliminary screenings, 6-OH-BDE-47 was subsequently slated to undergo SAR studies to
elucidate the structural features that allowed for its fungicidal behavior. While contemplating the
SAR study, strong considerations were given to possible industrial applications of 6-OH-BDE47, but with such an extremely lipophilic nature (CLog P = 6.7) 6-OH-BDE-47 would require an
extensive overhaul to reach the bioavailability needs of the human drug market. In contrast to the
needs of the drug market, a lipophilic character is highly suitable to the agrochemical sector.
This is because lipophilic compounds can readily incorporate themselves into the waxy leaf
coatings of many crops wherein they become less prone to removal from the leaf surface by
rainfall. Following the decision to exploit the agrochemical benefits of 6-OH-BDE-47, it and its
newly developed synthetic mimics discussed in Chapter 3 were reallocated to a set of assays
which screened for fungicidal activity in a number of critical fungal phytopathogens, e.g.:
Botrytic cinerea

Fusarium oxysporum

Colletotrichum acutatum

Phomopsis viticola

Collectotrichum fragariae

Phomopsis obscurans

Colletotrichum gloeosporoides
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4.1. BIOAUTOGRAPHIC TLC ASSAY
Originally, the plant pathogen screening was prearranged to be carried out in the plant
pathology labs of the U.S. Department of Agriculture. There, as a prelude to the extensive
quantitative reporting required for SAR studies, test compounds were first subjected to a
qualitative bioautographic TLC assay wherein dissolved test compounds were spotted onto a
chromatographic silica gel plate (20 X 20 cm).111, 112 Suspensions of fungal conidia in nutrient
rich broths were liberally applied to the TLC plates. Incubation in a humid atmosphere with a
12 h photoperiod permitted the growth of the fungi. Within 3-4 days, zones of inhibition could be
observed. Thus, antifungal compounds appeared as clear spots against a colored background
(Figure 33).

Figure 33. Bioautographic TLC assay of select compounds. Photo
demonstrates five antifungal compounds (Top Row) and duplicate runs
(Bottom Row). Background color represents Colletotrichum fragariae spores
which have freshly germinated hyphae. White spots are indicative of zonal
inhibition by the various test compounds. Left most TLC: 6-OH-BDE-47.
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If a compound proved inactive in the USDA‘s bioautography screen it most likely would
not have moved forward to their more extensive bioassays, i.e. the mycelial growth test and
detached leaf assay. Due to the high throughput appeal of the bioautography assay, dozens of
compounds could be qualitatively anaylzed within 3–4 days.

4.2. MYCELIAL GROWTH TEST
Once a compound proved active in the USDA‘s bioautography assay, it then progressed
to the mycelial growth test (also sometimes referred to as a microbroth assay). The mycelial
growth test involved using 96-well microtiter plates to determine the sensitivity of several
species of filamentous fungal plant pathogens to the various test compounds.113 As an example,
each well received roughly 90 μL of buffered broth, 100 μL of conidia at ca. 1.0 X 104 colony
forming units (CFU)/mL in buffered broth, and 10 μL of antifungal solution. In the current study,
compounds were assayed at 0.3, 3.0, and 30 μM concentrations. Growth of the fungal isolates
within each well were monitored using a microplate photometer set to record absorbance levels
at 620 nm. Inoculum density, i.e. CFU per milliliter, was monitored at 48 and 72 hours.
Graphical output data from the mycelial growth test can be viewed in APPENDIX A (p.166).
In many cases, the fungal isolates demonstrated suggestively more sensitivity to 6-OHBDE-47 and it bioisosteres than the commercially used agrofungicide captan. Precise inhibition
data cannot, unfortunately, be extrapolated from APPENDIX A because this particular batch of
compounds was not sufficiently purified prior to the mycelial growth test. Strongly implied from
the data was that the design concept of the project was heading in a highly positive direction,
which in turn cultivated a keen yearning to devise an appropriate purification strategy. This
moment marked the exact turning point in which preparative HPLC experiments were begun and
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effectively applied towards separating the 3-phenylindoles from their dehalogenated
counterparts.
Within six months time, eleven more highly unique—and highly pure—bioisosteres were
submitted to the USDA‘s mycelial growth test. Sadly, unanticipated health issues had begun
effecting the collaboration and those eleven compounds were never screened nor were they
returned. Anectodal observations appeared to suggest that the samples had, in fact, been
tampered with and even had the samples been returned they would likely not have been reliable
for resubmition to the biological screening. Because sample supplies were limited at the time, the
only rational approach to accumulate ample replacements was to resynthesize all eleven
compounds.
Further screening with the mycelial growth test was never pursued as the collaborative
commitments were deteriorating. Alternatives at this jucture were promptly prioritized and
endeavored.

4.3. DETACHED LEAF ASSAY
Despite the failed mycelial growth test attempts, personnel exchanges between the
University of Mississippi and the USDA made it possible to explore an advanced in vitro assay
which utilized live plant tissues. In 2008, Wang et al. developed a miniaturized 24-well leaf disk
bioassay in which 15 mm leaf disks were floated atop a nutrient rich media and inoculated with
filamentous fungal plant pathogens.114 The assay was designed such that compounds could be
applied directly to the leaf disk surface and evaluated in a dose-response fashion with regard to
fungicidal activity and phytotoxicity. A Lemnatec Lemna HTS and SAW Scanalyzer (a digital
imaging and analytical software technology; LemnaTec GmbH, Wuerselen, Germany) was used
to quantitate dose-response data as required for the SAR study.
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In the early development of the detached leaf assay, the investigators used 15 mm leaf
disks harvested from strawberry seedlings. Two week old seedlings were preferred because the
host defense systems were underdeveloped, thus allowing sufficient infection to take hold once
inoculated. Strawberry leaves proved susceptible enough to the inoculum conditions such that a
peer-reviewed publication was granted to the authors.114 However, one drawback to using
strawberry plants was the extreme difficulty in growing them inside the University greenhouse.
By the time 6-OH-BDE-47 and the synthetic bioisosteres were ready for the detached leaf
assay, the USDA investigators chose to substitute the strawberry leaf disks with cucumber leaf
disks. This modification to the assay was primarily done because of the ease at which cucumber
plants could be grown in the greenhouse. Dauntingly though, this seemingly small adjustment
required that every attribute of the assay be revalidated—from the nutrient media to the solvent
systems in which the antifungal compounds were dissolved.

4.3.1. Nutrient Media Validation
The first order of business to validate the use of cucumber material in the detached leaf
assay was to determine which media could best sustain the excised leaf disks. Upon the day of
media validation, cucumber seedlings were brought from the University greenhouse to the
USDA‘s plant pathology lab where the leaves were then disinfected and prepared as previously
described.114 A 15-mm stainless steel cork borer was used to harvest the leaf disks. Three
commerically available salt mixtures were evaluated: half-strength Hoagland‘s No. 2
(Phytotechnology Laboratories, Shawnee Mission, KS), 2-N-morpholino ethanesulfonic acid
(MES, Sigma M8250, Sigma-Aldrich, St. Louis, MO), and Murashige and Skoog basal salt
mixture (M&S, Sigma M5524). The salt solutions were transferred to 24-well microplates (1.5
mL each well) and the sterilized leaf disks were floated atop the media. Plates were maintained
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at 25.0 ± 0.1 °C with a 12 h photoperiod for 7-10 days. Throughout the incubation period the
plates were visually inspected for signs of tissue damage, i.e. leaf discoloration. Figure 34
represents one such media validation experiment observed at ca. 4 days.
At the end of the media validation experiments, the investigators chose Murashige and
Skoog basal salt mixture (M&S) as the media that best sustained the cucumber leaf disks. This
was different from the previously determined protocol as ½ strength Hoagland‘s No. 2 basal salt
media was recommended for sustaining the strawberry tissues.114 Thus, it was decided that if the
assay were to continue forward with cucumber leaves, M&S was the new best option for the
nutrient media.

Figure 34. Nutrient media validation. Each 15 mm cucumber leaf disk is floated atop 1.5 mL of
media. Row A: half strength Hogland‘s No. 2; Row B: Murashige and Skoog basal salt mixture
(M&S); Row C: 2-N-morpholino ethanesulfonic acid (MES); Row D: water (control). Medias were
evaluated for their ability to sustain harvested leaf disks for 7-10 days under controlled temperature
and 12 h photoperiod. Leaf color is indicative of chlorophyll content and, hence, tissue health (dark
green = healthier tissue).
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4.3.2. Solvent Validation
The solvents in which the test compounds were to be dissolved and applied to the leaf
surface had to meet several criteria to be validated for use in the detached leaf assay. First, the
proposed solvent, or mixture of solvents, could not be so harsh that it dissolved away the waxy
cuticle of the leaf. This would cause the leaves to be over susceptible to the onslaught of fungal
attack and would in turn provide for questionable interpretations of the assay data. Secondly, the
solvent could not be one which dissolved or etched the microplate. The microplates being used
were chemically non-resistant to harsh organic solvents such as acetone, DMSO, and CH2Cl2. If
etched, the microplate would certainly provide for inaccurate data. Thirdly, the solvent had to
sufficiently dissolve or suspend the test compounds. And lastly, and perhaps most obvious, the
solvent itself could not elicit toxicity to the leaf material.
Immediately, the use of organic solvents like acetone, DMSO, and CH2Cl2 was ruled out
due to their ability to ruin the microplate. Solvent systems exceeding ca. 30–40% EtOH or
MeOH were barred because they devalued the integrity of the leaf cuticle. Surfactants, e.g.
Tween® 20, Tween® 80, Cremophor®, etc., could fortunately be used to boost the solubility of
lipophilic compounds in aqueous mixes, yet their usage was restricted to a maximum
concentration of ca. 0.7% because they too could ruin the cuticle. Despairingly, 6-OH-BDE-47
and all its bioisosteres were so extremely lipophilic that they were immensely insoluble in
water— limiting the use of water.
With extensive experimentation, 20% EtOH/H2O spiked with 0.5% Tween® 20 provided
the best opportunity for introducing the compounds onto the leaf surface. Though still insoluble
within the matrix of this solvent mixture, the mixture provided for a well dispersed suspension.
The predominate drawback was that the mixture had to be vigorously shaken immediately before
application onto the leaf surface to insure uniform doses could be administered to each well.
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4.3.3. Application Considerations
Application method was another variable which had to be addressed. If, for instance, 20
μL of antifungal solution were pipetted onto the leaf disk, the compounds often did not disperse
evenly over the leaf surface. Instead, the hydrophobic nature of the leaf surface often caused the
tiny dose to bead atop the surface and roll off to one side of the leaf. On the other hand, the leaf
disk could be dipped into the antifungal solution prior to being placed into the microplate well.
This method also had flaws because the edges of the leaf disk, which had been freshly cut by the
cork borer, acted as artificial wounds which allowed test compounds and solvent to unwelcomely
enter the leaf. Such internalization negatively skewed the assessments of phytotoxicity. In the
end, dipping was preferred because the inoculum could easily destroy a leaf disk that was not
well coated with antifungal solution.

4.3.4. Inoculum Validation
Depending on the fungal species, isolates were grown on either ½ strength potato
dextrose agar (PDA) or potato dextrose & oatmeal agar (PO) in 9-cm Petri dishes and incubated
under fluorescent lighting (55 ± 5 µmols·m-2·sec-1) at 25 °C as previously described.115 Fungal
conidia were harvested from 7–14 day old solid cultures and filtered through sterile MiraCloth
(Calbiochem-Novabiochem Corp., La Jolla, CA) to remove hyphae. The aqueous conidial
suspensions were then analyzed photometrically at 625 nm to determine the stock concentrations
as described.113,

114, 116

Stock suspensions were then diluted to between 1.0 x 104–3.0 x 105

CFU·mL-1 using Tween® 20/H2O to aid spore dispersion and infection rate. Of course, as part of
the validation process, variable Tween® 20 concentrations (0.3, 0.5, & 0.7%) and conidial
concentrations had to be investigated to determine which set of parameters provided the best
infection rates. Figure 35 provides once such validation experiment with C. gloeosporioides.
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Figure 35. Validation experiment investigating Tween® 20 concentrations and conidial concentrations. Left
plate: Infected leaf disks with each well inoculated with 20 μL of conidia at 3.0 x 105 CFU·mL-1.
Tween® 20 concentrations were randomized. Right plate: Non-inoculated leaf disks. Again, Tween® 20
concentrations were randomized. As observed in the blank control, Tween® 20 concentrations of 0–0.7% all
allowed for good sustainability of the leaf tissue. This particular experiment inferred that cucumber leaf was
extremely too susceptible to these inoculum parameters. Follow-up experiments were done with lower
conidia concentrations. Photos taken 2–3 days post-inoculation.

C. gloeosporioides, C. fragariae, and B. cinerea all proved too virulent at
3.0 x 105 CFU·mL-1. Follow-up experiments investigating lower conidia concentrations began to
suggest that cucumber leaf was too susceptible at all standard concentrations of inoculum. Even
at 1.0 x 104 CFU·mL-1 the leaf disks were severely assaulted by the pathogens, i.e. the leaf disks
were destroyed within 3–4 days—not enough time to gauge the inhibitory effects of the
antifungal compounds. An infection rate of 7–10 days was preferred. Figure 36 depicts this
immense virulence C. gloeosporioides had on cucumber. C. fragariae and B. cinerea were
equally malicious to the cucumber leaves.
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Figure 36. Infected leaf disks under evaluation to determine inoculum concentrations. Photos are
of the same exact plate taken within 24 h. Note the explosion of fungal mycelium on Day 4.
Experiment suggests cucumber is too susceptible to this pathogen.

4.3.5. Antifungal Concentrations
When following the antifungal concentrations suggested by Wang et al.114 (antifungal
solutions were reported therein as ppm concentrations), the unit conversion suggested 6-OHBDE-47 and the bioisosteres should be evaluated at 1.25, 2.5, and 5.0 mM concentrations—
seemingly massive evaluation doses considering the mycelial growth test (APPENDIX A)
showed 6-OH-BDE-47 and the bioisostere to be active at submicromolar concentrations. In light
of this, 6-OH-BDE-47 had to undergo validation experiments to determine the optimal dose
ranges in the detached leaf assay. 6-OH-BDE-47 was tested at concentrations ranging from
0.5 µM to 5.0 mM. Dosing concentrations above 1.0 mM required astringent solvent conditions
to solubilize the compound. Phytotoxicity often resulted from these higher compound
concentrations though it was never ascertained whether it was 6-OH-BDE-47 or the solvent was
causing the observed phytotoxicity. Figure 37 exemplifies this observed toxicity within the
assay.
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Figure 37. Phytotoxicity study of 6-OH-BDE-47. Row A: Azoxystrobin applied in
various concentrations with 50% EtOH/H2O (positive control); Row B: 6-OH-BDE47 applied in various concentrations with 75% EtOH/H 2O; Row C: 6-OH-BDE-47
applied in various concentrations with 50% EtOH/H2O; Row D: Blank 50%
EtOH/H2O (negative control). Bleaching is indicative of phytotoxicity.

4.3.6. Detached Leaf Assay Summary
Attempts to bring together all aspects of the leaf assay—M&S basal salt mixtures,
excised cucumber leaves, mild conidia concentrations (ca. 1.0 x 104 CFU·mL-1), antifungal
solutions (0.5–1000 µM), etc.—completely failed to provide interpretable data due to the high
susceptibility of cucumber to the fungal isolates (Figure 37). USDA investigators were amidst
discussions to start the validation experiments from the beginning in hopes of validating the use
of yet another plant species, e.g. petunia or grape, but considering several months had already
been wasted on disastrous attempts to validate cucumber, the project leaders decided to forgo the
USDA and search for alternative collaborations. Thus, the detached leaf assays, mycelial growth
tests, and bioautography assays were all abandoned.
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Figure 38. Photo expresses the high susceptibility of the cucumber leaves. Top Row:
Blank (control). All other leaf disks were devastated by the pathogen, including the
positive controls which contained azoxystrobin.

4.4. HUMAN CELL ASSAY: A TEMPORARY FIX
While searching for new collaborators who could provide consistently reliable plant
assay data, the chemists synthesizing the 6-OH-BDE-47 bioisosteres were still in dire need of
SAR feedback to point the chemistry in a progressive direction. Being that 6-OH-BDE-47‘s
biological activity was first discovered in a human pathogen assay (p. 63), a snap decision was
made to temporarily supply the novel synthetics back to this initial collaborator who could at
least provide some form of meaningful biological activity during the interim. As before,
compounds were screened against the human pathogens listed in Table 5 (p. 63). APPENDIX B
provides the complete set of data gathered from the human pathogen assay (p. 175).
Notable attention was garnered from the carboxylates as none of the compounds from
this class showed biological activity. On the other hand, their indolic counterparts, which were
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unsubstituted in the C-2 position, elicited significant
biological

activity.

Even

the

simplistic

non-phenylindoles followed this same pattern
(Figure 39). In fact, this trend was true in all cases
within these series, regardless of the substituents
around the fused benzene ring of the indole or the
phenyl ring occupying the C-3 position.
From APPENDIX B it is also easy to see
that the indazoles possessed marginal biological
activity, often showing activities between that of the

Figure 39. Examples of carboxylates with no
biological activity, despite having significantly
active counterparts.

indoles and carboxylates. In some isolated cases, e.g. 5-chloro-3-phenylindazole 103 and
Aspergillus fumigatus, the indazoles elicited biological activities that were intriguing.
Unfortunately, the indazoles failed to demonstrate the same broad spectrum antimicrobial
activity as the indoles. Thus, the screeners deferred the indazoles from the tertiary screens as the
3-phenylindoles were more appealing.
What was certain from the human pathogen assay was that the 3-phenylindole series were
fungicidal, and in most cases also bactericidal. Compounds such as 4,6-dichloroindoles 32 and
54 conveyed biological activities exceptionally near that of 6-OH-BDE-47—exactly on course
with what the project was meant to achieve. Of course, the data from this particular assay could
only guide the project forward for so long, as questions still remained around the toxicity profiles
and the utility of these compounds with regard to plant pathogens. Simply put, more biological
data was demanded which this assay could not produce. The search for new collaborators
continued.
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Figure 40. 4,6-Dichloroindoles with comparable biological activities to
6-OH-BDE-47.

4.5. A NEW COLLABORATION AND
FUTURE PROMISE FOR 6-OH-BDE-47 BIOISOSTERES
While at the same time the provisional human pathogen SAR data was being pursued at
Mississippi‘s National Center for Natural Products Research, project leaders were actively
seeking an independent lab that could screen 6-OH-BDE-47 and its bioisosteres for fungicidal
activity in plant tissue assays. With much deliberation, exciting new research agreements were
locked into place between The University of Mississippi, School of Pharmacy and Syngenta
Crop Protection, Inc. As per the agreement, Mississippi was to supply Syngenta Crop Protection
with 6-OH-BDE-47 and seventeen (17) synthetic analogues of the natural product. In return,
Syngenta Crop Protection was to provide feedback to Mississippi regarding the compounds‘
performance within their biological assays, which screened for fungicide, herbicide, nematicide,
and insecticide activity.
Exciting to the new venture was the fact that Syngenta Crop Protection was a subsidiary
of the global agricultural colossus, Syngenta AG (hereinafter ―Syngenta‖). Headquartered in
Basel, Switzerland, Syngenta boasts a product portfolio that dominates more than 25% of the
global fungicide market.28, 117 In 2008 alone, Syngenta revenued more than US$2.6 billion from
its global fungicide sales.117 Table 8 (p. 79) illustrates several antifungal chemicals which
Syngenta uses throughout their fungicide product line. Although Syngenta markets dozens of
agrofungicidal mixtures worldwide, most all of them have unique formulations incorporating
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only those molecules mentioned in Table 8, e.g. azoxystrobin, chlorothalonil, difenoconazole,
etc. Ironically, the fungicide used as a positive control within many of the USDA‘s bioassays
mentioned in Section 4.3 (p. 67) was a Syngenta product, azoxystrobin. Further affirming the
status of Syngenta was a seminal publication by Syngenta scientists Eric Clarke and John
Delaney in which they put forth a set of ―Lipinski rules for agrochemicals‖.118 Their guidelines
are referred to as the Clarke-Delaney Rules and are used by chemists to help them design
compounds with optimal agrochemical properties.
Upon disclosure of the compound structures to Syngenta, a team of Syngenta scientists
handpicked 17 synthetic analogs to screen in their pesticide assays. Their preliminary screen for
fungicidal activity was similar to the USDA‘s mycelial growth test (p. 66) and leaf-piece assay
(p. 67), although Syngenta chose to screen against seven different fungal crop pathogens.
Compounds were screened in 96-well plates at concentrations ranging from 2–200 ppm,
depending on the pathogen of interest (Table 6 & 7).
Table 6. Mycelial growth testsa
Test species

Media

Rate (ppm)

Pythium dissimile

Semi-solid

20 and 2

Alternaria solani

Semi-solid

20 and 2

Botryotinia fuckeliana

Semi-solid

20 and 2

Gibberella zeae

Semi-solid

20 and 2

a

Compounds were evaluated in mycelial growth tests in
artificial media against Pythium dissimile, Alternaria solani,
Botryotinia fuckeliana and Gibberella zeae, at rates of
20ppm and 2ppm.

Table 7. Leaf-piece assaya
Test species

Host

Rate (ppm)

Septoria tritici

Wheat

100

Phytophthora infestans

Tomato

200 and 60

Uromyces viciae-fabae

Bean

100

a

The compounds were evaluated at 100ppm against Septoria
tritici on wheat, and 200ppm and 60ppm for Phytophthora
infestans on tomato and 100ppm for Uromyces viciae-fabae on
bean. Chemicals were applied prior to inoculation in the leaf-piece
assays.
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triazole

anilinopyrimidine
triazole

difenoconazole

cyprodinil
difenoconazole

Inspire®

Inspire Super®

chloronitrile

chlorothalonil

Bravo Ultrex®

triazole

benzothiadiazole

cyproconazole

acibenzolar-Smethyl

Actigard
50WG®

strobilurin

Fungicide Class

Alto 100SL®

azoxystrobin

Active Ingredient

Abound
Flowable®

Brand Name

Table 8. Fungicides from Syngenta‘s Product Portfolio

24.1
8.4

23.2

82.5

8.9

50.0

22.9

Percent Active
Ingredient
(w/w%)

see also Inspire®

Structure

controls cucurbit diseases

controls foliar almond disease

broad-spectrum control of foliar
disease

controls Asian soybean rust

control downy mildew in leafy
vegetables

broad-spectrum control of foliar
disease

Uses
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fludioxonil

mefenoxam
chlorothalonil

Ridomil Gold
Bravo SC®

Scholar®

mandipropamid

phenylpyrrole

acylalanine
chloronitrile

madelic acid
amide

pyridinamine

triazole
triazole

propiconazole
difenoconazole

fluazinam

Fungicide Class

Active Ingredient

Revus®

Omega 500F®

Inspire XT®

Brand Name

Table 8. (continued)

50.0

3.3
33.1

23.3

40.0

22.8
22.8

Percent Active
Ingredient
(w/w%)

see also Bravo Ultrex®

see also Inspire®

Structure

protects post-harvest stone fruit

blight and downy mildew

control of blight and downy
mildew

control of blight

controls sugarbeet disease

Uses

Herbicidal assays were carried out against Arabidopsis thaliana at 10 ppm and Pao
annua at 32 ppm (Table 9). Compounds were further tested for insecticidal activity against aphid
species in a leaf-disc assay at 1000 ppm and also evaluated on Plutella xylostella at 500 ppm in
an artificial diet assay (Table 10). Activity against nematode species were evaluated using
Caenorhabditis elegans in liquid cultures at 10 ppm (Table 10).

Table 9. Herbicide assaysa
Test species
Arabidopsis thaliana

Treatment timing

Rate (ppm)

Pre emergence

10

Poa annua
Pre emergence
32
a
Compounds were tested for herbicidal activity against Arabidopsis
thaliana at 10ppm and Poa annua at 32ppm. Test plates were stored for
seven days in a controlled environment cabinet.

Table 10. Insecticide & nematicide assaya
Test species

Treatment type

Media

Rate (ppm)

Aphid species
Plutella xylostella

Feeding/contact

leaf disc

1000

Feeding/contact

Artificial diet

500

Caenorhabditis elegans

Feeding/contact

Liquid culture

10

a

The compounds were tested for activity against an aphid species in a leaf-disc assay
at 1000ppm. The compounds were also evaluated at a rate of 500ppm on Plutella
xylostella in an artificial diet assay and against the nematode species Caenorhabditis
elegans in liquid culture at 10ppm. Chemicals were applied to feeding aphids, prior to
infestation with P. xylostella larvae, or diluted into the C. elegans culture.

Syngenta‘s preliminary pesticide assays were meant as a qualitative measure of
biological activity and, thus, did not seek to explore inhibitory concentrations. Inhibitory
concentrations would be evaluated during secondary-tier assays if compounds were to advance
beyond preliminary biological screening. Syngenta‘s methods and results from preliminary
screening are provided in APPENDIX D (p. 193).
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4.6. RESULTS AND DISCUSSIONS
As of the writing of this dissertation, the heterocyclic bioisosteres synthesized to date
have been screened in the USDA‘s bioautography and mycelial growth tests, the National Center
for Natural Products Research‘s human pathogen assay, and Syngenta‘s preliminary pesticide
screens. Though meaningful data can be extracted from these assays, this task is made difficult
due to less than ideal screening conditions and inconsistencies from assay to assay. Take for
instance the fact that the USDA‘s bioautography assay was merely qualitative in its assessment
of fungicidal activity and the mycelial growth test results were similarly qualitative in light of the
circumstance that compounds were screened prior to appropriate HPLC purification methods
being developed. The USDA‘s detached leaf assay failed validation studies and, moreover, was
hampered by defective imaging instrumentation; the opportunity to submit test compounds to the
detached leaf assay never presented itself. The human pathogen assay data, presented in
APPENDIX B (p. 175), proved quite useful, but again strayed far from ideal due to the lack of
agricultural relevance. And though the new collaboration with Syngenta promises the
opportunity for numerical ranking of test compounds based on their respective inhibitory
concentrations, the preliminary data provided to date is of qualitative character.

4.6.1. Insight from the Human Pathogen Assay
When considering only the human pathogen data, a number
of conclusions can be drawn around the SAR of the synthetic
analogues represented by Figure 41. In agreement with early
studies of the natural PBDEs, blocking the acid/base properties of
the N-1 position, using protecting groups, abolishes biological
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Figure 41. General
structure of synthetic
bioisosteres.

activity with regard to most pathogens. In the case of A. fumigatus and C. neoformans, some
biological activity remains though attenuated (APPENDIX B). This data affirms that the N-1
proton is important to biological activity.
Derivatives possessing carboxylate functionalities at the C-2 position showed a
widespread loss of activity across all pathogens studied in the human pathogen assay. Exampled
carboxylates RAS-06-074, AF-07-005, AF-06-086, and AF-07-041A are all prime examples of
this activity forfeiture, especially when compared head-to-head with their non-carboxylated
derivatives, e.g. AF-07-041B, RAS-07-032, and AF-07-024 (APPENDIX B). Replacing the C-2
carbon atom with a nitrogen atom, as in the case of indazoles RAS-04-080 and RAS-05-006, did
not completely destroy all activity but the activity was severely diminished. Investigations into
the carboxylate and indazole series strongly suggested that tampering with the C-2 position very
negatively affected biological activity.
In instances like AF-07-041B and AF-07-041C, where the C ring was omitted, activity
was still maintained though lessened (APPENDIX B). While modes of action are not yet known
for these compounds, it is reasonable to consider from this data that the C ring may have
significance in occupying a deep cleft within the enzymatic binding pocket, or alternatively it
may help with membrane permeation. Regardless of the logic, it seemed obvious that some form
of C-3 substitution was necessary.
pKa contributions to activity were interesting to note because pKa ranges of the synthetic
analogs were calculated to be relatively close to pKa ≈ 14—values significantly higher than that
of 6-OH-BDE-47 (ca. 6.8). The circumstance of having highly active compounds 10 million-fold
less acidic than the natural product PBDEs begins to suggest that either the indolic compounds
inhibit microbial growth via a different mode of action or the donatable N-1 proton is more
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important for its hydrogen bonding capabilities rather than its acid/base properties. Nonetheless,
it is thought-provoking that a pKa trend is still observable within the indolic compounds
(APPENDIX B). Take for example indoles AF-07-018C, AF-07-024, and AF-07-032 which
contain the halogens fluorine, chlorine, and bromine. Electron withdrawing functionalities
located around the ring system increase N-1 acidity and it follows that the electron withdrawing
ability of halogens follows as I < Br < Cl < F, where fluorine is the most electron withdrawing
halogen and thus most acidifies the indolic proton. In accordance with the pKa hypothesis
discussed in Chapter 1, AF-07-018C, AF-07-024, and AF-07-032 follow closely this trend of
potency, i.e. the fluorinated indole (AF-07-018C) is most potent, the chlorinated indole
(AF-07-024) less so, and the brominated indole (AF-07-032) least potent.
Exploring the substitution patterns allowed on the C ring gave way to the idea that the 4‘
position might be the most influential position on the C ring. APPENDIX B offers examples of
3-phenylindoles having ortho-, meta-, and para-chloro substitution on the C ring (Figure 41); as
well, there is an example of a meta/para-dichloro derivative. Data suggests that monosubstitution
is preferred on the C ring and of the monosubstituted derivatives, the para-substituted
compounds possessed more potent inhibitory activity. The monosubstituted preference is
illustrated yet again with RAS-03-016 (R2 = 2‘,4‘-difluoro) and AF-07-018C (R2 = 4‘-fluoro).
The human pathogen assay revealed relatively little insight as to the allowances around
the A ring because the 4,6-dichloro- and 4,6-dibromoindoles were predominately the only set of
compounds screened in this particular assay. What little differences do exist on the A ring again
suggest that the electron withdrawing strength of the chlorine atoms is preferred to bromine. This
once more advocates that the more acidic the N-1 proton, the better the biological potency.
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While a plethora of compounds have since been synthesized with a wide variety of
substituents occupying different positions around the A and C rings, many of these compounds
have yet to be screened in biological assays, even at the time of writing this manuscript. Many of
the more exotically adorned indoles were withheld from the human pathogen assay due their
limited availability and because there was a much greater demand to submit these compounds to
a more agriculturally relevant assay. Unfortunately, the USDA‘s detached leaf assay never
witnessed the introduction of the bioisosteric compounds and as per the Syngenta agreements,
Syngenta hand-selected only the compounds in which they were interested. So again, many of
the compounds synthesized for the purpose of this project have yet to be screened for biological
activity.

4.6.2. Insight from Syngenta’s Preliminary Assays
Little can be said about the structure-activity relationships of the compounds screened in
Syngenta‘s preliminary fungicide assays (APPENDIX C; p. 183). Few compounds showed
activity in this assay making it difficult to interpret SAR information. Complicating matters,
Syngenta screened against seven different fungal pathogens; pathogens that were different from
all of the USDA‘s biological assays and, of course, different from the human pathogen assays.
Fungicidal data pertaining to carboxylate RAS-06-074 and meta/para-dichloroindole
RAS-03-066 (APPENDIX C) fully disagreed with the results discussed above in the human
pathogen assay. While carboxylates proved inactive against all the human pathogens tested, the
carboxylates were among very few compounds active against Septoria tritici, a wheat fungal
pathogen. Additionally, the disubstitution on the C ring allowed for potentiated activity against
Septoria tritici when compared to the monosubstituted C ring, e.g. RAS-03-010 vs. RAS-03-066
(APPENDIX C). Intriguingly, even 6-OH-BDE-47 showed relatively little activity against
85

Syngenta‘s array of fungal pathogens. This lack of activity is likely due to selectivity and not
inhibitor concentrations. Recall that the USDA‘s mycelial growth test showed 6-OH-BDE-47
activities as low as 0.3 μM (APPENDIX A) while the human pathogen assays exposed activities
in the range of 40 nM–40 μM, depending on the pathogen (APPENDIX B). Syngenta‘s fungicide
assays screened 6-OH-BDE-47 and its synthetic bioisosteres at 4–400 μM, concentrations
10-fold greater than required to elicit biological responses from previous assays. What can be
deemed from this information is that 6-OH-BDE-47 and the indolic bioisosteres are selectively
active against particular fungal species.
Compounds showed no activity in the herbicidal assays (APPENDIX C) which came as a
relief as it‘s not desirable to elicit toxicity towards the very host one is trying to protect. But with
no apparent activity in the herbicide assay no conclusions can accurately be drawn about the
SAR of the compounds. And so attention must be turned to the insecticide and nematicide
assays.
At rates of 20 μM–2 mM, Syngenta‘s insecticide assays screened against Caenorhabditis
elegans, Plutella xylostella, and an aphid species (APPENDIX C). Compounds showed
selectivity from compound to compound and also from species to species. As with the SAR
information gathered from the human pathogen assays, the carboxylates presented no activity
towards the insects while the indazoles appeared to have a diminished amount of activity. Again,
these assays were qualitative and so direct comparisons are made difficult. In further agreement
with previous data, the compounds having para-substitution on the C ring provoked more
inhibitory responses in the insect assay. The more electron withdrawing adornments, and hence
more acidic compounds, also showed more activities in the assay.
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Contradictory to the pKa hypothesis was trinitro compound RAS-08-037 (APPENDIX C).
With a pKa 1000-fold more acidic than the other indoles, RAS-08-037 was expected to have a far
more improved potency than the other compounds. A passible cause for the deficient activity
may be related to compound instability. The thought for concern arose when several grams of the
intermediate 5,7-dinitroindole 84 (p. 120) was found to have decomposed while under an argon
atmosphere in the freezer for several weeks. Though the stability of RAS-08-037 was not
determined, it too had remained stored for several weeks before biological screening
commenced. The stability issues surrounding intermediate compound 84 were not realized until
weeks after all 3–5 mg of RAS-08-037 were submitted to assay; due to the limited availability of
RAS-08-037, no compound remained archived for instability studies. Another thought for
concern is that RAS-08-037 has a much higher polar surface area—about 15-fold greater than
that of the halogenated indoles and natural products. For purposes of SAR study, it would be
worthwhile to resubmit a freshly synthesized batch of RAS-08-037 to the biological assays while
retaining some sample for stability studies. Unfortunately, as per the material transfer agreement
it will likely be to Syngenta‘s discretion as to whether or not RAS-08-037 can be rescreened.
Curiously, when no substituents appeared around the C ring as in the case of
RAS-08-031, or when heteroatoms were incorporated into the C ring as in the case of
RAS-08-032, all insecticidal activity was abolished (APPENDIX C). Without a wider array of
compounds tested, it is difficult to discern the reason for the lost activity in these compounds.
Explanations may include, but are certainly not limited to, changes in the acid/base properties,
lipophilicity, polar surface area, etc.
Upon completion of their preliminary biological screens, Syngenta requested permission
to advance fourteen compounds to their secondary-tier assays which would elucidate inhibitory
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concentrations and perhaps modes of action. At the time of this writing, the secondary-tier assays
have not yet been completed. It is expected that further SAR conclusions will be passible once
secondary-tier assays are complete.
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V. CONCLUSIONS AND FUTURE DIRECTIONS

5.1. RESULTS SUMMARY
With regard to Syngenta‘s preliminary biological data (APPENDIX C), none of the
compounds were active on either herbicide assay, 12 compounds showed activity on the
insecticide screens against aphid species & Plutella xylostella, 12 compounds were active on the
nematicide assay, and 4 compounds showed weak to moderate activity in the fungicide assays
against Septoria tritici & Alternaria solani. Active compounds have garnered enough industrial
interest at this point to have progressed into secondary-tier assays where technical attention
continues. Many compounds synthesized during the course of this dissertation work have
additionally boasted fungicidal and bactericidal activity in other assays, such as those performed
by the USDA and National Center for Natural Products Research. 20 compounds elicited
inhibitory activity against a variety of human pathogens, e.g., Candida albicans and methicillinresistant Staphylococcus aureus.
Exampled IC50s of the synthetic analogs ranged 1–100 μM in the case of screens against
methicillin-resistant S. aureus, 6–40 μM with regard to C. albicans, and as low as 300 nM
according to the USDA‘s screens against Botrytis cinerea, Phomopsis obscurans, & Phomopsis
viticola. Control of nematode populations was observed quite readily at inhibitory concentrations
ranging 20–40 μM, while the preliminary insecticide assays explored inhibitory concentrations in
the range of 1–4 mM.
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While some of these inhibitory concentrations seem quite high compared to
pharmaceutical uses in humans, it may be important to first consider a commercial example.
Take for instance the commercial use of the insecticide thiamethoxam, a positive control used in
Syngenta‘s biological screening (p. 191). Thiamethoxam is a neonicotinoid marketed by
Syngenta under the brand name Actara®, a product which contains 25 wt. % thiamethoxam. To
protect barley crops against aphids, Syngenta‘s label directs users to apply Actara ® at a rate of
4 oz. per acre (oz./A) in a solvated state consisting of a minimum water volume of 10 gallons per
acre (GPA). Even at a more conventional 20 GPA volume the commercial application rate of
thiamethoxam is ca. 1.3 mM, as demonstrated by Equation 1,

4 oz. Actara in 20 gal. H2O 

28.4 g thiamethoxam mol 1000 mmol


 1.3 mM ,
75.7 L
292 g
mol

(1)

where 292 g•mol-1 is the molecular weight of thiamethoxam.
While a number of compounds show acceptable inhibitory concentrations towards a
variety of microorganisms, it is when all details are considered together that one comes closer to
understanding the SAR of these compounds. Indolic compounds of this class possessing
heteroatoms and/or substituents at the C-2 position generally have attenuated biological activity.
The C ring at the C-3 position appears important for the more potent inhibitory activities and it
appears that carbocycles are more conducive to biological response than heterocycles. Electronwithdrawing groups that do not increase polar surface area seem to be preferred at most positions
around the A and C ring, but they especially seem to be preferred at the 4‘-position of the C ring;
this is a position having significant electronic influence over the N-1 acidity. Increasing the
acidity of the indolic proton appears to be a promising strategy for designing compounds with
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superior potency as long as the polar surface area can remain at a minimum and the C-2 position
is left untouched.
Although the original hypothesis of this project endeavored to explore the design and
synthesis of novel fungicides as they pertained to agrochemical use, the assays have provided an
interesting twist to the project, evoking that the compounds may prove more valuable to crop
protection by means of their insecticidal function. Like agrofungicides, the global market for
insecticides hovers around US$10 billion per year and there exists a substantial interest for
scientists to continue development of novel insecticides. Along this line of interest, compound
classes designed and synthesized during the course of this dissertation remain under
investigational studies with regard to their biological activity and have demonstrated quite
valuable as investigational tools for use by the agrochemical industry.

5.2. FUTURE DIRECTIONS
5.2.1. Chemical Investigations
5.2.1.1. Suggested Thoughts for Optimization of the Suzuki Cross-Coupling

Recalling the problems associated with the Suzuki cross-coupling introduced on p. 43,
there exist a number of possible synthetic approaches to thwart the dehalogenation hurdle and
boost yields. The synthetic route towards 3-phenylindoles via the Pd-catalyzed hetero-Cope
rearrangement provides exceptional yields throughout the linear approach but bottlenecks at the
Suzuki coupling in which the C ring is introduced. As presented in Chapter III, the hetero-Cope
approach requires 7 synthetic steps to progress substituted nitrobenzenes to final compounds and
can be diligently completed during the course of an average work week. Overall yields
associated with this approach linger around 4%, a frustrating disappointment aggravated only by
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the lost yield of the Suzuki coupling—the last step of the synthesis. If it were possible to enhance
the yield of the Suzuki coupling to only ca. 70%, the overall yields would witness an 11-fold
increase, climbing from a modest 4% to a far more pleasing 43% overall yield.
During the past year, Phil Baran et al. published a promising methodology paper119 on
arylation reactions involving electron-deficient heterocycles with arylboronic acids. Therein they
present the use of catalytic amounts of silver(I) nitrate (< $1.00 g-1) in the presence of a
persulfate co-oxidant (ca. $0.01 g-1). Their reactions proceed under ambient conditions and
witness yields ranging 30% to >90%. While it is recognized that their methods sought to exploit
direct C-H arylations of heterocycles with arylboronic acids, it may prove beneficial to perform
some methodology studies using their coupling conditions to cross-couple substituted
3-iodoindoles with arylboronic acids. Alternatively, recall that that 3-iodoindoles can easily be
converted into indoleboronic acids (see Scheme 6; p. 44) and then coupled to other aryl groups,
perhaps using the silver(I) nitrate and persulfate conditions to promote C-H direct-couplings.
Other groups have additionally mentioned similar protonolysis problems120 as discussed
herein, but sometimes contribute the problem to coupling partners having significant steric
hindrance around the coupling handles. Chaumeil et al.120 attempted to address this problem with
anhydrous benzene refluxing in the presence of sodium phenoxide, Pd(PPh3)4, and silver(I)
carbonate. Their efforts may be worth investigating further with regard to the Suzuki
cross-couplings discussed herein.
5.2.1.2. Probing the pKa Questions Surrounding 6-OH-BDE-47

Pursuing compounds with lowered pKas is still of high interest to the exploring
hypothesis of this project. While the pKa of 6-OH-BDE-47 is understood to be ca. 6.5, it would
be interesting to investigate what happens to the biological activity should one be capable of

92

acidifying 6-OH-BDE-47 to a pKa ≈ 1. While transitioning between collaborators, steps were
being taken to access sulfate esters of 6-OH-BDE-47, but the synthesis was never completed as
Syngenta‘s team of scientists ultimately chose which compounds would undergo their
preliminary screening—the sulfate esters were not selected for preliminary screens. Nonetheless,
it is still desirable to access the sulfate esters of 6-OH-BDE-47 for future biological screening.
Initial attempts to perform a direct sulfation on 6-OH-BDE-47 using reagents like
chlorosulfuric acid failed to provide an isolable product because the resulting phenol sulfuric
acid was NOT hydrolytically stable and, unless neutralized, decomposed to form sulfuric acid
and the original phenol. An alternative approach that was being pursued is outlined in Scheme
16, in which an aryl sulfate protecting group strategy121 was hoped to allow for isolation of the
presumably stable sulfate 114. Compound 113 was successfully synthesized in respectable yields
and well characterized by NMR, but removal of the 2,2,2-trichloroethyl (TCE) moiety via
hydrogenolysis or Zn/NH4HCO2 was never endeavored as Syngenta‘s compound quota was
already filled. But should the opportunity for further testing present, it would be worthwhile to
complete the synthesis of sulfate ester 114 and its phosphate ester counterpart. The acidity of
these compounds is expected to be pKa ≈ 1 while the PSA is ca. 70 Å2. It would be appealing to
see how these groups effect biological activity.
Scheme 16a

a

Reagents and conditions: (a) 2,2,2-trichloroethoxysulfuryl chloride, Et3N, DMAP,
THF, room temp.; (b) 10% Pd/C, NH4HCO2, MeOH; or Zn poweder, NH4HCO2, MeOH.

93

5.2.1.3. Optimizing the Partial Reduction of Nitrobenzenes to Hydroxylamines

The need for performing partial reductions on nitrobenzenes was introduced on p. 39 in
order to access hydroxylamines which could then be acetylated and subsequently subjected to
hetero-Cope conditions providing high yields of substituted N-acylindoles. Ung et al. had
modified a conventional approach (Zn/NH4Cl) to the partial reduction of nitrobenzenes by the
introduction of ultrasound,94 and it was this modified approach which was used throughout this
project to access various N-aryl hydroxylamines. Though these reaction conditions proved
exceptionally useful, they rarely went to completion without over reducing and quite often had to
be stopped when only 60% complete. The other 40% of the crude reaction mixture was often
recovered as unreacted starting material.
A slightly more recent approach optimized the ultrasound conditions by instead using a
convenient Zn/HCOONH4/CH3CN system.122 This procedure, reported by Shi and co-workers,
allowed for repeated yields in excesses of 90%. In optimizing the syntheses described herein, it
may be sensible to perform some methodology studies regarding the reduction procedures
communicated by Ung et al.94 and Shi et al.122
5.2.1.4. Improving the Protecting Group Strategy and Reflections on the Hetero-Cope

Acetyl protected N-arylhydroxylamines were pursued as precursory intermediates for the
hetero-Cope rearrangement due to literature precedence (introduced on p. 37).86,
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Nitrogen

protection is required for successful hetero-Cope rearrangements of these compounds, but it is
uncertain as to the allowance of the protecting group functionality. Because late in the synthetic
development of this project it was discovered that BOC protection of the indole nitrogen
provided optimal yields during the cross-coupling reactions (p. 48), there was a loss of elegance
in having to toggle between protecting groups to fit the needs of the cross-coupling step (Scheme
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9; p. 52). It seems highly possible, though unexplored, that one could instead BOC protect the
N-arylhydroxylamines and still accomplish the hetero-Cope rearrange to provide a direct route
towards BOC protected indoles. Porzelle et al. have already reported on chemistries surrounding
differentially protected N-arylhydroxylamines, including BOC protected analogs.123 It seems
quite likely that using BOC protected intermediates exemplified by Scheme 17 would present a
facile solution to the drawbacks of the current protection strategy and allow for a more
streamlined synthesis. Additionally, the expensive Li2PdCl4 required in the hetero-Cope
rearrangement can be generated in situ using LiCl and PdCl2; this may present a cheaper
alternative for the hetero-Cope conditions and should be explored further.
Scheme 17a

a

Reagents and conditions: (a) zinc dust, sat. aq. NH4Cl, H2O, acetone, ))), room temp,
5 min.; (b) BOC2O, THF; (c) LiCl, PdCl2, vinyl acetate, HCO2H; (d) EtOH, H2O, KIaq, I2;
(e) phenylboronic acid, PhH, MeOH, sat. aq. Na2CO3, Pd(PPh3)4, 110 °C, 8 h; (f) C18
reversed phase HPLC, 65% ACN/H2O → 100% ACN.

5.2.1.5. Prodrug Considerations

A recent synthetic study employed a prodrug approach to increasing the antibacterial
potency of triclosan and successfully illustrated a 4-fold increase in potency when tested against
Escherichia coli and Plasmodium falciparum.124 Because of the structural similarities of triclosan
and the natural OH-PBDEs (Figure 6; p. 8), it seems appropriate that introducing a prodrug
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functionality mimicking that discussed by Surolia et al. could increase the potency of 6-OHBDE-47, and perhaps the synthetic analogs as well. Their approach used a pro-moiety containing
an amine functionality to enhance hydrophilicity and cellular uptake, as the weakly basic nature
facilitated accumulation inside the bacterial cells. Scheme 18 exemplifies one such pro-moiety
used by Surolia et al.
Scheme 18a

a

Reagents and conditions: (a) CH2Cl2, DIPEA; (b) i. CDI, DMF; ii. triclosan, CH 2Cl2;
(c) methyl iodide, THF; (d) Sephadex.

5.2.1.6. Advice for the Completion of Pipeline Intermediates

Inopportune circumstances repeatedly halted the flow of synthetic progress throughout
this project and as a result there exist a number of highly advanced intermediates which never
secured advancement to final compounds. Several of these advanced intermediates are
highlighted in Figure 42. Compounds S3 and S4 were the predominate series of compounds
subjected to biological testing, but there exist more opportunities to exploit the iodine handle for
derivatizations. Compound S10 was advanced to only one final compound (73; described on
p. 147) but due to the low quantity that was yielded from that reaction compound 73 never
visited the biological screenings. Compound 86 was also advanced to only one final compound.
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And many, but not all, of the compounds listed in Figure 42 have been inventoried in-house on
multi-gram scales and await further synthetic development.

Figure 42. Advanced intermediates which were successfully synthesized and described herein, but
never advanced to final compounds—with the exception of only a few, e.g., S3 and S4.

In addition to the many advanced intermediates mentioned in Figure 42, numerous
different boronic acids have been purchased and inventoried in-house with the anticipation of
producing a plethora of final compounds for biological screening and SAR studies. Figure 43
illustrates many of the boronic acids purchased for this derivatization purpose. Unfortunately due
to the inconsistent nature of the collaborations discussed herein, less than 50% those boronic
acids purchased in Figure 43 were actually utilized during the course of this project. By simply
combining the under exploited indolic intermediates in Figure 42 with only the available boronic
acids in

Figure 43, one could synthesize 384 possible final compounds for biological
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screening—a sum far exceeding the allowed number of compounds screened herein. If the
diversity-oriented synthesis of these compound classes were to continue, it is advisable to start
from the readily accessible building blocks outlined in Figure 42 & 43.

Figure 43. Boronic acids purchased and inventoried in-house. Less than 50% were utilized
during the course of the project due to the inconsistent nature of the collaborations for
biological screening.

5.2.2. Biological Investigations
5.2.2.1. Potential for Anticancer Activity

Recent publications like that of Chang et al. report that 6-OH-BDE-47 and similar
OH-PBDEs illustrated in Figure 44 showed antiproliferative activities against the human breast
adenocarcinoma cancer cell line MCF-7 at low micromolar concentrations.8 Interestingly, the
authors progressed 6-OH-BDE-47 to a secondary-tier assay for evaluation in a cell cycle
progression study. While the synthetic bioisosteres presented herein are expected to possess poor
bioavailability profiles in mammals, it remains intriguing that, like the OH-PBDEs, they too may
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possess anticancer activity in in vitro models. If the opportunity presents, the synthetic
bioisosteres of this dissertation work should be screened in similar MCF-7 biological assays as
discussed by Chang et al.8

Figure 44. Chemical structures of compounds isolated from the sponge Dysidea sp. which elicited
antiproliferative activities against the cancer cell line MCF-7.

5.2.2.2. Antimalarial Potential

Publications like that Surolia et al. have pointed out that triclosan elicits low micromolar
IC50s against the malaria parasite Plasmodium falciparum,124 and others have also worked out the
mechanism of P. falciparum inhibition by triclosan.125-129 With the apparent similarities of
triclosan and compounds discussed herein, it is likely that the synthetic analogs of this
dissertation work may possess antimalarial activity. If the opportunity presents, the synthetics
bioisosteres of this dissertation should be screening in similar P. falciparum biological assays as
discussed by Surolia et al.124

5.2.3. Closing Thoughts
While there are numerous pesticide options commercially available to farmers, no single
product is a cure-all for the thousands of crop pests around the world. Over time, regulation
agencies will undoubtedly ban many of the currently used pesticides as environmental awareness
continues to grow, while other currently used compounds will assuredly someday loose
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importance due to the natural development of acquired resistance. And as the world population
persists to enlarge and farmland remains limited the options for feeding a growing population are
narrow: farm new land or get more production from existing farmland. Food production will
have to increase 70% by the 2050130 and producing more from less will be essential to
agriculturalists. The continued development of better ways to protect crops from insects, weeds,
and disease will be forever important.
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VI. EXPERIMENTAL

General methods:
Moisture- and oxygen sensitive reactions were carried out in flame dried glassware under an
inert argon atmosphere. Dry tetrahydrofuran (THF), diethyl ether (Et2O), and 1,4-dioxane were
distilled from sodium metal and benzophenone. Dry dichloromethane (CH2Cl2) was distilled
from CaH2. All commercially available starting materials and reagents were purchased at the
highest commercial quality and used without further purification, unless otherwise stated.
Reactions were monitored by thin-layer chromatography (TLC) carried out on 225 µm aluminum
backed TLC sheets coated with silica gel 60 F254 (EMD Chemicals Inc. Gibbstown, NJ, USA).
TLCs were visualized under UV (254 nm) and by staining with either ethanolic p-anisaldehyde
stain or aqueous acidic iron(III) chloride solution. NMR spectra were recorded at room
temperature on Bruker Avance DRX 400 (400 MHz) and DRX 500 (500 MHz) spectrometers.
The following abbreviations were used to explain the multiplicities: s = singlet, d = doublet, t =
triplet, q = quartet, m = multiplet. IR spectra were recorded on a Bruker Vector 33 FT-IR
spectrometer. Electrospray ionization (ESI) mass spectrometry (MS) experiments were
performed on a Waters ZQ single quadrupole mass spectrometer. High resolution mass spectra
(HR-MS) were recorded using a Micromass Q-TOF micro instrument. HPLC analysis was
conducted using a Waters Delta Prep 4000 System with a 7725I Rheodyne injector, a Waters
2487 Dual Wavelength Absorbance Detector, and a XTerraTM MS C18 5 µm 4.6 x 100 mm
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Column. Elemental Analysis was obtained using a PerkinElmer 2400 Series II CHNS/O
Analyzer.

Preparation of bromoindole (S3):

Nitrobenzene (20):

Using an adapted method of Chanteau et al.131 and Carlin et al.,132 NaNO2 (14.90 g, 215.9 mmol,
3.2 eq) was slowly added to a refluxing solution of 2,6-dibromo-4-nitroaniline (19.80 g,
66.9 mmol, 1 eq) and conc. H2SO4(aq) (25.0 mL) in EtOH (250 mL). Reaction stirred under air at
reflux for 40 min before being cooled to RT and subsequently poured onto ice H2O (~400 mL).
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The resulting crude orange precipitate of nitrobenzene 20 (17.04 g) was collected via vacuum
filtration over sintered glass and further washed with ice-cold H2O, and later used directly in the
next step. Rf = 0.23 (100% Hexanes); 1H NMR (400 MHz, CDCl3) δ 8.33 (d, J = 1.6 Hz, 2H),
8.00 (d, J = 1.6 Hz, 1H); LRMS (ESI-) m/z: [ion] (rel. int. %) 281 [M+2]- (100), 279 [M]- (51),
283 [M+4]- (50). Spectroscopic data provided on p. 194–195.

Hydroxylamine (S1):

Using an adapted method of Ung et al.,94 H2O (~67 mL) was added to a suspension of 20
(17.02 g, 60.6 mmol, 1 eq; p. 102) in acetone (350 mL) and sat. aq. NH4Cl (25 mL) until the
solution became clear. Zinc dust (8.24 g, 126.8 mmol, 2.1 eq) was added slowly by portions
while sonicating the mixture at RT for 5-10 min. TLC monitoring (SiO2; 25% EtOAc/Hexanes)
of the reaction was done until the starting material was no longer getting consumed. Resulting
zinc salts were filtered off and the filtrate was concentrated in vacuo. Resulting residue was
partitioned in H2O/EtOAc and extracted with EtOAc (3 x 150 mL). Organic extracts were
combined and dried over Na2SO4, filtered and concentrated in vacuo to give a crude red oil of S1
(18.63 g) which was then directly engaged in the following step. Rf = 0.00 (100% Hexanes);
LRMS (ESI-) m/z: [ion] (rel. int. %) 264 [M-H]- (49), 266 [M-H+2]- (100), 268 [M-H+4]- (51).
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Hydroxamic acid (21):

Using an adapted method of Lobo et al.,133 AcCl (6.19 g, 79.4 mmol, 1.14 eq) was added to a
solution of S1 (18.63 g, 69.8 mmol, 1 eq; p. 103) and NaHCO3 (6.55 g, 78.0 mmol, 1.12 eq) in
Et2O (360 mL) stirring under air at 0 °C. Reaction continued stirring for 1 h at 0 °C and was
subsequently quenched with H2O. The organic layer was set aside and the aqueous layer
extracted with Et2O (2 x 150 mL). Combined extracts were dried over Na2SO4, filtered and
concentrated in vacuo, taking care not to allow the temperature to vary above 30–35 °C. Note:
Product decomposes at temperatures > 35 °C! Purification of the crude residue by flash
chromatography (35% EtOAc/Hexanes) gave 21 as an off-white solid (10.58 g, 51% over 3
steps). Rf = 0.46 (50% EtOAc/Hexanes; stains red with FeCl3); LRMS (ESI-) m/z: [ion] (rel. int.
%) 308 [M-H+2]- (100), 306 [M-H]- (51), 310 [M-H+4]- (51).

N-Acetylindole (24):

Using an adapted method of Martin et al.,86 a solution of 21 (10.58 g, 34.2 mmol, 1 eq; p. 104)
and Li2PdCl4•xH2O (467.0 mg, 1.8 mmol, 0.05 eq) in vinyl acetate (200 mL) was refluxed for
2 h under argon, after which time 96% formic acid (15 mL, 375.7 mmol, 11.0 eq) was added and
the reaction continued to stir at reflux for another 40 min. Solvent was removed in vacuo and the
residue then dissolved in EtOAc (200 mL) and washed with H2O (3 x 50 mL). The organic layer
was dried over MgSO4, filtered and concentrated in vacuo. Purification of the resulting crude red
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oil by flash chromatography (20% EtOAc/Hexanes) gave pure 24 as a white solid (7.0 g, 64%).
Rf = 0.53 (35% EtOAc/Hexanes; stains red with p-anisaldehyde); 1H NMR (500 MHz, CDCl3) δ
8.52 (s, 1H), 7.53 (s, 1H), 7.38 (s, 1H), 6.59 (s, 1H), 2.62 (s, 3H); 13C NMR (126 MHz, CDCl3) δ
168.56, 135.80, 129.96, 129.10, 126.12, 118.65, 118.53, 114.79, 108.59, 23.89; DEPT-135 (126
MHz, CDCl3) δ 129.10, 126.13, 118.65, 108.59, 23.89. Elemental Analysis Calcd for
C10H7Br2NO: C, 37.89; H, 2.23; N, 4.42. Found: C, 37.71; H, 1.96; N, 4.37. Spectroscopic data
provided on p. 196–198.

Iodoindole (S2):

Using an adapted method of Tanoue et al.,134 a solution of 24 (436.2 mg, 1.4 mmol, 1 eq; p. 104)
and NaOH (126.2 mg, 3.2 mmol, 2.3 eq) in absolute EtOH (25 mL) was stirred under air at RT
for 1.5 h. KI (226.8 mg, 1.4 mmol, 1 eq) in H2O (2 mL) was added, quickly followed by I2
(368.3 mg, 1.5 mmol, 1.1 eq). After 1 h at RT, the reaction was quenched with 5% aq. sodium
metabisulfite and concentrated in vacuo. Upon concentrating, S2 crashed out of solution as an
off-white solid and was collected by vacuum filtration over sintered glass then washed with H2O
(533.1 mg, 95%). Product had to be used immediately in subsequent step or else decomposition
occurred. Rf = 0.31 (20% EtOAc/Hexanes); 1H NMR (400 MHz, DMSO) δ 11.97 (s, 1H), 7.68
(s, 2H), 7.37 (d, J = 1.4 Hz, 1H); LRMS (ESI-) m/z: [ion] (rel. int. %) 400 [M-H+2]- (100), 398
[M-H]- (51), 402 [M-H+4]- (51). Elemental Analysis Calcd for C8H4Br2IN: C, 23.97; H, 1.01; N,
3.49. Found: C, 24.21; H, 0.82; N, 3.46. Spectroscopic data provided on p. 199–200.
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N-Boc-Indole (S3):

Using an adapted method of Mothes et al.,135 a solution of iodoindole S2 (1.28 g, 3.18 mmol, 1
eq; p. 105), Boc2O (1.07 g, 4.90 mmol, 1.6 eq), Et3N (1.50 mL, 10.8 mmol, 3.4 eq), and DMAP
(276.6 mg, 2.26 mmol, 0.7 eq) in CH2Cl2 (60 mL) was stirred under air at RT for 3 h. Solution
was washed with 5% aq. sodium metabisulfite (3 x 50 mL) and the organic layer concentrated in
vacuo to afford crude N-Boc-indole S3 as a yellow solid (1.51 g, 95%). Product was directly
engaged in next reaction without further purification. Rf = 0.57 (20% EtOAc/Hexanes); 1H NMR
(400 MHz, DMSO) δ 8.31 (s, 1H), 7.91 (d, J = 1.2 Hz, 1H), 7.62 (d, J = 1.6 Hz, 1H), 1.59 (s,
9H). Elemental Analysis Calcd for C13H12Br2INO2: C, 31.17; H, 2.41; N, 2.80. Found: C, 31.52;
H, 2.20; N, 2.79. Spectroscopic data provided on p. 201.

Preparation of Chloroindole (S4):
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3,5-Dichlorophenylhydroxylamine (27):

The same procedure employed in the synthesis of hydroxylamine S1 (p. 103) was followed using
3,5-dichloronitrobenzene (5.04 g, 26.3 mmol, 1 eq), Zn dust (3.85 g, 59.2 mmol, 2.3 eq), sat. aq.
NH4Cl (17 mL), H2O (50 mL), with acetone (260 mL) as solvent undergoing sonication for 5-10
min. at RT. The resulting crude solid (3.78 g) was directly engaged in the next step without
further purification. Rf = 0.38 (5% EtOAc/Hexanes); LRMS (ESI-) m/z: [ion] (rel. int. %) 176
[M-H]- (100), 178 [M-H+2]- (66).

N-Phenyl-3,5-dichloroacetylhydroxamic acid (28):

The same procedure employed in the synthesis of hydroxamic acid 21 (p. 104) was followed
using 27 (2.90 g, 16.3 mmol, 1 eq; p. 107), NaHCO3 (1.52 g, 18.1 mmol, 1.1 eq), and AcCl (1.40
mL, 19.6 mmol, 1.2 eq) with Et2O (85 mL) as solvent for 1 h at 0 °C. Isolation and
chromatographic purification (10% EtOAc/Hexanes → 20% EtOAc/Hexanes) afforded the title
compound as an off-white solid (2.63 g, 79% over 2 steps). Rf = 0.21 (10% EtOAc/Hexanes;
stains red with FeCl3); 1H NMR (400 MHz, CDCl3) δ 7.46 (s, 2H), 7.23 (s, 1H), 2.24 (s, 3H);
LRMS (ESI-) m/z: [ion] (rel. int. %) 218 [M-H]- (100), 220 [M-H+2]- (65), 176 [M-COCH3](40), 178 [M-COCH3+2]- (25). Spectroscopic data provided on p. 202–203.
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N-Acetyl-4,6-dichloroindole (29):

The same procedure employed in the synthesis of N-acetylindole 24 (p. 104) was followed using
28 (2.65 g, 11.6 mmol, 1 eq; p. 107) and Li2PdCl4•xH2O (218 mg, 0.83 mmol, 0.07 eq) in vinyl
acetate (40 mL) for 4 h at reflux, later adding 96% formic acid (5 mL, 125.2 mmol, 10.4 eq) and
continuing the reflux for another 1 h. Isolation and chromatographic purification (20%
EtOAc/Hexanes) afforded pure 29 as a yellow solid (2.15 g, 78%). Rf = 0.49 (25%
EtOAc/Hexanes; stains red with p-anisaldehyde); 1H NMR (400 MHz, CDCl3) δ 8.27 (d, J = 0.9
Hz, 1H), 7.34 (d, J = 3.8 Hz, 1H), 7.19 (d, J = 1.7 Hz, 1H), 6.61 (dd, J = 3.8, 0.6 Hz, 1H), 2.59
(s, 3H); 13C NMR (101 MHz, CDCl3) δ 168.47, 135.75, 130.93, 127.65, 126.16, 126.12, 123.65,
115.32, 106.76, 23.74; DEPT-135 (101 MHz, CDCl3) δ 126.12, 123.65, 115.32, 106.76, 23.74.
Elemental Analysis Calcd for C10H7Cl2NO: C, 52.66; H, 3.09; N, 6.14. Found: C, 52.54; H, 2.94;
N, 6.05. Spectroscopic data provided on p. 204–206.

3-Iodo-4,6-dichloroindole (39):

The same procedure employed in the synthesis of iodoindole S2 (p. 105) was followed using Nacetyl-4,6-dichloroindole 29 (498.7 mg, 2.2 mmol, 1.0 eq; p. 108), NaOH (196.6 mg, 4.9 mmol,
2.2 eq), abs. EtOH (40 mL), I2 (577.2 mg, 2.3 mmol, 1.0 eq), and KI (381.7 mg, 2.3 mmol,
1.0 eq). Product was collected over a sintered glass filter (579.3 mg, 85%). Rf = 0.49 (25%
EtOAc/Hexanes); 1H NMR (400 MHz, DMSO) δ 11.94 (s, 1H), 7.64 (s, 1H), 7.49 (s, 1H), 7.07
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(s, 1H); 13C NMR (101 MHz, DMSO) δ 137.63, 134.12, 126.61, 126.04, 122.48, 120.98, 111.67,
51.78; DEPT-135 (101 MHz, DMSO) δ 134.12, 120.98, 111.67; LRMS (ESI-) m/z: [ion] (rel. int.
%) 309.7 [M-H]- (100), 311.7 [M-H+2]- (77). Spectroscopic data provided on p. 207–210.

N-Boc-Indole (S4):

The same procedure employed in the synthesis of compound S3 (p. 106) was followed using 39
(373.6 mg, 1.20 mmol, 1 eq; p. 108), Boc2O (425.0 mg, 1.95 mmol, 1.6 eq), Et3N (0.6 mL,
4.32 mmol, 3.6 eq), DMAP (82.4 mg, 0.67 mmol, 0.6 eq), and CH2Cl2 (10 mL). Crude product
presented as a brownish solid which was immediately engaged in the next reaction. 1H NMR
(400 MHz, CDCl3) δ 8.25 (s, 1H), 7.74 (s, 1H), 7.25 (d, J = 1.7 Hz, 1H), 1.66 (s, 9H); LRMS
(ESI-) m/z: [ion] (rel. int. %) 309.7 [M-C5H9O2]- (100), 311.7 [M-C5H9O2+2]- (66.2).
Spectroscopic data provided on p. 211–212.

Preparation of Bis(trifluoromethyl)indole (S10):
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Hydroxylamine (S6):

The same procedure employed in the synthesis of S1 (p. 103) was followed using 3,5bis(trifluoromethyl)nitrobenzene (26.6 g, 102.5 mmol, 1 eq), Zn dust (14.1 g, 215.5 mmol, 2.1
eq), sat. aq. NH4Cl (44 mL), H2O (100 mL), with acetone (500 mL) as solvent undergoing
sonication for 5-10 min. at RT. The resulting crude solid (33.2 g) was directly engaged in the
next step without further purification. Rf = 0.63 (50% EtOAc/Hexanes).

Hydroxamic acid (S7):

The same procedure employed in the synthesis of hydroxamic acid 21 (p. 104) was followed
using S6 (33.2 g, 102 mmol, 1 eq; p. 110), NaHCO3 (9.72 g, 115 mmol, 1.1 eq), and AcCl (8.0
mL, 112 mmol, 1.1 eq) with Et2O (500 mL) as solvent for 14 h. Reaction warmed from 0 °C to
RT overnight. Crude product was subjected to next reaction conditions without further
purification. Rf = 0.33 (35% EtOAc/Hexanes; stains red with FeCl3).

N-Acetylindole (S8):

The same procedure employed in the synthesis of N-acetylindole 24 (p. 104) was followed using
27 (30.1 g, 90.0 mmol, 1 eq; p. 110) and Li2PdCl4•xH2O (421.1 mg, 1.61 mmol, 0.02 eq) in vinyl

110

acetate (400 mL) for 3 h at reflux, later adding 96% formic acid (35 mL, 0.84 mol, 9.3 eq) and
continuing the reflux for another 3.5 h. Isolation and chromatographic purification (25%
EtOAc/Hexanes) afforded pure N-acetylindole S8 as a white crystalline solid (17.9 g, 59% over 3
steps). Rf = 0.3 (25% EtOAc/Hexanes; stains red with p-anisaldehyde); 1H NMR (500 MHz,
CDCl3) δ 8.98 (s, 1H), 7.81 (s, 1H), 7.69 (d, J = 3.7 Hz, 1H), 6.88 (s, 1H), 2.71 (s, 3H);
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NMR (126 MHz, CDCl3) δ 168.55, 135.40, 129.39, 129.30, 127.05, 126.79, 125.06, 124.75,
122.89, 122.87, 122.60, 117.74, 117.70, 117.46, 117.43, 106.87, 23.64; DEPT-135 (126 MHz,
CDCl3) δ 129.30, 117.74, 117.71, 117.67, 117.46, 117.43, 106.87. Elemental Analysis Calcd for
C12H7F6NO: C, 48.83; H, 2.39; N, 4.75. Found: C, 48.63; H, 2.12; N, 4.69. Spectroscopic data
provided on p. 213–216.

Iodoindole (S9):

The same procedure employed in the synthesis of iodoindole S2 (p. 105) was followed using S8
(656.1 mg, 2.2 mmol, 1.0 eq; p. 110), NaOH (354.7 mg, 8.9 mmol, 4.0 eq), abs. EtOH (30 mL),
I2 (645.5 mg, 2.5 mmol, 1.1 eq), and KI (470.0 mg, 2.8 mmol, 1.3 eq). Product collected via
vacuum filtration over a cellulose filter (849.0 mg, quant.). Rf = 0.3 (25% EtOAc/Hexanes); 1H
NMR (500 MHz, DMSO) δ 9.41 (s, 1H), 8.12 (s, 1H), 8.05 (s, 1H), 7.64 (s, 1H); 13C NMR (126
MHz, DMSO) δ 140.17, 138.13, 126.48, 125.98, 123.82, 114.80, 114.23, 51.48; DEPT135 (126
MHz, DMSO) δ 140.17, 114.83, 114.22; LRMS (ESI+) m/z: [ion] (rel. int. %) 380.1 [M+1]+
(100). Spectroscopic data provided on p. 217–220.
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Bis(trifluoromethyl)indole (S10):

The same procedure employed in the synthesis of compound S3 (p. 106) was followed using S9
(419.7 mg, 1.1 mmol, 1.0 eq; p. 111), Boc2O (339.7 mg, 1.6 mmol, 1.4 eq), Et3N (0.5 mL,
3.6 mmol, 3.3 eq), DMAP (69.5 mg, 0.6 mmol, 0.5 eq), and CH2Cl2 (7 mL). Crude product
presented as a brownish solid (445.9 mg, 85%) which was immediately engaged in the next
reaction. 1H NMR (400 MHz, DMSO) δ 8.77 (s, 1H), 8.30 (s, 1H), 7.92 (s, 1H), 1.65 (s, 9H).
Spectroscopic data provided on p. 221.

Preparation of N-Acetyl-5-chloroindole (S14):

N-(4-Chlorophenyl)hydroxylamine (S12):

The same procedure employed in the synthesis of hydroxylamine S1 (p. 103) was followed using
4-chloronitrobenzene (24.75 g, 157.1 mmol, 1.0 eq), Zn dust (21.2 g, 324.3 mmol, 2.1 eq), sat.
aq. NH4Cl (65 mL), H2O (175 mL), with acetone (500 mL) as solvent undergoing sonication for
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5-10 min. at RT. Crude product presented as a yellow solid. The resulting crude product
(19.23 g) was directly engaged in the next step without further purification.

N-(4-Chlorophenyl)-N-hydroxamic acid (S13):

The same procedure employed in the synthesis of hydroxamic acid 21 (p. 104) was followed
using S12 (19.23 g, 133.5 mmol, 1.0 eq; p. 112), NaHCO3 (12.37 g, 147.3 mmol, 1.1 eq), and
AcCl (10.5 mL, 147.1 mmol, 1.1 eq) with Et2O (600 mL) as solvent for 19 h. Reaction warmed
from 0 °C to RT overnight. Isolation and chromatographic purification (60% EtOAc/Hexanes)
provided 10.48 g of pure product as a yellow solid (36% over two steps). Rf = 0.12 (35%
EtOAc/Hexanes; stains red with FeCl3).

N-Acetyl-5-chloroindole (S14):

The same procedure employed in the synthesis of N-acetylindole 24 (p. 104) was followed using
S13 (10.48 g, 56.3 mmol, 1.0 eq; p. 113) and Li2PdCl4•xH2O (579.9 mg, 2.2 mmol, 0.04 eq) in
vinyl acetate (250 mL) for 2 h at reflux, later adding 96% formic acid (24 mL, 601.0 mmol,
10.7 eq) and continuing the reflux for another 11.5 h. Isolation and chromatographic purification
(35% EtOAc/Hexanes) afforded pure S14 as a white crystalline solid (6.90 g, 63%). Rf = 0.45
(35% EtOAc/Hexanes; stains red with p-anisaldehyde); 1H NMR (500 MHz, CDCl3) δ 8.32 (d, J
= 8.7 Hz, 1H), 7.46 (d, J = 1.9 Hz, 1H), 7.35 (d, J = 3.6 Hz, 1H), 7.25 (dd, J = 8.8, 2.0 Hz, 1H),
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6.50 (d, J = 3.7 Hz, 1H), 2.57 (s, 3H);
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C NMR (126 MHz, CDCl3) δ 168.46, 133.82, 131.61,

129.07, 126.52, 125.07, 120.35, 117.50, 108.26, 23.68; DEPT-135 (126 MHz, CDCl3) δ 126.52,
125.07, 120.35, 117.50, 108.27, 23.69. Elemental Analysis Calcd for C10H8ClNO: C, 62.03; H,
4.16; N, 7.23. Found: C, 61.82; H, 4.03; N, 7.01. Spectroscopic data provided on p. 222–225.

Preparation of N-Acetyl-5-bromoindole (S18):

N-(4-Bromophenyl)hydroxylamine (S16):

The same procedure employed in the synthesis of hydroxylamine S1 (p. 103) was followed using
4-bromonitrobenzene (26.00 g, 128.7 mmol, 1.0 eq), Zn dust (17.3 g, 264.6 mmol, 2.1 eq), sat.
aq. NH4Cl (53 mL), H2O (150 mL), with acetone (600 mL) as solvent undergoing sonication for
5-10 min. at RT. Crude product presented as a yellow solid. The resulting crude product (19.35
g) was directly engaged in the next step without further purification. Rf = 0.33 (35%
EtOAc/Hexanes).
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N-(4-Bromophenyl)-N-hydroxamic acid (S17):

The same procedure employed in the synthesis of hydroxamic acid 21 (p. 104) was followed
using S16 (19.35 g, 102.9 mmol, 1.0 eq; p. 114), NaHCO3 (9.65 g, 114.9 mmol, 1.1 eq), and
AcCl (8.0 mL, 112.1 mmol, 1.1 eq) with Et2O (500 mL) as solvent for 14 h. Reaction warmed
from 0 °C to RT overnight. Isolation and chromatographic purification (60% EtOAc/Hexanes)
provided pure product as a solid. Rf = 0.32 (60% EtOAc/Hexanes; stains red with FeCl3).

N-Acetyl-5-bromoindole (S18):

The same procedure employed in the synthesis of N-acetylindole 24 (p. 104) was followed using
S17 (14.67 g, 63.8 mmol, 1.0 eq; p. 115) and Li2PdCl4•xH2O (795.0 mg, 3.0 mmol, 0.05 eq) in
vinyl acetate (370 mL) for 2 h at reflux, later adding 96% formic acid (28 mL, 0.70 mol, 11.0 eq)
and continuing the reflux for another 15 h. Isolation and chromatographic purification (35%
EtOAc/Hexanes) afforded pure S18 as an off-white solid (10.21 g, 33% over 3 steps). Rf = 0.43
(35% EtOAc/Hexanes; stains red with p-anisaldehyde); 1H NMR (500 MHz, CDCl3) δ 8.22 (d, J
= 8.6 Hz, 1H), 7.58 (d, J = 1.6 Hz, 1H), 7.47 – 7.20 (m, 2H), 6.44 (d, J = 3.7 Hz, 1H), 2.52 (s,
3H);
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C NMR (126 MHz, CDCl3) δ 168.47, 134.09, 132.09, 127.69, 126.41, 123.38, 117.85,

116.80, 108.10, 23.73; DEPT-135 (126 MHz, CDCl3) δ 127.69, 126.41, 123.38, 117.85, 108.10,
23.74. Elemental Analysis Calcd for C10H8BrNO: C, 50.45; H, 3.39; N, 5.88. Found: C, 50.31;
H, 3.29; N, 5.64. Spectroscopic data provided on p. 226–229.
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Preparation of Indoles via Leimgruber-Batcho Synthesis:

6-Chloroindole (79):

Using an adapted method of Prieto et al.,136 a 1000 mL flask was charged with
4-chloro-2-nitrotoluene (6.92 g, 40.3 mmol, 1.0 eq), DMF-DMA (6.2 mL, 46.3 mmol, 1.2 eq),
pyrrolidine (3.9 mL, 47.2 mmol, 1.2 eq), DMF (86 mL) and purged with argon. Reaction was
refluxed for 1.5 h, after which it was cooled to 0 °C. To the flask was added DMF (350 mL), 4 M
NH4OAc(aq) (175 mL), and 20% TiCl3 in 3% HCl (125 mL, 197.5 mmol, 4.9 eq). Mixture stirred
under air at 0 °C for 15 min, then 4 M NaOH(aq) was added until pH > 9. Reaction was extracted
with Et2O (4 x 100 mL) to give light brown solid as crude product. Chromatographic purification
on silica gel (35% EtOAc/Hexanes) afforded pure product as a yellowish solid (4.30 g, 70%).
Rf = 0.50 (35% EtOAc/Hexanes; stains red with p-anisaldehyde); 1H NMR (500 MHz, DMSO) δ
11.24 (s, 1H), 7.56 (d, J = 8.4 Hz, 1H), 7.48 (s, 1H), 7.44 – 7.37 (m, 1H), 7.02 (dd, J = 8.4, 1.8
Hz, 1H), 6.47 (s, 1H); 13C NMR (126 MHz, DMSO) δ 136.78, 126.92, 126.87, 126.13, 121.78,
119.60, 111.50, 101.75; DEPT-135 (126 MHz, DMSO) δ 126.86, 121.76, 119.59, 111.49,
101.74. Spectroscopic data provided on p. 230–233.
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4-Chloroindole (78):

The same procedure employed in the synthesis of 6-chloroindole 79 (p. 116) was followed using
6-chloro-2-nitrotoluene (6.98 g, 40.7 mmol, 1.0 eq), DMF-DMA (6.2 mL, 44.7 mmol, 1.1 eq),
pyrrolidine (3.9 mL, 47.2 mmol, 1.2 eq), and DMF (85 mL). Reaction was refluxed 1.5 h, then
cooled to 0 °C. To the flask was added DMF (350 mL), 4 M NH4OAc(aq) (175 mL), and 20%
TiCl3 in 3% HCl (100 mL, 158.0 mmol, 3.9 eq). Mixture stirred under air at 0 °C for 15 min,
then 4 M NaOH(aq) was added until pH > 9. Isolation and chromatographic purification (20%
EtOAc/Hexanes) afford desired product (3.26 g, 53%) as a red oil. Rf = 0.44 (35%
EtOAc/Hexanes; stains red with p-anisaldehyde); 1H NMR (500 MHz, CDCl3) δ 8.16 (s, 1H),
7.40 (dd, J = 6.6, 1.4 Hz, 1H), 7.31 (d, J = 6.8 Hz, 2H), 7.23 – 7.16 (m, 1H), 6.90 (d, J = 1.9 Hz,
1H);
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C NMR (126 MHz, CDCl3) δ 136.73, 126.92, 126.06, 125.41, 122.84, 119.79, 110.28,

101.16; DEPT-135 (126 MHz, CDCl3) δ 125.41, 122.84, 119.79, 110.28, 101.16. Elemental
Analysis Calcd for C8H6ClN: C, 63.38; H, 3.99; N, 9.24. Found: C, 61.90; H, 3.93; N, 9.14.
Spectroscopic data provided on p. 234–237.

6-Bromoindole (77):

The same procedure employed in the synthesis of 6-chloroindole 79 (p. 116) was followed using
4-bromo-2-nitrotoluene (4.93 g, 22.8 mmol, 1.0 eq), DMF-DMA (4.6 mL, 34.3 mmol, 1.5 eq),
pyrrolidine (2.5 mL, 30.2 mmol, 1.3 eq), and DMF (50 mL). Reaction was refluxed 1.5 h, then
cooled to 0 °C. To the flask was added DMF (200 mL), 4 M NH4OAc(aq) (100 mL), and 20%
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TiCl3 in 3% HCl (60 mL, 94.8 mmol, 4.2 eq). Mixture stirred under air at 0 °C for 15 min, then
4 M NaOH(aq) was added until pH > 9. Isolation and chromatographic purification (20%
EtOAc/Hexanes) afford desired product (2.10 g, 47%) as a light yellowish solid. Rf = 0.47 (35%
EtOAc/Hexanes; stains red with p-anisaldehyde); 1H NMR (500 MHz, DMSO) δ 11.27 (s, 1H),
7.67 (s, 1H), 7.52 (d, J = 8.4 Hz, 1H), 7.40 (d, J = 2.4 Hz, 1H), 7.16 (dd, J = 8.3, 1.3 Hz, 1H),
6.49 (s, 1H);
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C NMR (126 MHz, DMSO) δ 137.33, 127.19, 126.78, 122.22, 122.19, 114.51,

114.20, 101.84; DEPT-135 (126 MHz, DMSO) δ 126.78, 122.22, 122.19, 114.51, 101.84.
Spectroscopic data provided on p. 238–241.

Preparation N-Boc-indole (86):

N-Acetylindoline (81):

Using an adapted method of Helgen et al.,137 a 200 mL flask was charged with indoline 80
(5.29 g, 44.4 mmol, 1.0 eq), AcOH (60 mL), and AcCl (16 mL, 224.2 mmol, 5.0 eq). Solution
was refluxed under air for 5 h then subsequently concentrated in vacuo to afford product as a
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light brown solid (7.21 g, quant). Product was subjected to next reaction conditions with no
further purification. Rf = 0.31 (80% EtOAc/Hexanes); 1H NMR (400 MHz, CDCl3) δ 8.18 (d, J
= 8.0 Hz, 1H), 7.14 (dd, J = 14.3, 7.2 Hz, 2H), 6.96 (t, J = 7.4 Hz, 1H), 3.93 (t, J = 8.5 Hz, 2H),
3.10 (t, J = 8.5 Hz, 2H), 2.14 (s, 3H);
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C NMR (101 MHz, CDCl3) δ 168.67, 142.88, 131.18,

127.38, 124.52, 123.48, 116.79, 48.68, 27.89, 24.16; DEPT-135 (101 MHz, CDCl3) δ 127.38,
124.52, 123.48, 116.79, 48.67, 27.89, 24.16; LRMS (ESI+) m/z: [ion] (rel. int. %) 161.9 [M+1]+
(100). Spectroscopic data provided on p. 242–245.

N-Acetyl-5,7-dinitroindoline (82):

Using an adapted method of Helgen et al.,137 NaNO3 (12.40 g, 145.9 mmol, 2.9 eq), TFA
(75 mL), and indoline 81 (8.10 g, 50.2 mmol, 1.0 eq; p. 118) were stirred under air at RT for
20.5 h then poured over ice cold H2O. Precipitate was collected via vacuum filtration over
cellulose. Precipitate was recrystallized from hot toluene/EtOH (1:1) to afford pure product as
yellow crystals (10.56 g, 84%). NOTE: Rubber septa should NOT be used because the
corrosive conditions will dissolve the septa. Rf = 0.18 (80% EtOAc/Hexanes; stains yellow
with p-anisaldehyde); 1H NMR (400 MHz, DMSO) δ 8.40 (d, J = 5.0 Hz, 2H), 4.35 (t, J = 8.3
Hz, 2H), 3.32 (t, J = 8.2 Hz, 2H), 2.25 (s, 3H); 13C NMR (101 MHz, DMSO) δ 169.76, 143.05,
140.34, 139.61, 138.67, 124.02, 119.56, 51.00, 28.48, 23.71; DEPT-135 (101 MHz, DMSO) δ
124.02, 119.56, 51.00, 28.48; LRMS (ESI-) m/z: [ion] (rel. int. %) 250.7 [M]- (100).
Spectroscopic data provided on p. 246–249.
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5,7-Dinitroindoline (83):

Using an adapted method of Helgen et al.,137 N-acetylindoline 82 (10.56 g, 42.0 mmol, 1.0 eq;
p. 119), MeOH (200 mL), THF (100 mL), and NaOH (10.12 g, 253.0 mmol, 6.0 eq) were stirred
under air at RT for 3 h and thereafter concentrated in vacuo. H2O was added to the residue and
the product was collected via vacuum filtration over sintered glass. Additional material was
obtained by extracting the filtrate with EtOAc. Product presented as a light brown solid (6.07 g,
69%). Rf = 0.52 (100% EtOAc; stains yellow with p-anisaldehyde); 1H NMR (400 MHz, DMSO)
δ 9.01 (s, 1H), 8.51 (d, J = 2.1 Hz, 1H), 7.94 (s, 1H), 3.88 (t, J = 8.4 Hz, 2H), 3.16 (t, J = 8.2 Hz,
2H);
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C NMR (101 MHz, DMSO) δ 152.08, 137.87, 136.06, 125.71, 122.98, 121.51, 48.20,

27.02. Spectroscopic data provided on p. 250–251.

5,7-Dinitroindole (84):

A 500 mL flame dried flask was charged with 5,7-dinitroindoline 83 (6.16 g, 29.5 mmol, 1.0 eq;
p. 120), DDQ (12.04 g, 53.0 mmol, 1.8 eq), and anhydrous 1,4-dioxane (350 mL). Reaction was
refluxed under argon for 15 min, at which time 96% formic acid (5.0 mL, 130.4 mmol, 4.4 eq)
was added. Reflux was continued for 18 h and subsequently the reaction was concentrated in
vacuo. The resulting residue was dissolved in EtOAc and then washed with sat. aq. K2CO3
(6 x 200 mL) until the aqueous layers were colorless. The organic layer was dried (Na2SO4),
filtered, and concentrated in vacuo to afford the desired product as a yellow solid (5.65 g, 93%)
which could be recrystallized from hot EtOAc. 1H NMR (400 MHz, DMSO) δ 12.43 (s, 1H),
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8.83 (d, J = 2.0 Hz, 1H), 8.61 (d, J = 2.1 Hz, 1H), 7.74 – 7.59 (m, 1H), 6.91 (d, J = 2.3 Hz, 1H);
13

C NMR (101 MHz, DMSO) δ 139.58, 132.47, 132.17, 131.82, 130.59, 123.71, 113.67, 106.27;

DEPT-135 (101 MHz, DMSO) δ 132.47, 123.71, 113.67, 106.27; LRMS (ESI-) m/z: [ion] (rel.
int. %) 205.7 [M-H]- (100). Spectroscopic data provided on p. 252–255.

3-Iodo-5,7-dinitroindole (85):

The same procedure employed in the synthesis of iodoindole S2 (p. 105) was followed using 84
(105.4 mg, 0.51 mmol, 1.0 eq; p. 120), NaOH (53.7 mg, 1.34 mmol, 2.6 eq), and abs. EtOH
(8 mL). Reaction was stirred under air at RT for 15 min and thereafter I2 (155.1 mg, 0.61 mmol,
1.2 eq) and KI (98.9 mg, 0.60 mmol, 1.2 eq; dissolved in 1 mL of H2O) were added. Reaction
continued to stir under air at RT for 2 h. Product collected via vacuum filtration over a cellulose
filter (160.0 mg, 94%). 1H NMR (400 MHz, DMSO) δ 12.85 (s, 1H), 8.79 (d, J = 2.0 Hz, 1H),
8.45 (d, J = 2.0 Hz, 1H), 7.93 (s, 1H). Spectroscopic data provided on p. 256.

N-Boc-indole (86):

The same procedure employed in the synthesis of compound S3 (p. 106) was followed using 85
(109.3 mg, 0.33 mmol, 1.0 eq; p. 121), Boc2O (104.8 mg, 0.48 mmol, 1.5 eq), Et3N (150 µL,
1.1 mmol, 3.3 eq), DMAP (18.2 mg, 0.15 mmol, 0.5 eq), and CH2Cl2 (2 mL). Crude product
presented as a brownish solid (140.0 mg, 98%) which was immediately engaged in the next
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reaction. 1H NMR (400 MHz, DMSO) δ 8.77 (s, 1H), 8.30 (s, 1H), 7.92 (s, 1H), 1.65 (s, 9H). 1H
NMR (400 MHz, DMSO) δ 8.64 (d, J = 2.0 Hz, 1H), 8.36 (d, J = 2.0 Hz, 1H), 8.26 (s, 1H), 1.56
(s, 9H); 13C NMR (101 MHz, DMSO) δ 147.02, 143.08, 137.55, 137.21, 135.95, 127.43, 121.89,
116.67, 87.88, 67.44, 27.67; DEPT-135 (101 MHz, DMSO) δ 137.21, 121.89, 116.67, 27.67.
Spectroscopic data provided on p. 257–259.

Preparation of Ethyl Carboxylate (S23):

3,5-Dibromoaniline (S19):

Using an adapted method of Chanteau et al.,131 SnCl2·2H2O (19.65 g, 87.1 mmol, 4.9 eq) was
added to a room temperature solution of 3,5-dibromonitrobenzene 20 (5.02 g, 17.8 mmol, 1.0 eq)
in abs. EtOH (40 mL) and THF (40 mL). Solution was stirred under air at RT for 15 h, after
which the solvent was removed in vacuo and 4 M NaOH(aq) was added. Solution was stirred
under air at RT for 6 h and the slurry was subsequently extracted with Et2O. The combined
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organic layers were dried (MgSO4), filtered, and concentrated in vacuo to provide pure product
as a yellowish-brown solid (3.73 g, 83%). Rf = 0.45 (20% EtOAc/Hexanes); 1H NMR (400 MHz,
CDCl3) δ 7.02 (s, 1H), 6.75 (d, J = 1.5 Hz, 2H), 3.78 (s, 2H); LRMS (ESI-) m/z: [ion] (rel. int.
%) 247.7 [M-H]- (47), 249.7 [M-H+2]- (100), 251.8 [M-H+4]- (51). Spectroscopic data provided
on p. 260–261.

3,5-Dibromophenylhydrazine hydrochloride (S20):

Using an adapted method of Jansen et al.138 and Chattaway et al.,139 conc. HCl was added to a
solution of aniline S19 (9.34 g, 37.2 mmol, 1.0 eq; p. 123), in AcOH (150 mL) until a thin paste
was achieved. The suspension was cooled to -4 °C and subsequently a -4 °C solution of NaNO2
(2.81 g, 40.7 mmol, 1.1 eq) in H2O (20 mL) was slowly added, insuring that the internal
temperature of the reaction remained below 0 °C. Manual stirring was necessary as the
suspension was too thick for magnetic stirring. Stirring continued under air at -4 °C for 15 min.
Next was slowly added a -4 °C solution of SnCl2·2H2O (17.0 g, 75. 4 mmol, 2.0 eq) in a minimal
amount of conc. HCl, again making certain not to allow the reaction to warm above 0 °C.
Reaction continued to stir under air at -4 °C for 1 h. Precipitate was collected via vacuum
filtration over sintered glass and washed with ice cold 1 M HCl(aq) then dissolved in a minimal
amount of boiling 1 M HCl(aq). Product recrystallized upon slow cooling towards room
temperature (7.42 g, 66%).
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Hydrazone (S21):

Using an adapted method of Cugola et al.,140 a solution of hydrazine S20 (7.42 g, 24.5 mmol,
1.1 eq; p. 123), abs. EtOH (50 mL), 9 M H2SO4(aq) (2 mL), and ethyl pyruvate (2.6 mL,
23.4 mmol, 1.0 eq) was stirred under argon at reflux for 5.5 h. Reaction was poured into ice cold
H2O and extracted with Et2O (3 x 150 mL). Organic layers were combined, dried (Na2SO4),
filtered, and concentrated in vacuo to afford crude product as a yellow solid (9.2 g, quant.).
Product was directly engaged in next reaction without further purification. E/Z isomers R f = 0.39
& 0.67 (20% EtOAc/Hexanes).

Ethyl 4,6-dibromoindole-2-carboxylate (S22):

Using an adapted method of Cugola et al.,140 a mixture of hydrazone S21 (9.2 g, 24.5 mmol,
1.0 eq; p. 124) in PPA (32.5 g) was heated under air at 90 °C for 20 min until the mixture
thinned and became paste-like. To this paste was added 400 mL H2O and then extracted with
Et2O (3 x 150 mL). Organic layers were combined, dried (Na2SO4), filtered, and concentrated in
vacuo to afford pure product as a light brown solid (7.0 g, 82%). Rf = 0.43 (20%
EtOAc/Hexanes); 1H NMR (400 MHz, DMSO) δ 12.41 (s, 1H), 7.61 (s, 1H), 7.45 (s, 1H), 6.98
(s, 1H), 4.34 (q, J = 7.1 Hz, 2H), 1.33 (t, J = 7.1 Hz, 3H);
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C NMR (101 MHz, DMSO) δ

161.02, 138.09, 129.41, 126.92, 125.62, 117.41, 116.26, 115.18, 107.37, 61.41, 14.63;
DEPT-135 (101 MHz, DMSO) δ 125.63, 115.19, 107.37, 61.41, 14.63; LRMS (ESI-) m/z: [ion]
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(rel. int. %) 343.7 [M-H]- (50), 345.7 [M-H+2]- (100), 347.7 [M-H+4]- (54). Elemental Analysis
Calcd for C11H9Br2NO2: C, 38.07; H, 2.61; N, 4.04. Found: C, 38.35; H, 2.51; N, 3.96.
Spectroscopic data provided on p. 262–265.

Ethyl carboxylate (S23):

The same procedure employed in the synthesis of iodoindole S2 (p. 105) was followed using S22
(426.8 mg, 1.23 mmol, 1.0 eq; p. 124), NaOH (55.1 mg, 1.38 mmol, 1.1 eq), and abs. EtOH
(26 mL). Reaction was stirred under air at RT for 15 min and thereafter I2 (333.1 mg, 1.31 mmol,
1.1 eq) and KI (212.0 mg, 1.28 mmol, 1.0 eq; dissolved in 2.5 mL of H2O) were added. Reaction
continued to stir under air at RT for 1 h. Product collected via vacuum filtration over a cellulose
filter and washed with H2O (552.5 mg, 95%). Rf = 0.43 (25% EtOAc/Hexanes); 1H NMR (400
MHz, DMSO) δ 12.68 (s, 1H), 7.71 (d, J = 1.3 Hz, 1H), 7.46 (d, J = 1.3 Hz, 1H), 4.36 (q, J = 7.1
Hz, 2H), 1.36 (t, J = 7.1 Hz, 3H);
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C NMR (101 MHz, DMSO) δ 160.36, 138.57, 129.80,

128.35, 124.32, 117.71, 117.19, 115.99, 63.01, 61.67, 14.62; DEPT-135 (101 MHz, DMSO) δ
128.34, 115.99, 61.67, 14.62; LRMS (ESI-) m/z: [ion] (rel. int. %) 469.7 [M-H]- (50), 471.8 [MH+2]- (100), 473.7 [M-H+4]- (50). Spectroscopic data provided on p. 266–269.
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Preparation of Ethyl Carboxylate (S28):

3,5-Chlorophenylhydrazine hydrochloride (S25):

The same procedure employed in the synthesis of compound S20 (p. 123) was followed using
3,5-dichloroaniline (5.10 g, 31.48 mmol, 1 eq) in AcOH (20 mL) adding conc. HCl until a thin
paste was achieved. Subsequently was added NaNO2 (2.40 g, 34.78 mmol, 1.1 eq) in H2O
(15 mL) and then SnCl2·2H2O (21.61 g, 95.78 mmol, 3.0 eq) in conc. HCl (40 mL). Precipitate
was collected after 17.5 h at -4 °C to afford hydrazine S25 (3.29 g, 49%) as a white solid. LRMS
(ESI+) m/z: [ion] (rel. int. %) 176.9 [M-Cl]+ (100), 178.9 [M-Cl+2]+ (92); m.p. = 219 °C.
Spectroscopic data provided on p. 270.

Hydrazone (S26):
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The same procedure employed in the synthesis of compound S21 (p. 124) was followed using
hydrazine S25 (2.0 g, 9.37 mmol, 1.1 eq; p. 126), abs. EtOH (20 mL), 1.5 M H2SO4(aq) (2.0 mL),
and ethyl pyruvate (1.0 mL, 9.01 mmol, 1.0 eq) stirred under argon at reflux for 5 h. A cold
H2O/Et2O workup afforded the desired crude product from the organic extracts as a yellow solid
(2.21 g, 86%). No further purification was required for next step. E/Z isomers Rf = 0.34 & 0.60
(20% EtOAc/Hexanes); 1H NMR (400 MHz, CDCl3) δ 7.79 (s, 1H), 7.10 (s, 2H), 6.92 (s, 1H),
4.33 (q, J = 7.1 Hz, 2H), 2.10 (s, 3H), 1.38 (t, J = 7.1 Hz, 3H); LRMS (ESI-) m/z: [ion] (rel. int.
%) 272.9 [M-H]- (100), 274.9 [M-H+2]- (63). Spectroscopic data provided on p. 271–272.

Ethyl 4,6-dichloroindole-2-carboxylate (S27):

The same procedure employed in the synthesis of compound S22 (p. 124) was followed using
S26 (1.31 g, 4.76 mmol, 1.0 eq; p. 126) in PPA (6.61 g) heated to 105 °C for 30 min. An
EtOAc/H2O workup afforded S27 as a yellow solid (1.14 g, 93%). Rf = 0.58 (20%
EtOAc/Hexanes); 1H NMR (400 MHz, CDCl3) δ 9.24 (s, 1H), 7.35 (d, J = 1.2 Hz, 1H), 7.31 –
7.28 (m, 1H), 7.18 (d, J = 1.6 Hz, 1H), 4.45 (q, J = 7.1 Hz, 2H), 1.44 (t, J = 7.1 Hz, 3H);
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NMR (101 MHz, CDCl3) δ 161.66, 137.08, 131.04, 128.50, 128.40, 125.34, 121.29, 110.54,
107.11, 61.56, 14.32; IR (film) νmax 3317, 1699 cm-1; LRMS (ESI-) m/z: [ion] (rel. int. %) 227.8
[M-CH2CH3]- (84), 229.8 [M-CH2CH3+2]- (57), 255.8 [M-H]- (100); 257.8 [M-H+2]- (65).
Spectroscopic data provided on p. 273–276.
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Ethyl Carboxylate (S28):

The same procedure employed in the synthesis of iodoindole S2 (p. 105) was followed using S27
(500.5 mg, 1.94 mmol, 1.0 eq; p. 127), NaOH (85.3 mg, 2.13 mmol, 1.1 eq), and abs. EtOH
(20 mL). Reaction was stirred under air at RT for 15 min and thereafter I2 (543.6 mg, 2.14 mmol,
1.1 eq) and KI (321.9 mg, 1.94 mmol, 1.0 eq; dissolved in 2 mL of H2O) were added. Reaction
continued to stir under air at RT for 1 h. Product collected via vacuum filtration over a cellulose
filter and washed with H2O (600.1 mg, 81%). Rf = 0.35 (20% EtOAc/Hexanes); 1H NMR (500
MHz, DMSO) δ 7.52 (s, 1H), 7.20 (s, 1H), 4.39 (s, 2H), 1.39 (s, 3H);

13

C NMR (126 MHz,

DMSO) δ 160.36, 138.45, 129.81, 129.58, 128.50, 123.41, 122.55, 112.48, 61.63, 61.15, 14.65;
DEPT-135 (126 MHz, DMSO) δ 122.54, 112.47, 61.62, 14.65. Elemental Analysis Calcd for
C11H8Cl2INO2: C, 34.41; H, 2.10; N, 3.65. Found: C, 32.10; H, 2.08; N, 3.42. Spectroscopic data
provided on p. 277–280.

4,6-Dichloroindole-2-carboxylic acid (S29):

Using an adapted method of Salituro et al.141 and Jansen et al.,138 a solution of carboxylate S27
(1.14 g, 4.96 mmol, 1.0 eq; 127), THF (20 mL), H2O (4 mL), LiOH·H2O (285.0 mg, 6.79 mmol,
1.4 eq) was stirred under air at reflux for 1 h. The solution was then cooled to RT and
concentrated in vacuo. H2O (150 mL) was added and then acidified with 6 M HCl(aq) and
extracted with EtOAc (3 x 50 mL). Organic extracts were combined, dried (Na2SO4), filtered,

128

and concentrated in vacuo to afford crude product (0.92 g, ca. 90%). Rf = 0.00 (20%
EtOAc/Hexanes); 1H NMR (400 MHz, DMSO) δ 13.34 (s, 1H), 12.28 (s, 1H), 8.26 – 6.25 (m,
3H); LRMS (ESI-) m/z: [ion] (rel. int. %) 227.8 [M-H]- (100), 229.8 [M-H+2]- (97).
Spectroscopic data provided on p. 281.

Preparation of 5,7-Dibromoindole-2-carboxylic acid (S33):

2,5-Dibromopheneyl hydrazine (S31):

The same procedure employed in the synthesis of compound S20 (p. 123) was followed using
2,5-dichloroaniline (2.02 g, 6.68 mmol, 1.0 eq) in AcOH (16 mL) adding conc. HCl until a thin
paste was achieved. Subsequently was added NaNO2 (621.0 mg, 9.00 mmol, 1.3 eq) in H2O
(10 mL) and then SnCl2·2H2O (5.52 g, 24.47 mmol, 3.7 eq) in conc. HCl (16 mL). Precipitate
was collected after 26 h at -4 °C to afford hydrazine S31 (1.07 g, 44%) as a white solid which
was subjected to the next reaction without further purification.
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Hydrazone (S32):

The same procedure employed in the synthesis of compound S21 (p. 124) was followed using
hydrazine S31 (1.06 g, 3.51 mmol, 1.0 eq; p. 129), abs. EtOH (7.0 mL), 2.4 M H2SO4(aq)
(0.6 mL), and ethyl pyruvate (0.40 mL, 3.60 mmol, 1.0 eq) stirred under argon at reflux for 19 h.
A cold H2O/Et2O workup afforded the desired crude product from the organic extracts as a
yellow solid (1.01 g, 80%). No further purification was required for next step. Rf = 0.69 (20%
EtOAc/Hexanes); LRMS (ESI-) m/z: [ion] (rel. int. %) 247.7 [M-C5H8NO2]- (43), 249.7 [MC5H8NO2+2]- (82), 251.7 [M-C5H8NO2+4]- (45), 332.8 [M-C2H5]- (53), 334.8 [M-C2H5+2](100), 336.8 [M-C2H5+4]- (57). Spectroscopic data provided on p. 282.

Ethyl 5,7-Dibromoindole-2-carboxylate (S33):

The same procedure employed in the synthesis of compound S22 (p. 124) was followed using
S32 (0.99 g, 2.72 mmol, 1.0 eq; p. 130) in PPA (4.16 g) heated to 105 °C for 30 min. An
EtOAc/H2O workup afforded S33 as a yellow solid (0.85 g, 90%). Rf = 0.55 (20%
EtOAc/Hexanes); 1H NMR (400 MHz, CDCl3) δ 9.14 (s, 1H), 7.56 (dd, J = 19.2, 4.9 Hz, 1H),
7.34 (dd, J = 10.0, 1.9 Hz, 1H), 7.27 (s, 1H), 4.47 (dd, J = 14.2, 7.1 Hz, 2H), 1.47 (t, J = 7.2 Hz,
3H); LRMS (ESI-) m/z: [ion] (rel. int. %) 315.7 [M-CH2CH3]- (51), 317.8 [M-CH2CH3+2]-
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(100), 319.8 [M-CH2CH3+4]- (51); 343.8 [M-H]- (18), 345.8 [M-H+2]- (36), 347.8 [M-H+4](18). Spectroscopic data provided on p. 283–284.

5,7-Dibromoindole-2-carboxylic acid (S34):

The same procedure employed for the synthesis of S29 (p. 128) was followed using carboxylate
S33 (0.76 g, 2.19 mmol, 1.0 eq; p. 130), THF (100 mL), H2O (11 mL), LiOH·H2O (285.0 mg,
6.79 mmol, 3.1 eq) stirring under air at reflux for 17 h. The solution was then cooled to RT and
concentrated in vacuo. H2O (150 mL) was added and then acidified with 6 M HCl(aq) and
extracted with EtOAc (3 x 50 mL). Organic extracts were combined, dried (Na2SO4), filtered,
and concentrated in vacuo to afford crude product (0.66 g, ca. 95%). Rf = 0.00 (20%
EtOAc/Hexanes); 1H NMR (400 MHz, DMSO) δ 12.25 (s, 1H), 7.65 – 7.06 (m, 3H); LRMS
(ESI-) m/z: [ion] (rel. int. %) 315.8 [M-H]- (59), 317.8 [M-H+2]- (100), 319.8 [M-H+4]- (48).
Spectroscopic data provided on p. 285–286.
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Preparation of 5-Bromoindole-2-carboxylic acid (S39):

4-Bromophenylhydrazine (S36):

The same procedure employed in the synthesis of compound S20 (p. 123) was followed using
4-bromoaniline (5.25 g, 30.52 mmol, 1.0 eq) in AcOH (20 mL) adding conc. HCl until a thin
paste was achieved. Subsequently was added NaNO2 (2.34 g, 33.91 mmol, 1.1 eq) in H2O
(15 mL) and then SnCl2·2H2O (21.25 g, 94.19 mmol, 3.1 eq) in conc. HCl (40 mL). Precipitate
was collected after 26 h at -4 °C to afford hydrazine S36 as a white solid which recrystallized
from boiling 1 M HCl(aq) (4.49 g, 66%). LRMS (ESI+) m/z: [ion] (rel. int. %) 186.9 [M+H]+ (97),
188.9 [M+H+2]+ (100). Spectroscopic data provided on p. 287.

Hydrazone (S37):
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The same procedure employed in the synthesis of compound S21 (p. 124) was followed using
hydrazine S36 (4.47 g, 20.00 mmol, 1.0 eq; p. 132), abs. EtOH (40 mL), 2.4 M H2SO4(aq)
(2.8 mL), and ethyl pyruvate (2.20 mL, 19.82 mmol, 1.0 eq) stirred under argon at reflux for
19 h. A cold H2O/Et2O workup afforded the desired crude product from the organic extracts as a
yellow solid (4.96 g, ca. 87%). No further purification was required for next step. E/Z isomers
Rf = 0.44 & 0.75 (100% CH2Cl2); LRMS (ESI-) m/z: [ion] (rel. int. %) 282.9 [M-H]- (97), 284.9
[M-H+2]- (99). Spectroscopic data provided on p. 288

Ethyl 5-Bromoindole-2-carboxylate (S38):

The same procedure employed in the synthesis of compound S22 (p. 124) was followed using
S37 (4.92 g, 17.26 mmol, 1.0 eq; p. 132) in PPA (21.68 g) heated to 105 °C for 30 min. An
EtOAc/H2O workup afforded S38 as a brown solid (4.86 g, quant). Rf = 0.60 (20%
EtOAc/Hexanes); 1H NMR (400 MHz, CDCl3) δ 9.36 (s, 1H), 7.83 (d, J = 1.7 Hz, 1H), 7.40 (dd,
J = 8.8, 1.9 Hz, 1H), 7.32 (d, J = 8.8 Hz, 1H), 7.16 (d, J = 1.2 Hz, 1H), 4.44 (q, J = 7.1 Hz, 2H),
1.43 (t, J = 7.1 Hz, 3H); LRMS (ESI+) m/z: [ion] (rel. int. %) 268.0 [M+H]+ (100), 270.0
[M+H+2]+ (96). Spectroscopic data provided on p. 289–290.

5-Bromoindole-2-carboxylic acid (S39):

The same procedure employed for the synthesis of S29 (p. 128) was followed using carboxylate
S38 (4.77 g, 17.79 mmol, 1.0 eq; p. 133), THF (200 mL), H2O (22 mL), LiOH·H2O (2.21 g,
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52.62 mmol, 3.0 eq) stirring under air at reflux for 19 h. The solution was then cooled to RT and
concentrated in vacuo. H2O (300 mL) was added and then acidified with 6 M HCl(aq) and
extracted with EtOAc (3 x 75 mL). Organic extracts were combined, dried (Na2SO4), filtered,
and concentrated in vacuo to afford crude product (3.37 g, ca. 79%). Rf = 0.00 (20%
EtOAc/Hexanes); 1H NMR (400 MHz, DMSO) δ 13.08 (s, 1H), 11.95 (s, 1H), 7.85 (d, J = 1.6
Hz, 1H), 7.35 (dt, J = 8.8, 5.3 Hz, 2H), 7.05 (d, J = 2.0 Hz, 1H); LRMS (ESI-) m/z: [ion] (rel. int.
%) 237.8 [M-H]- (100), 239.8 [M-H+2]- (99). Spectroscopic data provided on p. 291–292.

Preparation of 5-Chloroindole-2-carboxylic acid (S44):

4-Chlorophenylhydrazine (S41):

The same procedure employed in the synthesis of compound S20 (p. 123) was followed using
4-chloroaniline (4.01 g, 31.43 mmol, 1.0 eq) in AcOH (20 mL) adding conc. HCl until a thin
paste was achieved. Subsequently was added NaNO2 (2.40, 34.78 mmol, 1.1 eq) in H2O (15 mL)
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and then SnCl2·2H2O (21.54 g, 80.23 mmol, 2.6 eq) in conc. HCl (40 mL). Precipitate was
collected after 20 h at -4 °C to afford hydrazine S41 as a white solid (4.10 g, 73%) which was
directly engaged in the next reaction without further purification. NOTE: Hydrazine S41
decomposes readily at RT in the presence of light!

Hydrazone (S42):

The same procedure employed in the synthesis of compound S21 (p. 124) was followed using
hydrazine S41 (4.10 g, 22.91 mmol, 1.0 eq; p. 134), abs. EtOH (46 mL), 2.4 M H2SO4(aq)
(3.0 mL), and ethyl pyruvate (2.50 mL, 22.53 mmol, 1.0 eq) stirred under argon at reflux for
19 h. A cold H2O/Et2O workup afforded the desired crude product from the organic extracts as a
yellow solid (4.26 g, 77%). No further purification was required for next step. E/Z isomers
Rf = 0.44 & 0.77 (20% EtOAc/Hexanes); LRMS (ESI-) m/z: [ion] (rel. int. %) 210.8 [M-C2H5](99), 212.8 [M-C2H5+2]- (34), 238.8 [M-H]- (100), 240.8 [M-H+2]- (33). Spectroscopic data
provided on p. 293.

Ethyl 5-Chloroindole-2-carboxylate (S43):

The same procedure employed in the synthesis of compound S22 (p. 124) was followed using
S42 (4.29 g, 19.18 mmol, 1.0 eq; p. 135) in PPA (24.50 g) heated to 105 °C for 30 min. An
EtOAc/H2O workup afforded S43 as a brown solid (4.13 g, 96%). Rf = 0.55 (20%
EtOAc/Hexanes); 1H NMR (400 MHz, CDCl3) δ 9.30 (s, 1H), 7.66 (d, J = 1.9 Hz, 1H), 7.36 (d,
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J = 8.8 Hz, 1H), 7.28 – 7.25 (m, 1H), 7.16 (dd, J = 2.0, 0.8 Hz, 1H), 4.43 (q, J = 7.1 Hz, 2H),
1.43 (t, J = 7.1 Hz, 3H); LRMS (ESI+) m/z: [ion] (rel. int. %) 224.0 [M+H]+ (100), 226.0
[M+H+2]+ (34). Spectroscopic data provided on p. 294–295.

5-Chloroindole-2-carboxylic acid (S44):

The same procedure employed for the synthesis of S29 (p. 128) was followed using carboxylate
S43 (4.08 g, 18.24 mmol, 1.0 eq; p. 135), THF (300 mL), H2O (33 mL), LiOH·H2O (2.19 g,
52.14 mmol, 2.9 eq) stirring under air at reflux for 17 h. The solution was then cooled to RT and
concentrated in vacuo. H2O (300 mL) was added and then acidified with 6 M HCl(aq) and
extracted with EtOAc (3 x 75 mL). Organic extracts were combined, dried (Na2SO4), filtered,
and concentrated in vacuo to afford crude product (2.92 g, ca. 82%). Purification was achievable
via isocratic

flash

column

chromatography (40% EtOAc/Hexanes) and subsequent

recrystallization from hot EtOAc. Rf = 0.00 (20% EtOAc/Hexanes); 1H NMR (400 MHz,
DMSO) δ 13.12 (s, 1H), 11.94 (s, 1H), 7.70 (d, J = 1.7 Hz, 1H), 7.43 (d, J = 8.8 Hz, 1H), 7.23
(dd, J = 8.8, 2.0 Hz, 1H), 7.05 (d, J = 1.3 Hz, 1H); LRMS (ESI-) m/z: [ion] (rel. int. %) 193.9
[M-H]- (100), 195.9 [M-H+2]- (37). Spectroscopic data provided on p. 296–297.
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Preparation of 3-(4-Bromophenyl)indazole (104):

Bromo oxime (S46):

Using an adapted method of Counceller et al.142 and Leroux et al.,143 a solution of 2-amino-4'bromobenzophenone (634.0 mg, 2.30 mmol, 1.0 eq), NH2OH·HCl (1.59 g, 22.88 mmol,
10.0 eq), MeOH (16 mL), and pyridine (16 mL) were stirred under argon are reflux for 24 h.
Thereafter, the reaction was cooled to RT and concentrated in vacuo. To the residue was added
EtOAc (150 mL) and washed with 1 M HCl(aq) (3 x 50 mL). The organic layer was subsequently
dried (Na2SO4), filtered, and concentrated in vacuo to afford a crude mixture of E/Z product
isomers (594.1 mg, ca. 89%). Crude isomers were directly engaged in next reaction without
further purification. E/Z isomers Rf = 0.30 & 0.38 (15% acetone/CHCl3); LRMS (ESI-) m/z:
[ion] (rel. int. %) 288.8 [M-H]- (100), 290.8 [M-H+2]- (99). Spectroscopic data provided on
p. 298.
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3-(4-Bromophenyl)indazole (104):

Using an adapted method of Counceller et al.,142 Et3N (0.56 mL, 4.03 mmol, 2.0 eq) and MsCl
(0.20 mL, 2.58 mmol, 1.3 eq) were added to a solution of anhydrous CH2Cl2 (30 mL) and oxime
S46 (594.0 mg, 2.04 mmol, 1.0 eq; p. 137) under argon at 0 °C. The reaction was left in the
cooling bath to warm gradually to RT overnight (16 h). The solvent was subsequently removed
in vacuo and chromatographic purification (5% acetone/CHCl3) afforded the desired product
(103.4 mg, 19%). Rf = 0.27 (5% acetone/CHCl3); 1H NMR (400 MHz, CDCl3) δ 12.30 (s, 1H),
7.97 (d, J = 8.2 Hz, 1H), 7.90 (d, J = 8.5 Hz, 2H), 7.67 (d, J = 8.5 Hz, 2H), 7.42 – 7.33 (m, 1H),
7.29 – 7.21 (m, 1H), 7.18 (d, J = 8.4 Hz, 1H);

13

C NMR (101 MHz, CDCl3) δ 144.51, 141.73,

132.47, 132.18, 129.23, 127.06, 122.37, 121.69, 120.78, 120.71, 110.45; DEPT-135 (101 MHz,
CDCl3) δ 132.18, 129.23, 127.06, 121.69, 120.78, 110.45; ); LRMS (ESI-) m/z: [ion] (rel. int. %)
270.8 [M-H]- (99), 272.8 [M-H+2]- (100). Elemental Analysis Calcd for C13H9BrN2: C, 57.17;
H, 3.32; N, 10.26. Found: C, 56.96; H, 3.13; N, 10.20. Spectroscopic data provided on p. 299–
302.

Preparation of 5-Chloro-3-phenylindazole (103):
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Chloro oxime (S48):

The same procedure employed for the synthesis of S46 (p. 137) was followed using 2-amino-5chlorobenzophenone (10.04 g, 43.33 mmol, 1.0 eq), NH2OH·HCl (12.50 g, 179.86 mmol,
4.2 eq), MeOH (120 mL), and pyridine (54 mL). Isolation and chromatographic purification
(15% acetone/CHCl3) afforded mixture of E/Z isomers (6.36 g, 59%) which were directly
engaged in the next reaction without further purification. E/Z isomers Rf = 0.29 & 0.37 (15%
acetone/CHCl3); LRMS (ESI-) m/z: [ion] (rel. int. %) 244.9 [M-H]- (100), 246.8 [M-H+2]- (28).
Spectroscopic data provided on p. 303.

5-Chloro-3-phenylindazole (103):

The same procedure employed for the synthesis of indazole 104 (p. 138) was followed using
oxime S48 (488.2 mg, 1.98 mmol, 1.0 eq), anhydrous CH2Cl2 (40 mL), Et3N (0.55 mL,
3.96 mmol, 2.0 eq), and MsCl (0.18 mL, 2.33 mmol, 1.2 eq). Chromatographic purification (5%
acetone/CHCl3) afforded pure indazole 103 (27.0 mg, 6.0%). Rf = 0.34 (15% acetone/CHCl3); 1H
NMR (400 MHz, CDCl3) δ 12.59 (s, 1H), 7.98 (dd, J = 5.8, 1.5 Hz, 3H), 7.58 (dd, J = 11.4, 4.4
Hz, 2H), 7.54 – 7.48 (m, 1H), 7.28 – 7.22 (m, 1H), 6.89 (d, J = 8.9 Hz, 1H);

13

C NMR (101

MHz, CDCl3) δ 145.39, 140.27, 133.01, 129.39, 128.78, 127.99, 127.78, 127.25, 121.89, 120.35,
111.83; DEPT-135 (101 MHz, CDCl3) δ 129.23, 128.63, 127.82, 127.62, 120.19, 111.67; LRMS
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(ESI+) m/z: [ion] (rel. int. %) 229.0 [M+H]+ (100), 231.0 [M+H+2]+ (34). Spectroscopic data
provided on p. 304–307.

Preparation of 3-Phenylindazole (102):

Aminophenyl oxime (S50):

The same procedure employed for the synthesis of S46 (p. 137) was followed using 2-amino-3phenylbenzophenone (5.00 g, 25.35 mmol, 1.0 eq), NH2OH·HCl (17.88 g, 257.27 mmol, 5.9 eq),
MeOH (176 mL), and pyridine (176 mL). Isolation and chromatographic purification (15%
acetone/CHCl3) afforded mixture of E/Z isomers (6.49 g, 71%) which were directly engaged in
the next reaction without further purification. E/Z isomers Rf = 0.27 & 0.36 (15%
acetone/CHCl3).

3-Phenylindazole (102):
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The same procedure employed for the synthesis of indazole 104 (p. 138) was followed using
oxime S50 (6.10 g, 28.75 mmol, 1.0 eq; p. 140), anhydrous CH2Cl2 (200 mL), Et3N (8.0 mL,
57.56 mmol, 2.0 eq), and MsCl (2.9 mL, 37.47 mmol, 1.3 eq). Chromatographic purification
(40% EtOAc/Hexanes) afforded pure indazole 102 (400.1 mg, 7.1%). Rf = 0.41 (40%
EtOAc/Hexanes); 1H NMR (400 MHz, CDCl3) δ 11.63 (s, 1H), 8.05 (dd, J = 5.2, 3.2 Hz, 3H),
7.57 (dd, J = 10.3, 4.7 Hz, 2H), 7.48 (ddd, J = 7.4, 3.9, 1.2 Hz, 1H), 7.41 – 7.34 (m, 1H), 7.31 –
7.20 (m, 2H);
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C NMR (101 MHz, CDCl3) δ 145.62, 141.78, 133.67, 129.11, 128.27, 127.96,

126.78, 121.32, 121.01, 120.95, 110.58; DEPT-135 (101 MHz, CDCl3) δ 129.11, 128.28,
127.96, 126.78, 121.32, 121.01, 110.59; LRMS (ESI-) m/z: [ion] (rel. int. %) 193.0 [M-H]- (100).
Elemental Analysis Calcd for C13H10N2: C, 80.39; H, 5.19; N, 14.42. Found: C, 79.14; H, 4.97;
N, 14.18. Spectroscopic data provided on p. 308–311.

General Procedure for Suzuki Cross-Coupling:

Using an adapted method of Kawasaki et al.,144 a typical experimental procedure for the Suzuki
cross-coupling was as follows: a mixture of 3-iodoindole (1.1 mmol, 1 eq), arylboronic acid (1.8
mmol, 1.6 eq), MeOH (6 mL), benzene (6 mL), sat. aq. NaHCO3 (6 mL) and Pd(PPh3)4 (139.0
mg, 0.12 mmol, 0.1 eq) was refluxed under argon for 14 h. After cooling to RT, the reaction was
extracted with EtOAc (3 x 20 mL). The combined organic extracts were dried over Na2SO4,
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filtered, and concentrated in vacuo. Purification of the resulting crude residue by silica gel flash
column chromatography (20% EtOAc/Hexanes) gave a mixture of 3-unsubstituted indole and the
desired 3-arylindole. Further purification using semi-preparative C18 reversed phase HPLC
(35% H2O/MeCN → 100% MeCN) gave pure 3-arylindole (5–25%), which was then ready for
biological assay.

4,6-Dichloro-3-(2,4-difluorophenyl)indole (70):

Prepared by the general procedure described on p. 141 using N-Boc-indole S4 (p. 109) and
2,4-difluorophenylboronic

acid.

Rf = 0.28

(25%

EtOAc/Hexanes;

stains

violet

with

p-anisaldehyde); 1H NMR (500 MHz, CDCl3) δ 8.31 (s, 1H), 7.38 (dt, J = 14.7, 7.5 Hz, 1H),
7.28 (t, J = 4.3 Hz, 1H), 7.17 (dd, J = 3.6, 2.0 Hz, 2H), 7.05 – 6.86 (m, 2H);

13

C NMR (126

MHz, CDCl3) δ 163.65, 163.55, 162.08, 161.99, 161.67, 161.58, 160.11, 160.02, 137.07, 133.75,
133.72, 133.68, 133.64, 128.17, 126.88, 125.51, 122.75, 121.72, 118.61, 118.58, 118.48, 118.45,
110.78, 110.64, 110.61, 110.47, 110.44, 110.23, 103.79, 103.58, 103.38; DEPT-135 (126 MHz,
CDCl3) δ 133.75, 133.72, 133.68, 133.64, 125.52, 121.72, 110.64, 110.61, 110.48, 110.45,
110.23, 103.79, 103.58, 103.38; LRMS (ESI-) m/z: [ion] (rel. int. %) 295.9 [M-H]- (100), 297.8
[M-H+2]- (78). Spectroscopic data provided on p. 312–315.
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4,6-Dichloro-3-(4-chlorophenyl)indole (32):

Prepared by the general procedure described on p. 141 using N-Boc-indole S4 (p. 109) and
4-chlorophenylboronic acid. Rf = 0.30 (25% EtOAc/Hexanes; stains violet with p-anisaldehyde);
1

H NMR (400 MHz, CDCl3) δ 8.32 (s, 1H), 7.43 (d, J = 8.5 Hz, 2H), 7.38 (d, J = 8.5 Hz, 2H),

7.30 (d, J = 1.5 Hz, 1H), 7.17 (d, J = 1.5 Hz, 1H), 7.14 (d, J = 2.4 Hz, 1H); 13C NMR (101 MHz,
CDCl3) δ 137.36, 132.95, 132.79, 132.12, 128.07, 127.67, 126.84, 124.99, 121.92, 121.80,
118.00, 110.21; DEPT-135 NMR (101 MHz, CDCl3) δ 132.12, 127.67, 124.99, 121.80, 110.21;
LRMS (ESI-) m/z: [ion] (rel. int. %) 293.8 [M-H]- (100), 295.9 [M-H+2]- (100); HRMS
(ESI-TOF); calcd for C14H7Cl3N- [M-H+]: 293.9644, found 293.9628. Spectroscopic data
provided on p. 316–319.

4,6-Dichloro-3-(2-chlorophenyl)indole (74):

Prepared by the general procedure described on p. 141 using N-Boc-indole S4 (p. 109) and
2-chlorophenylboronic acid. Rf = 0.28 (25% EtOAc/Hexanes; stains violet with p-anisaldehyde);
1

H NMR (400 MHz, CDCl3) δ 8.30 (s, 1H), 7.50 (dd, J = 7.7, 1.1 Hz, 1H), 7.42 (dd, J = 7.1, 1.9

Hz, 1H), 7.39 – 7.25 (m, 3H), 7.16 (d, J = 2.2 Hz, 2H); 13C NMR (101 MHz, CDCl3) δ 136.83,
135.82, 133.73, 133.12, 128.97, 128.86, 128.09, 127.07, 125.98, 124.99, 122.97, 121.53, 115.70,
110.15; DEPT-135 NMR (101 MHz, CDCl3) δ 133.12, 128.97, 128.86, 125.98, 124.99, 121.53,
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110.15; LRMS (ESI-) m/z: [ion] (rel. int. %) 293.9 [M-H]- (100), 295.9 [M-H+2]- (98).
Elemental Analysis Calcd for C14H8Cl3N: C, 56.70; H, 2.72; N, 4.72. Found: C, 55.98; H, 2.48;
N, 4.65. Spectroscopic data provided on p. 320–323.

4,6-Dichloro-3-(4-(trifluoromethyl)phenyl)indole (69):

Prepared by the general procedure described on p. 141 using N-Boc-indole S4 (p. 109) and
2-chlorophenylboronic acid. Rf = 0.27 (25% EtOAc/Hexanes; stains violet with p-anisaldehyde);
1

H NMR (500 MHz, CDCl3) δ 8.38 (s, 1H), 7.68 (d, J = 8.1 Hz, 2H), 7.63 (d, J = 8.1 Hz, 2H),

7.36 (d, J = 1.4 Hz, 1H), 7.22 (dd, J = 10.5, 1.9 Hz, 2H); 13C NMR (126 MHz, CDCl3) δ 138.25,
138.24, 137.44, 130.99, 128.91, 128.65, 128.33, 126.84, 125.61, 125.25, 124.44, 124.41, 124.38,
124.35, 123.45, 122.02, 121.81, 118.04, 110.24; DEPT-135 (126 MHz, CDCl3) δ 130.99,
125.26, 124.44, 124.41, 124.38, 124.35, 122.02, 110.24; LRMS (ESI-) m/z: [ion] (rel. int. %)
327.9 [M-H]- (100), 329.9 [M-H+2]- (59). Elemental Analysis Calcd for C15H8Cl2F3N: C, 54.57;
H, 2.44; N, 4.24. Found: C, 54.37; H, 2.26; N, 4.19. Spectroscopic data provided on p. 324–327.

3-(4-Bromophenyl)-4,6-dichloroindole (71):

144

Prepared by the general procedure described on p. 141 using N-Boc-indole S4 (p. 109) and
4-bromophenylboronic acid. Rf = 0.24 (25% EtOAc/Hexanes; stains violet with p-anisaldehyde);
1

H NMR (500 MHz, CDCl3) δ 8.32 (s, 1H), 7.54 (d, J = 7.9 Hz, 2H), 7.35 (dd, J = 32.8, 16.8 Hz,

3H), 7.18 (s, 2H);

13

C NMR (126 MHz, CDCl3) δ 137.38, 133.41, 132.45, 130.62, 128.17,

126.92, 124.84, 121.88, 121.00, 118.12, 110.17; DEPT-135 (126 MHz, CDCl3) δ 132.45,
130.62, 124.85, 121.87, 110.17; LRMS (ESI-) m/z: [ion] (rel. int. %) 337.8 [M-H]- (26), 339.8
[M-H+2]- (100). Spectroscopic data provided on p. 328–331.

4,6-Dichloro-3-(4-fluorophenyl)indole (54):

Prepared by the general procedure described on p. 141 using N-Boc-indole S4 (p. 109) and
4-fluorophenylboronic acid. Rf = 0.22 (10% EtOAc/Hexanes; stains violet with p-anisaldehyde);
1

H NMR (400 MHz, CDCl3) δ 8.31 (s, 1H), 7.50 – 7.42 (m, 2H), 7.31 (d, J = 1.7 Hz, 1H), 7.17

(d, J = 1.7 Hz, 1H), 7.14 (d, J = 2.5 Hz, 1H), 7.11 (ddd, J = 9.6, 5.9, 2.5 Hz, 2H); 13C NMR (126
MHz, CDCl3) δ 163.15, 161.20, 137.31, 132.44, 132.38, 130.41, 130.39, 127.98, 126.88, 124.91,
122.09, 121.71, 118.13, 114.49, 114.32, 110.20; DEPT-135 (126 MHz, CDCl3) δ 132.44,
132.38, 124.92, 121.71, 114.49, 114.32, 110.20; LRMS (ESI-) m/z: [ion] (rel. int. %) 277.9 [MH]- (100), 279.9 [M-H+2]- (87). Spectroscopic data provided on p. 332–335.
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4,6-Dichloro-3-(3-chlorophenyl)indole (55):

Prepared by the general procedure described on p. 141 using N-Boc-indole S4 (p. 109) and
3-chlorophenylboronic acid. Rf = 0.37 (25% EtOAc/Hexanes; stains violet with p-anisaldehyde);
1

H NMR (400 MHz, CDCl3) δ 8.41 (s, 1H), 7.48 (s, 1H), 7.39 – 7.35 (m, 1H), 7.32 (dd, J = 6.3,

1.8 Hz, 3H), 7.16 (dd, J = 6.1, 2.0 Hz, 2H); LRMS (ESI-) m/z: [ion] (rel. int. %) 293.8 [M-H](100), 295.8 [M-H+2]- (99). Spectroscopic data provided on p. 336–337.

4,6-Dichloro-3-(3,4-dichlorophenyl)indole (72):

Prepared by the general procedure described on p. 141 using N-Boc-indole S4 (p. 109) and
3,4-dichlorophenylboronic

acid.

Rf = 0.27

(25%

EtOAc/Hexanes;

stains

violet

with

p-anisaldehyde); 1H NMR (400 MHz, CDCl3) δ 8.40 (s, 1H), 7.57 (d, J = 2.0 Hz, 1H), 7.44 (d, J
= 8.2 Hz, 1H), 7.31 (dd, J = 7.8, 1.8 Hz, 2H), 7.16 (dd, J = 5.4, 2.1 Hz, 2H);

13

C NMR (101

MHz, CDCl3) δ 137.33, 134.57, 132.35, 131.35, 130.80, 130.26, 129.35, 128.29, 126.68, 125.20,
121.98, 121.68, 116.88, 110.29; DEPT-135 (101 MHz, CDCl3) δ 132.34, 130.25, 129.34,
125.18, 121.97, 110.28; ); LRMS (ESI-) m/z: [ion] (rel. int. %) 327.9 [M-H]- (62), 329.8 [MH+2]- (100). Elemental Analysis Calcd for C14H7Cl4N: C, 50.80; H, 2.13; N, 4.23. Found: C,
50.40; H, 1.94; N, 4.16. Spectroscopic data provided on p. 338–341.
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3-(2,4-Bis(trifluoromethyl)phenyl)-4,6-bis(trifluoromethyl)indole (73):

Prepared by the general procedure described on p. 141 using bis(trifluoromethyl)indole S10
(p. 112) and 2,4-bis(trifluoromethyl)phenylboronic acid. Rf = 0.29 (25% EtOAc/Hexanes);
1

H NMR (400 MHz, DMSO) δ 12.49 (s, 1H), 8.17 (s, 1H), 8.11 (s, 1H), 8.08 (d, J = 8.2 Hz, 1H),

7.88 (s, 1H), 7.72 (d, J = 8.0 Hz, 1H), 7.64 (s, 1H); DEPT-135 (101 MHz, DMSO) δ 136.40,
132.32, 131.98, 129.26, 129.14, 128.50, 122.77, 114.58; LRMS (ESI-) m/z: [ion] (rel. int. %)
463.9 [M-H]- (100). Spectroscopic data provided on p. 342–344.

4,6-Dibromo-3-(4-bromophenyl)indole (64):

Prepared by the general procedure described on p. 141 using N-Boc-indole S3 (p. 106) and
4-bromophenylboronic acid. Rf = 0.37 (20% EtOAc/Hexanes; stains violet with p-anisaldehyde);
1

H NMR (400 MHz, CDCl3) δ 8.36 (s, 1H), 7.57 – 7.43 (m, 4H), 7.33 (d, J = 8.3 Hz, 2H), 7.16

(d, J = 2.4 Hz, 1H);

13

C NMR (101 MHz, CDCl3) δ 137.41, 133.15, 132.96, 130.46, 127.46,

125.03, 123.72, 121.18, 118.78, 115.50, 114.84, 113.62; LRMS (ESI-) m/z: [ion] (rel. int. %)
425.6 [M-H]- (31), 427.6 [M-H+2]- (98), 429.6 [M-H+4]- (100), 431.5 [M-H+6]- (33). Elemental
Analysis Calcd for C14H8Br3N: C, 39.11; H, 1.88; N, 3.26. Found: C, 39.14; H, 1.63; N, 3.20.
Spectroscopic data provided on p. 345–348.
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4,6-Dibromo-3-(2-bromophenyl)indole (65):

Prepared by the general procedure described on p. 141 using N-Boc-indole S3 (p. 106) and
2-bromophenylboronic acid. Rf = 0.31 (25% EtOAc/Hexanes; stains violet with p-anisaldehyde);
1

H NMR (400 MHz, CDCl3) δ 8.39 (s, 1H), 7.65 (d, J = 7.9 Hz, 1H), 7.53 (d, J = 1.3 Hz, 1H),

7.45 (dd, J = 11.3, 1.3 Hz, 1H), 7.39 (dd, J = 7.5, 1.6 Hz, 1H), 7.33 (t, J = 7.4 Hz, 1H), 7.29 –
7.21 (m, 1H), 7.16 (d, J = 2.4 Hz, 1H); LRMS (ESI-) m/z: [ion] (rel. int. %) 425.6 [M-H]- (33),
427.7 [M-H+2]- (100), 429.7 [M-H+4]- (99), 431.5 [M-H+6]- (30). Elemental Analysis Calcd for
C14H8Br3N: C, 39.11; H, 1.88; N, 3.26. Found: C, 39.78; H, 1.81; N, 3.22. Spectroscopic data
provided on p. 349–350.

4,6-Dibromo-3-phenylindole (68):

Prepared by the general procedure described on p. 141 using N-Boc-indole S3 (p. 106) and
phenylboronic acid. Rf = 0.30 (25% EtOAc/Hexanes; stains violet with p-anisaldehyde);
1

H NMR (400 MHz, CDCl3) δ 8.32 (s, 1H), 7.73 – 7.64 (m, 1H), 7.54 (d, J = 1.5 Hz, 1H), 7.47

(dd, J = 7.3, 1.7 Hz, 4H), 7.38 (dd, J = 4.6, 2.5 Hz, 2H), 7.17 (d, J = 2.5 Hz, 1H); LRMS (ESI-)
m/z: [ion] (rel. int. %) 347.7 [M-H]- (51), 349.8 [M-H+2]- (100), 351.7 [M-H+4]- (51).
Spectroscopic data provided on p. 351–352.
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4,6-Dibromo-3-(6-bromopyridin-3-yl)indole (67):

Prepared by the general procedure described on p. 141 using N-Boc-indole S3 (p. 106) and
2-bromopyridine-5-boronic acid. Rf = 0.14 (25% EtOAc/Hexanes); 1H NMR (400 MHz, DMSO)
δ 11.96 (s, 1H), 8.42 (d, J = 2.5 Hz, 1H), 8.30 (s, 1H), 7.80 (dd, J = 8.1, 2.3 Hz, 1H), 7.70 (d, J =
0.9 Hz, 1H), 7.68 – 7.61 (m, 2H), 7.42 (d, J = 1.0 Hz, 1H); LRMS (ESI-) m/z: [ion] (rel. int. %)
426.8 [M-H]- (32), 428.7 [M-H+2]- (98), 430.7 [M-H+4]- (100); 432.7 [M-H+6]- (35). Elemental
Analysis Calcd for C13H7Br3N2: C, 36.23; H, 1.64; N, 6.50. Found: C, 36.53; H, 1.44; N, 6.35.
Spectroscopic data provided on p. 353–354.

4,6-Dinitro-3-(3-nitrophenyl)indole (87):

Prepared by the general procedure described on p. 141 using N-Boc-indole 86 (p. 121) and
3-nitrophenylboronic acid. 1H NMR (400 MHz, DMSO) δ 12.89 (s, 1H), 8.97 (d, J = 1.9 Hz,
1H), 8.80 (d, J = 1.9 Hz, 1H), 8.44 (t, J = 1.8 Hz, 1H), 8.25 (s, 1H), 8.22 – 8.13 (m, 2H), 7.78 (t,
J = 8.0 Hz, 1H); LRMS (ESI-) m/z: [ion] (rel. int. %) 326.9 [M-H]- (100). Spectroscopic data
provided on p. 355–356.
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6-Chloro-3-(4-chlorophenyl)indole (S52):

N-Boc-3-iodo-6-chloroindole S51 was first prepared from 6-chloroindole 79 (p. 116) using the
previously described methods for iodination and Boc-protection (p. 105–106). 3-Phenylindole
S52 was then prepared by the general procedure described on p. 141 using S51 and
4-chlorophenylboronic acid. Rf = 0.32 (25% EtOAc/Hexanes; stains violet with p-anisaldehyde);
1

H NMR (400 MHz, CDCl3) δ 8.24 (s, 1H), 7.78 (d, J = 8.6 Hz, 1H), 7.56 (d, J = 8.5 Hz, 2H),

7.43 (d, J = 8.1 Hz, 3H), 7.34 (d, J = 2.5 Hz, 1H), 7.18 (dd, J = 8.6, 1.7 Hz, 1H); 13C NMR (101
MHz, CDCl3) δ 136.97, 133.41, 131.98, 128.98, 128.60, 128.53, 124.19, 122.34, 121.25, 120.48,
117.45, 111.39; DEPT-135 (101 MHz, CDCl3) δ 128.98, 128.60, 122.34, 121.25, 120.48,
111.39; LRMS (ESI-) m/z: [ion] (rel. int. %) 259.8 [M-H]- (100), 261.8 [M-H+2]- (68).
Elemental Analysis Calcd for C14H9Cl2N: C, 64.15; H, 3.46; N, 5.34. Found: C, 63.56; H, 3.25;
N, 5.24. Spectroscopic data provided on p. 357–360.

Ethyl 4,6-dichloro-3-(4-bromophenyl)indole-2-carboxylate (109):

Prepared by the general procedure described on p. 141 using carboxylate S28 (p. 128) and
4-bromophenylboronic acid. Rf = 0.32 (25% EtOAc/Hexanes); 1H NMR (400 MHz, CDCl3)
δ 9.13 (s, 1H), 7.53 (d, J = 8.4 Hz, 2H), 7.38 (d, J = 1.5 Hz, 1H), 7.26 (d, J = 8.8 Hz, 3H), 7.13
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(d, J = 1.5 Hz, 1H), 4.22 (q, J = 7.1 Hz, 2H), 1.13 (t, J = 7.1 Hz, 3H); DEPT-135 (400 MHz,
CDCl3) δ 133.06, 130.53, 123.07, 110.78, 61.47, 13.92; ; LRMS (ESI-) m/z: [ion] (rel. int. %)
409.7 [M-H]- (29), 411.7 [M-H+2]- (100) , 413.7 [M-H+4]- (10). Elemental Analysis Calcd for
C17H12BrCl2NO2: C, 49.43; H, 2.93; N, 3.39. Found: C, 49.19; H, 2.75; N, 3.32. Spectroscopic
data provided on p. 361–363.

Ethyl 4,6-dibromo-3-(4-bromophenyl)indole-2-carboxylate (112):

Prepared by the general procedure described on p. 141 using carboxylate S23 (p. 125) and
4-bromophenylboronic acid. Rf = 0.37 (25% EtOAc/Hexanes); 1H NMR (400 MHz, DMSO) δ
12.44 (s, 1H), 7.69 (s, 1H), 7.54 (d, J = 8.2 Hz, 2H), 7.42 (s, 1H), 7.26 (d, J = 8.2 Hz, 2H), 4.11
(q, J = 7.0 Hz, 2H), 1.02 (t, J = 7.1 Hz, 3H); 13C NMR (101 MHz, DMSO) δ 160.92, 137.79,
133.95, 133.33, 130.25, 127.29, 126.37, 123.99, 122.15, 121.16, 117.62, 116.09, 115.34, 61.03,
14.11; LRMS (ESI-) m/z: [ion] (rel. int. %) 497.7 [M-H]- (32), 499.7 [M-H+2]- (98), 501.7 [MH+4]- (100), 503.7 [M-H+6]- (32); HRMS (ESI-TOF); calcd for C17H11Br3NO2- [M-H+]:
497.8340, found 497.8338. Elemental Analysis Calcd for C17H12Br3NO2: C, 40.67; H, 2.41; N,
2.79. Found: C, 41.14; H, 2.42; N, 2.65. Spectroscopic data provided on p. 364–366.
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MYCELIAL GROWTH TEST RESULTS
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For the purpose of data interpretation the following structures and code names are
provided for Appendix A.
These compounds were submitted to David Wedge at the USDA-ARS for analysis in his
mycelial growth test (described on p. 66). All compounds were compared against known
fungicides, 6-OH-BDE-47 and captan. Purity was questionable of all compounds except for 6OH-BDE-47 and captan; namely because this particular assay was (1) executed before full
understanding of the dehalogenation problem was appreciated (p. 43) and (2) because these
compounds were not HPLC purified. Based on TLC and NMR data, impurities could easily have
accounted for as much as 50% of the sample weight in some cases. The graphical biological data
is presented hereafter on the following page. Inhibition is the desirable characteristic to note in
the following graphs.
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IC50 (µg/mL)

2.40

1.71

6.93

1.59

<0.8

-

3.36

1.12

12.00

-

MRSA IC50
(µg/mL)

-

-

-

-

-

-

-

-

-

-

E. coli IC50
(µg/mL)

-

-

-

-

-

-

-

-

-

-

P.
aeruginosa
IC50 (µg/mL)

11.52

-

-

-

-

-

-

-

-

-

M.
intracellulare
IC50 (µg/mL)

RT

RT

RT

RT

RT

RT

RT

RT

Tertiary/<2?
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Structure

7.60

9.65

-

AF-07-041B

AF-07-041C

AF-06-086

-

15.91

12.81

-

-

0.87

AF-07-005

2.27

AF-07-024

18.23

5.20

11.05

PBDE-1

-

16.59

-

RAS-05-036B

-

AF-07-032

-

-

11.59

11.45

-

10.99

1.53

1.39

-

-

C. albicans C. glabrata C. krusei IC50
IC50 (µg/mL) IC50 (µg/mL)
(µg/mL)

RAS-05-036A

Sample Code

Table B.1. (continued )

-

7.38

5.10

-

11.47

2.37

17.61

-

-

NT

1.56

1.47

-

1.37

0.44

<0.8

3.27

-

-

14.13

8.06

-

1.06

0.39

<0.8

-

-

A.
C. neoformans S. aureus
fumigatus
IC50 (µg/mL) IC50 (µg/mL)
IC50 (µg/mL)

-

18.18

14.33

-

0.81

0.60

<0.8

-

-

MRSA IC50
(µg/mL)

-

-

-

-

-

-

0.70

-

-

E. coli IC50
(µg/mL)

NT

NT

NT

-

NT

NT

-

-

-

P.
aeruginosa
IC50 (µg/mL)

NT

NT

NT

-

NT

NT

-

-

-

M.
intracellulare
IC50 (µg/mL)

RT

RT

RT

RT

RT

Tertiary/<2?
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a

-

-

10.03

3.70

15.53

AF-07-029

AF-07-024-Red

PBDE 1

RAS-07-032

4.37

1.37

15.44

-

-

-

6.51

AF-06-085

10.56

AF-07-036-P2

14.48

-

9.37

AF-07-018B

1.49

AF-07-041A

1.70

10.92

1.16

13.21

-

-

-

6.87

10.32

1.42

C. albicans C. glabrata C. krusei IC50
IC50 (µg/mL) IC50 (µg/mL)
(µg/mL)

AF-07-018C

Sample Code

15.19

5.73

9.68

-

11.05

-

9.92

6.56

2.36

0.47

0.25

2.77

11.79

3.17

-

1.46

1.69

0.18

0.78

0.16

4.64

-

-

-

6.66

12.79

0.67

A.
C. neoformans S. aureus
fumigatus
IC50 (µg/mL) IC50 (µg/mL)
IC50 (µg/mL)

All data is reported in concentrations (µg/mL) that afford 50% inhibition of growth

Structure

Table B.1. (continued )

0.76

<0.019

5.27

-

-

-

8.17

18.93

0.77

MRSA IC50
(µg/mL)

-

1.70

-

-

-

-

-

-

-

E. coli IC50
(µg/mL)

NT

NT

NT

-

NT

-

NT

NT

NT

P.
aeruginosa
IC50 (µg/mL)

NT

NT

NT

-

NT

-

NT

NT

NT

M.
intracellulare
IC50 (µg/mL)

RT

RT

RT

RT

RT

RT

Tertiary/<2?
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Structure

10.00

20.00

20.00

-

2.50

20.00

20.00

-

-

-

2.50

-

20.00

AF-07-024

AF-07-032

AF-07-041B

AF-07-041C

AF-06-086

AF-07-018C

AF-07-018B

AF-07-036-P2

20.00

1.25

5.00

Sample Code

C. glabrata
MIC
(µg/m L)

C. albicans
MIC
(µg/m L)

20.00

-

2.50

-

-

20.00

20.00

2.50

C. krusei
MIC
(µg/m L)

20.00

10.00

5.00

-

20.00

10.00

-

5.00

A.
fumigatus
MIC
(µg/m L)

2.50

5.00

0.31

NT

2.50

2.50

2.50

0.31

C.
neoformans
MIC
(µg/m L)

Table B.2. Minimum Inhibitory Concentration (MIC) Data from Human Pathogen Assay a

10.00

20.00

1.25

-

20.00

20.00

2.50

0.63

S. aureus
MIC
(µg/m L)

20.00

-

1.25

-

-

20.00

1.25

1.25

MRSA MIC
(µg/mL)

-

-

-

-

-

-

-

-

NT

NT

NT

NT

NT

NT

NT

NT

P.
E. coli MIC aeruginosa
(µg/m L)
MIC
(µg/m L)

NT

NT

NT

NT

NT

NT

NT

NT

M.
intracellulare
MIC (µg/m L)
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a

PBDE 1

10.00

2.50

20.00

AF-07-024-Red

20.00

20.00

20.00

AF-06-085

RAS-07-032

-

-

Sample Code

20.00

2.50

20.00

-

C. krusei
MIC
(µg/m L)

-

10.00

20.00

-

A.
fumigatus
MIC
(µg/m L)

0.63

0.63

5.00

10.00

C.
neoformans
MIC
(µg/m L)

1.25

0.63

10.00

-

S. aureus
MIC
(µg/m L)

1.25

0.02

10.00

-

MRSA MIC
(µg/mL)

Minimum Inhibitory Concentration (MIC) is the lowest test concentration (mg/ml) that allows no detectable growth

Structure

C. glabrata
MIC
(µg/m L)

C. albicans
MIC
(µg/m L)

Table B.2. (continued )

-

5.00

-

-

NT

NT

NT

NT

P.
E. coli MIC aeruginosa
(µg/m L)
MIC
(µg/m L)

NT

NT

NT

NT

M.
intracellulare
MIC (µg/m L)
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Structure

10.00

20.00

20.00

-

AF-07-024

AF-07-032

AF-07-041B

2.50

-

-

5.00

-

20.00

AF-06-086

AF-07-018C

AF-07-018B

AF-07-036-P2

-

-

-

AF-07-041C

-

1.25

5.00

Sample Code

C. glabrata
MFC
(µg/m L)

C. albicans
MFC
(µg/m L)

20.00

-

2.50

-

-

-

20.00

2.50

C. krusei
MFC
(µg/m L)

-

-

10.00

-

-

-

-

10.00

A.
fumigatus
MFC
(µg/m L)

2.50

5.00

0.31

NT

2.50

2.50

2.50

0.31

C.
neoformans
MFC
(µg/m L)

-

-

5.00

-

-

-

5.00

5.00

S. aureus
MBC
(µg/m L)

-

-

5.00

-

-

-

5.00

2.50

-

-

-

-

-

-

-

-

MRSA MBC E. coli MBC
(µg/mL)
(µg/m L)

Table B.3. Minimum Fungicidal/Bactericidal Concentration (MFC/MBC) Data from Human Pathogen Assay a

NT

NT

NT

NT

NT

NT

NT

NT

P. aeruginosa
MBC (µg/m L)

NT

NT

NT

NT

NT

NT

NT

NT

M. intracellulare
MBC (µg/m L)
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a

PBDE 1

10.00

2.50

20.00

AF-07-024-Red

20.00

20.00

-

AF-06-085

RAS-07-032

-

-

Sample Code

20.00

2.50

-

-

C. krusei
MFC
(µg/m L)

-

-

-

-

A.
fumigatus
MFC
(µg/m L)

1.25

0.63

5.00

10.00

C.
neoformans
MFC
(µg/m L)

5.00

5.00

20.00

-

S. aureus
MBC
(µg/m L)

10.00

5.00

20.00

-

-

5.00

-

-

MRSA MBC E. coli MBC
(µg/mL)
(µg/m L)

NT

NT

NT

NT

P. aeruginosa
MBC (µg/m L)

NT

NT

NT

NT

M. intracellulare
MBC (µg/m L)

Minimum Fungicidal Concentration (MFC) & Minimum Bactericidal Concentration (MBC) is the lowest test concentration (mg/ml) that kills the organism

Structure

C. glabrata
MFC
(µg/m L)

C. albicans
MFC
(µg/m L)

Table B.3. (continued )

APPENDIX C

PLANT ASSAY DATA PROVIDED
BY SYNGENTA CROP PROTECTION, INC.
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Materials & Methods
Methodology

All testing was carried out in 96-well plates.
Herbicide assays: Compounds were tested for herbicidal activity against Arabidopsis thaliana at
10ppm and Poa annua at 32ppm. Test plates were stored for seven days in a controlled environment
cabinet. Scores were given as 0 or 99, where 99 is any herbicidal effect, and 0 is no effect.
Test species

Treatment timing

Rate (ppm)

Arabidopsis thaliana

Pre emergence

10

Poa annua

Pre emergence

32

Insecticide assays: The compounds were tested for activity against an aphid species in a leaf-disc
assay at 1000ppm. The compounds were also evaluated at a rate of 500ppm on Plutella xylostella in
an artificial diet assay and against the nematode species Caenorhabditis elegans in liquid culture at
10ppm. Chemicals were applied to feeding aphids, prior to infestation with P. xylostella larvae, or
diluted into the C. elegans culture.
Mortality was assessed relative to control wells using a 2 band system (0 or 99 where 99 is
significant mortality, and 0 is no significant effect), 5-9d after the treatments depending on the assay.
C. elegans were also assessed for symptomology.
Test species

Treatment type

Media

Rate (ppm)

Aphid species

Feeding/contact

leaf disc

1000

Plutella xylostella

Feeding/contact

Artificial diet

500

Caenorhabditis elegans

Feeding/contact

Liquid culture

10

Fungicide assays: Compounds were evaluated in mycelial growth tests in artificial media against
Pythium dissimile, Alternaria solani, Botryotinia fuckeliana and Gibberella zeae, at rates of 20ppm
and 2ppm.
Test species
Media
Rate (ppm)
Pythium dissimile

Semi-solid

20 and 2

Alternaria solani

Semi-solid

20 and 2

Botryotinia fuckeliana

Semi-solid

20 and 2

Gibberella zeae

Semi-solid

20 and 2

Leaf-piece assays were also conducted. The compounds were evaluated at 100ppm against Septoria
tritici on wheat, and 200ppm and 60ppm for Phytophthora infestans on tomato and 100ppm for
Uromyces viciae-fabae on bean. Chemicals were applied prior to inoculation in the leaf-piece
assays.
Test species
Host
Rate (ppm)
Septoria tritici

Wheat

100

Phytophthora infestans

Tomato

200 and 60

Uromyces viciae-fabae

Bean

100

Mycelial growth or disease inhibition was assessed visually and scored using a 3 band system (0, 55
and 99 where 99 is total inhibition of hyphal growth/disease development, 55 is partial inhibition,
and 0 is no inhibition), 4-14d after inoculation depending on the assay.
Positive controls: Positive control compounds were included in each test (Azoxystrobin and
Prochloraz for fungicide assays, Thiamethoxam and Indoxacarb for insecticide assays and
Norflurazon for herbicide assays, all applied at rates).
In all cases, data were recorded and averaged across replicates.
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Table C.1. Syngenta‘s preliminary data from fungicidal assays

Substance
Br

Mississipi ID
Br

O

Rate

Fungicide active

Gibberella zeae

Pythium dissimile

Alternaria solani

Septoria tritici (wheat)

Disease control

Uromyces viciae-fabae
(bean)

Phytophthora infestans
(tomato)

Disease control

Botryotinia fuckeliana

FUNGICIDE ASSAYS
Scores are given for numbered replicates, and average scores
for the replicates (avg); Scores are
99- any herbicide effect (Herbicide assays); >70% mortality
(Insecticide assays); complete control of pathogen in that
replicate (Fungicide assays)
55- Partial control of pathogen (Fungicide assays only)
0- no activity
NC- data not captured for this replicate (test failure)
NCH- replicate not assessable because of herbicidal effect on
leaf-piece

Disease control Disease control Disease control Disease control Disease control

Rep 1 Rep 2 avg Rep 1 Rep 2 Rep 3 avg Rep 1 Rep 2 avg Rep 1 Rep 2 avg Rep 1 Rep 2 avg Rep 1 Rep 2 avg Rep 1 Rep 2 avg

2High

55

0

27

1low

0

0

0

2High

0

0

0

1low

0

0

0

2High

0

0

0

1low

0

0

0

2High

0

0

0

1low

0

0

0

2High

0

0

0

1low

0

0

0

2High

0

0

0

1low

0

0

0

2High

0

0

0

1low

0

0

0

2High

0

0

0

1low

0

0

0

2High

0

0

0

1low

0

0

0

2High

0

0

0

1low

0

0

0

2High

0

0

0

1low

0

0

0

0

55

0

18

NCH

NC

0

0

0

99

99

99

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

99

49

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

55

0

27

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

99

49

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

PDBE1
Br

HO

Br

Y

CS A A 403019
H
N

Cl

Cl

Cl

0

0

0

0

0

NC

0

RAS-03-015

N

CS A A 577296
H
N

Cl

F
Cl

55

0

0

18

0

NC

0

RAS-03-016

F

N

CS CD763190
H
N

Cl

0

0

0

0

0

NC

0

RAS-03-010

Cl

Cl

N

CS CD763191
H
N

Cl

O

O

99

55

0

51

0

NC

0

RAS-06-074

Cl

Br

Y

CS CD763192
H
N

Cl

Cl

55

55

99

69

0

NC

0

RAS-03-018
F

F
F

Y

CS CD763193
H
N

Cl

0

55

55

36

0

NC

0

RAS-03-017

Cl

Br

N

CS CD763194
H
N

Cl

99

0

0

33

0

NC

0

RAS-02-086
Cl

N

CS CD763195
H
N

Br

0

0

0

0

0

NC

0

RAS-08-030

Br

Br

N

CS CD763196
H
N

Cl

0

0

0

0

0

NC

0

RAS-07-018C

Cl

F

N

CS CD763197
H
N

Br

O

O

0

0

0

0

0

NC

0

RAS-07-005

Br

Br

N

CS CD763198
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Table C.1. (continued)

Substance

Mississipi ID

H
N

Cl

Rate

Fungicide active

Gibberella zeae

Pythium dissimile

Alternaria solani

Septoria tritici (wheat)
Disease control

Uromyces viciae-fabae
(bean)

Phytophthora infestans
(tomato)
Disease control

Botryotinia fuckeliana

FUNGICIDE ASSAYS
Scores are given for numbered replicates, and average scores
for the replicates (avg); Scores are
99- any herbicide effect (Herbicide assays); >70% mortality
(Insecticide assays); complete control of pathogen in that
replicate (Fungicide assays)
55- Partial control of pathogen (Fungicide assays only)
0- no activity
NC- data not captured for this replicate (test failure)
NCH- replicate not assessable because of herbicidal effect on
leaf-piece

Disease control Disease control Disease control Disease control Disease control

Rep 1 Rep 2 avg Rep 1 Rep 2 Rep 3 avg Rep 1 Rep 2 avg Rep 1 Rep 2 avg Rep 1 Rep 2 avg Rep 1 Rep 2 avg Rep 1 Rep 2 avg

2High

0

0

0

1low

0

0

0

2High

0

0

0

1low

0

0

0

2High

0

0

0

1low

0

0

0

2High

0

0

0

1low

0

0

0

2High

0

99

49

1low

0

0

0

2High

0

0

0

1low

0

0

0

2High

0

0

0

1low

0

0

0

0

0

0

0

0

NC

0

0

0

0

0

55

27

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

55

27

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

RAS-08-026

Cl
Cl

N

CS CD763199
H
N

Br

Br

0

0

55

18

0

NC

0

RAS-08-032

N

Br

N

CS CD763200
H
N

Br

Br
Br

0

55

0

18

0

NC

0

RAS-08-029

N

CS CD763201
H
N

Br

55

0

0

18

0

NC

0

RAS-08-031

Br

N

CS CD763202
H
N
N

0

0

0

0

0

NC

0

RAS-05-006
Br

N

CS CD763203
H
N

Cl

0

55

99

51

0

NC

0

RAS-03-066

Cl

Y

Cl
Cl

CS CD763204
O

N

+

O

-

H
N
O

0

0

0

0

0

NC

0

-

N

RAS-08-037

+

O

N

O
N

+

O

-

CS CD773306
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Table C.2. Syngenta‘s preliminary data from herbicide, insecticide, & nematicide assays

Substance
Br

Mississipi ID
Br

Rate
2High

O

Mixed population
mortality

Rep 1 Rep 2 avg Rep 1 Rep 2 avg
0

0

0

0

0

HO

Br

Inscecticide active

Caenorhabditis elegans

Larval mortality

Nematode
mortality

Rep 1 Rep 2 Rep 3 avg Rep 1 Rep 2 Rep 3 avg Rep 1 Rep 2 avg

0

PDBE1
Br

Plutella xylostella

Herbicide
effect

Aphid species

Poa annua

Herbicide
effect

INSECTICIDE ASSAYS

Herbicide active

Arabidopsis thalania

HERBICIDE ASSAYS
Scores are given for numbered replicates, and average scores
for the replicates (avg); Scores are
99- any herbicide effect (Herbicide assays); >70% mortality
(Insecticide assays); complete control of pathogen in that
replicate (Fungicide assays)
55- Partial control of pathogen (Fungicide assays only)
0- no activity
NC- data not captured for this replicate (test failure)
NCH- replicate not assessable because of herbicidal effect on
leaf-piece

0

99

99

66

0

0

0
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0
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Herbicide
effect
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Scores are given for numbered replicates, and average scores
for the replicates (avg); Scores are
99- any herbicide effect (Herbicide assays); >70% mortality
(Insecticide assays); complete control of pathogen in that
replicate (Fungicide assays)
55- Partial control of pathogen (Fungicide assays only)
0- no activity
NC- data not captured for this replicate (test failure)
NCH- replicate not assessable because of herbicidal effect on
leaf-piece

Arabidopsis thalania

Table C.2. (continued)
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Table C.3. Syngenta‘s fungicide standards
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Table C.3. (continued)
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Table C.4. Syngenta‘s insecticide standards
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Table C.5. Syngenta‘s herbicide standards
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Results
Herbicide: None of the compounds were active on either herbicide assay. (Table C.2)
Insecticide: 12 compounds showed activity on the insecticide screens: CSAA403019 (PDBE1), CSCD763190 (RAS-03-016) and
CSCD763191 (RAS-03-010) against the aphid species, and CSAA577296 (RAS-03-015), CSCD763190 (RAS-03-016),
CSCD763191 (RAS-03-010), CSCD763193 (RAS-03-018), CSCD763194 (RAS-03-017), CSCD763195 (RAS-02-086),
CSCD763196 (RAS-08-030), CSCD763197 (RAS-07-018C), CSCD763199 (RAS-08-028), CSCD763201 (RAS-08-029) and
CSCD763204 (RAS-03-066) against P. xylostella. (Table C.2)
Nematicide: 12 compounds were active on the nematicide assay: CSAA577296 (RAS-03-015), CSCD763190 (RAS-03-016),
CSCD763191 (RAS-03-010), CSCD763193 (RAS-03-018), CSCD763194 (RAS-03-017), CSCD763195 (RAS-02-086),
CSCD763196 (RAS-08-030), CSCD763197 (RAS-07-018C), CSCD763199 (RAS-08-028), CSCD763201 (RAS-08-029),
CSCD763204 (RAS-03-066) and CSCD763203 (RAS-05-006). (Table C.2)
Fungicide: The following compounds showed weak/moderate activity against Septoria tritici: CSCD763192 (RAS-06-074),
CSCD763193 (RAS-03-018) and CSCD763204 (RAS-03-066). CSAA403019 (PDBE1), has shown activity at 20ppm against
Alternaria solani. (Table C.1)
Positive control- The results for positive controls were variable but within acceptable limits. (Table C.3–C.5)

Conclusion
13 compounds showed activity on the nematicide and/or insecticide assays, and 4 had weak activity on fungicide assays. None
were active on the herbicide assays.

Syngenta’s Recommendations
The compounds active on fungicide and insecticide assays should be progressed to the fungicide and insecticide second-tier
assays respectively, and the results of these tests communicated once screening is complete.
For the following compounds, further fungicide testing should be carried out using the sample remaining at Jealott‘s Hill.
CSAA403019 (PDBE1), CSCD763192 (RAS-06-074), CSCD763193 (RAS-03-018), CSCD763204 (RAS-03-066).
For the following compounds, further insecticide testing should be carried out using the sample remaining at Jealott‘s Hill.
CSAA403019 (PDBE1), CSAA577296 (RAS-03-015), CSCD763190 (RAS-03-016), CSCD763191 (RAS-03-010),
CSCD763193 (RAS-03-018), CSCD763194 (RAS-03-017), CSCD763195 (RAS-02-086), CSCD763196 (RAS-08-030),
CSCD763197 (RAS-07-018C), CSCD763199 (RAS-08-028), CSCD763201 (RAS-08-029), CSCD763204 (RAS-03-066).
In addition to these tests, further evaluation in mini pouch experiments to evaluate nematode control are recommended in the first
instance.
CSAA577296 (RAS-03-015), CSCD763190 (RAS-03-016), CSCD763191 (RAS-03-010), CSCD763193 (RAS-03-018),
CSCD763194 (RAS-03-017), CSCD763195 (RAS-02-086), CSCD763196 (RAS-08-030), CSCD763197 (RAS-07-018C),
CSCD763199 (RAS-08-028), CSCD763201 (RAS-08-029), CSCD763204 (RAS-03-066), CSCD763203 (RAS-05-006),
For the following compounds, additional sample is required to complete these assays (5mg minimum).
CSCD763196 (RAS-08-030) and CSCD763201 (RAS-08-029)
Depending on the outcome of these experiments, compounds may be recommended for further tested on cell and enzyme based
assays to detect known modes of action, or in further nematode assays (e.g. soil based test systems). This testing will be
dependent on sufficient sample being available, and on approval from University of Mississippi.
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